data_5x37_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x37 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.41 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.225 0 CA-C-O 121.199 0.523 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -76.35 163.77 26.67 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.633 1.173 . . . . 0.0 114.157 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -65.02 129.18 38.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 74.93 17.94 2.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.502 1.121 . . . . 0.0 113.43 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.37 165.55 12.15 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.47 116.98 20.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.231 0.515 . . . . 0.0 110.315 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.9 p -81.53 -51.65 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.849 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.51 96.19 0.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 119.39 -1.386 . . . . 0.0 112.759 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.5 -176.85 20.77 Favored Glycine 0 C--N 1.291 -1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.1 mt -61.1 115.32 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 117.181 0.491 . . . . 0.0 109.718 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 -13.93 56.36 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.379 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -89.98 114.23 26.03 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.3 m -108.97 121.75 45.8 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.94 -157.15 28.89 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.36 102.92 1.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.68 2.254 . . . . 0.0 110.748 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -87.68 -10.52 51.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.441 0.638 . . . . 0.0 111.653 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -82.42 123.73 38.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.5 m -85.46 167.74 15.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 122.618 0.367 . . . . 0.0 110.357 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.45 155.63 39.51 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.246 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.69 119.89 4.66 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.462 0.705 . . . . 0.0 112.16 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.17 -13.11 57.31 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.768 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -110.09 137.86 47.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.296 0.548 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.9 p -108.92 136.68 48.06 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -76.07 97.79 4.16 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -102.87 125.73 49.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.006 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.1 t -78.81 104.94 7.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 mt -87.45 -44.29 11.43 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.579 0.704 . . . . 0.0 109.67 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -127.83 167.27 19.0 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.68 -38.1 76.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.644 2.229 . . . . 0.0 113.197 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.41 -25.23 10.63 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.788 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -92.52 115.3 27.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.431 0.634 . . . . 0.0 111.714 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -124.0 136.07 54.05 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.408 ' OE1' HD23 ' A' ' 36' ' ' LEU . 35.4 tt0 -129.04 142.39 50.92 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 117.926 0.33 . . . . 0.0 111.458 -171.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -80.17 108.33 13.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.408 HD23 ' OE1' ' A' ' 34' ' ' GLN . 92.7 mt . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 123.596 0.758 . . . . 0.0 109.365 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 121.351 0.596 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 m -61.32 155.83 20.34 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.069 1.747 . . . . 0.0 114.876 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.433 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.1 t-160 -68.23 132.71 47.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 74.32 7.3 4.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.06 0.944 . . . . 0.0 112.861 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.42 160.78 23.82 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.622 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -72.75 113.5 9.85 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.821 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 p -88.05 -38.72 15.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.22 75.08 0.05 OUTLIER Glycine 0 CA--C 1.476 -2.391 0 C-N-CA 117.177 -2.44 . . . . 0.0 113.79 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 171.93 15.2 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.36 122.87 10.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.15 -26.47 12.21 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.782 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -102.14 148.27 25.61 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 p -158.81 156.18 29.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.686 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.22 -121.95 4.77 Favored Glycine 0 C--N 1.308 -1.018 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.43 100.69 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 121.964 1.776 . . . . 0.0 109.841 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.7 p -99.21 -20.39 16.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.796 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -87.11 124.73 40.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.834 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.0 m -79.02 167.29 21.3 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.541 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 148.64 51.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -54.23 123.24 12.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.032 0.444 . . . . 0.0 110.707 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -14.58 31.01 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.3 p -117.0 142.25 47.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 31.5 p -115.72 141.29 48.28 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.134 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.53 102.46 9.75 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -105.16 119.56 39.34 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.535 0.683 . . . . 0.0 110.92 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.85 106.98 6.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.089 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 mt -91.37 -44.2 9.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -128.0 166.23 25.19 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -57.12 -33.87 96.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.661 1.574 . . . . 0.0 111.911 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 9.7 m-85 -102.23 -27.63 12.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.92 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.551 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 25.9 t80 -94.65 114.92 26.92 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.119 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -133.66 130.51 38.33 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.551 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.2 tt0 -126.86 140.18 52.54 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 123.032 0.207 . . . . 0.0 110.986 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.821 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.1 m -76.2 111.29 11.47 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.287 -2.121 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.539 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -81.61 165.35 21.16 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.811 0.844 . . . . 0.0 112.863 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.3 136.02 44.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 73.11 21.21 3.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.525 0.73 . . . . 0.0 112.41 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.66 151.6 18.34 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.08 121.08 15.96 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -87.1 -42.36 13.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.97 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 168.97 98.18 0.12 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.592 -1.765 . . . . 0.0 113.531 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.88 -179.72 20.83 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 174.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.97 116.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 117.655 0.728 . . . . 0.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.43 -18.19 48.8 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.44 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 64.2 t80 -80.97 136.08 35.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.762 0.281 . . . . 0.0 111.417 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -124.66 113.82 18.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.63 -161.56 30.47 Favored Glycine 0 C--N 1.306 -1.105 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.2 114.87 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.89 2.393 . . . . 0.0 110.459 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p -90.04 -23.68 21.39 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.17 120.6 36.74 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.83 164.41 19.51 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.174 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 141.31 57.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.7 120.67 7.08 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.418 0.448 . . . . 0.0 109.824 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.51 -10.46 28.29 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.8 p -121.7 140.49 52.24 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -113.87 135.3 54.12 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.875 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.91 98.05 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.54 145.06 30.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.286 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.2 t -87.98 111.73 22.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' C ' HD21 ' A' ' 29' ' ' ASN . 6.7 mp -88.26 -43.59 11.46 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.392 0.615 . . . . 0.0 109.687 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.496 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -138.82 169.55 12.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.57 -29.17 89.24 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.245 1.48 . . . . 0.0 111.622 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.494 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.4 m-85 -102.53 -25.57 13.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.23 114.18 26.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.5 m -138.04 129.37 27.66 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -137.01 147.31 46.17 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.385 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.4 m -76.39 107.77 8.88 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.431 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.28 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.105 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -72.31 160.91 31.6 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -68.68 131.85 45.88 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 71.73 17.52 5.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.029 0.932 . . . . 0.0 112.403 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.04 164.68 12.3 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.7 tt0 -82.14 110.22 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 122.586 0.354 . . . . 0.0 110.241 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -73.32 -41.87 63.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.97 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.95 96.97 0.13 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.947 -1.597 . . . . 0.0 113.833 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.63 -152.58 13.09 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.413 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.5 mt -70.54 125.97 29.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.7 -21.18 37.23 Favored Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.616 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.15 121.08 30.39 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.421 -0.458 . . . . 0.0 109.842 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -141.22 111.99 7.1 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.1 -116.95 0.39 Allowed Glycine 0 C--N 1.304 -1.222 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 2.6 Cg_endo -77.65 90.16 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 CA-C-N 119.587 1.694 . . . . 0.0 108.631 173.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -82.83 -20.68 35.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.344 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.4 t -84.76 128.28 39.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -82.16 163.46 21.94 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.388 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.3 152.49 43.65 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.316 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -53.56 122.78 10.47 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.973 0.909 . . . . 0.0 111.349 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -19.92 25.59 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.734 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 p -118.77 147.94 43.35 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.481 -0.423 . . . . 0.0 111.686 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 20.5 p -115.81 146.44 41.96 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.012 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -81.24 99.54 8.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.8 127.48 49.95 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.069 0.461 . . . . 0.0 110.366 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.71 106.64 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.91 -52.99 4.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.13 163.36 30.38 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.86 -41.58 62.25 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.688 2.259 . . . . 0.0 113.458 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.413 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 45.5 m-85 -99.15 -26.59 14.15 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.012 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 26.1 t80 -94.05 114.6 26.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -120.35 133.19 55.49 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -129.26 144.27 51.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 117.785 0.266 . . . . 0.0 110.956 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.0 m -79.41 110.65 14.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.061 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -94.11 176.49 6.31 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.09 129.03 39.76 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.778 0.831 . . . . 0.0 110.087 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.26 13.3 m-85 71.58 59.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -157.42 155.11 26.12 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.6 tt0 -72.87 115.1 11.76 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 117.541 0.67 . . . . 0.0 109.648 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.2 p -90.74 -36.42 14.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.889 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.56 88.43 0.07 OUTLIER Glycine 0 CA--C 1.488 -1.655 0 C-N-CA 118.835 -1.65 . . . . 0.0 112.662 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.64 178.96 20.06 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 175.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 59.4 mt -64.2 116.71 3.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.68 -10.22 55.88 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.416 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -84.88 144.17 28.56 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.7 m -138.73 99.12 3.72 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.97 -142.38 4.62 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.945 -1.122 . . . . 0.0 112.467 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 106.91 1.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.332 2.688 . . . . 0.0 111.302 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.3 p -88.9 -9.58 51.04 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.781 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -89.32 121.88 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.41 154.8 19.77 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.31 148.18 19.31 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.912 0.758 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -57.84 119.84 7.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.518 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.83 27.86 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.84 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -116.33 140.23 49.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -114.45 141.78 47.24 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.204 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.28 97.61 7.06 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -103.47 135.52 44.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.52 99.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -46.16 19.7 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.74 164.24 39.79 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.52 -35.25 65.79 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.642 2.228 . . . . 0.0 113.503 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.635 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 80.5 m-85 -110.21 -24.98 10.4 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.163 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 57.1 t80 -93.38 114.68 27.16 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.1 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -116.38 138.43 51.35 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.0 tt0 -131.39 143.36 50.41 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 117.977 0.353 . . . . 0.0 110.873 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.4 m -77.6 105.98 9.1 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.412 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -82.95 160.26 22.09 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -65.44 133.14 50.67 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.103 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 77.18 7.34 3.0 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.581 1.153 . . . . 0.0 112.355 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 161.14 18.34 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.483 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -74.7 120.0 19.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.195 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.7 p -82.91 -52.82 6.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.468 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.94 85.68 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.0 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.23 179.35 20.4 Favored Glycine 0 C--N 1.293 -1.825 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.457 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.9 mt -62.42 112.9 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 117.668 0.734 . . . . 0.0 109.508 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.51 -17.1 26.2 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.378 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -94.07 138.81 31.73 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.653 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -136.34 136.01 39.34 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.5 -142.13 11.02 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.66 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.91 101.74 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.734 2.289 . . . . 0.0 111.757 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 p -90.93 -0.57 57.77 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.24 0.543 . . . . 0.0 112.315 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.48 113.41 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.0 m -77.36 167.41 21.73 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.678 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.28 154.12 24.58 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.968 0.507 . . . . 0.0 110.844 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -57.6 112.43 1.44 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.312 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.88 -9.71 29.69 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -113.86 139.31 49.28 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.477 -0.425 . . . . 0.0 109.855 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.8 p -113.1 145.13 41.44 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.49 100.83 7.89 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -105.49 131.97 52.24 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.48 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.92 100.25 7.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.02 -58.15 3.29 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.856 0.836 . . . . 0.0 108.818 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.18 165.75 13.0 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -38.28 94.83 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.184 1.922 . . . . 0.0 112.621 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.8 m-85 -104.45 -26.11 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.0 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -93.35 114.89 27.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.93 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.69 131.05 53.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -125.73 145.1 50.33 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.604 0.184 . . . . 0.0 110.989 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -79.55 104.45 10.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--N 1.293 -1.871 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.425 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.969 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -78.94 171.64 14.91 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -65.38 132.9 50.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.65 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 76.95 7.43 3.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.975 1.31 . . . . 0.0 113.747 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.425 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -96.16 171.03 27.93 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.7 tt0 -85.35 120.17 26.53 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.6 p -81.09 -50.7 9.32 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.262 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.94 87.48 0.07 OUTLIER Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.267 -1.444 . . . . 0.0 111.877 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 -176.28 20.83 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 174.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.2 mt -64.6 125.87 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 117.52 0.66 . . . . 0.0 109.26 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.69 60.03 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.307 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -107.65 142.61 37.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -145.31 139.98 27.43 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.81 -134.49 4.75 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.951 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.01 97.12 0.98 Allowed 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.324 2.016 . . . . 0.0 110.885 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 38.9 p -82.05 -19.11 40.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.295 0.569 . . . . 0.0 111.459 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -82.14 122.15 36.46 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -85.53 163.68 18.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.352 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 150.6 39.91 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 p -57.32 122.82 13.44 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.666 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.82 26.86 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.373 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -110.46 143.17 41.17 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -116.63 141.21 48.49 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 121.994 0.117 . . . . 0.0 111.164 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.61 104.84 5.44 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -110.51 127.75 55.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.255 0.55 . . . . 0.0 110.916 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -81.29 109.1 15.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.55 -48.46 7.29 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -122.77 164.63 25.68 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.27 -36.22 77.26 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.296 1.998 . . . . 0.0 113.087 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -102.98 -25.73 13.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.553 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 39.2 t80 -94.36 114.74 26.84 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -124.87 129.03 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.6 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.6 tt0 -127.38 142.9 51.31 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.637 0.256 . . . . 0.0 111.57 -173.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -78.49 107.41 11.12 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.297 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -74.06 162.33 29.12 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -64.03 135.54 56.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.133 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 71.54 17.78 5.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.792 0.837 . . . . 0.0 112.522 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -110.5 165.41 12.25 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.187 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.9 tt0 -76.42 111.94 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.4 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.0 p -89.98 -30.78 17.56 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.73 75.8 0.05 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 118.882 -1.628 . . . . 0.0 112.534 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.49 179.45 29.33 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.91 113.46 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 117.585 0.692 . . . . 0.0 110.028 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.66 -17.31 36.35 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.018 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -86.5 137.74 32.29 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -140.96 130.22 23.59 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.54 -126.97 3.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.521 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.14 98.59 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.84 2.36 . . . . 0.0 112.254 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.9 p -96.68 -17.31 20.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.314 0.578 . . . . 0.0 111.792 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.41 121.57 37.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -84.3 167.43 16.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 167.62 11.84 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 122.966 0.506 . . . . 0.0 111.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -54.8 113.55 1.37 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.057 0.943 . . . . 0.0 111.881 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -0.59 60.38 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.975 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.9 p -112.94 141.61 46.57 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.136 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.2 p -114.47 142.46 46.36 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.327 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.74 111.66 18.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -122.94 139.55 53.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.66 120.34 21.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -97.51 -44.57 6.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -134.71 166.8 26.49 Favored Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.46 -43.5 22.08 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.95 2.434 . . . . 0.0 114.034 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.627 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 77.8 m-85 -101.91 -24.97 13.95 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.293 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 46.1 t80 -93.8 114.45 26.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.909 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.2 m -113.72 136.17 53.14 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.97 142.71 50.84 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 117.93 0.332 . . . . 0.0 111.298 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.7 m -77.83 117.91 19.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 124.213 1.005 . . . . 0.0 108.627 178.819 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 161.5 27.54 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.478 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 23.3 t-160 -66.14 134.82 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.51 5.98 2.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.555 1.542 . . . . 0.0 112.532 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.06 163.95 27.05 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.3 tt0 -79.99 116.69 20.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -80.92 -43.73 19.34 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.806 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.501 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 163.36 97.18 0.12 Allowed Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.11 -170.53 19.95 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.9 121.6 12.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.39 -9.85 59.35 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.167 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.501 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 23.5 t80 -98.81 136.52 38.72 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -141.05 106.09 4.97 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.61 -149.4 8.63 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.419 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.16 104.24 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.975 2.45 . . . . 0.0 111.557 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 p -85.33 -15.38 43.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.338 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.8 109.85 2.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.494 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -83.42 164.51 19.88 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.714 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.04 154.04 27.93 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.425 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 m -60.28 118.78 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.12 0.486 . . . . 0.0 110.567 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.68 -9.8 55.66 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.08 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -110.16 136.66 49.04 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.8 p -116.2 134.61 54.73 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.728 0.299 . . . . 0.0 111.685 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -67.37 112.17 4.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -122.5 135.36 54.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.111 0.481 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.1 102.86 4.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.359 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.28 -44.93 14.39 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -129.31 164.3 40.42 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.92 -40.14 86.31 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 121.559 1.506 . . . . 0.0 112.026 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -97.72 -27.83 14.17 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 118.894 -1.123 . . . . 0.0 111.089 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.17 114.12 25.88 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.313 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.1 m -120.42 133.59 55.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -125.59 143.04 51.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 120.437 0.16 . . . . 0.0 111.284 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -78.62 108.02 11.72 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.6 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.412 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -87.45 169.82 11.89 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -60.0 130.87 48.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.191 1.396 . . . . 0.0 109.848 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 78.76 7.2 2.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.807 1.243 . . . . 0.0 112.988 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -98.75 158.41 20.26 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.0 tt0 -76.54 113.19 13.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.9 p -82.48 -21.35 35.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.03 87.17 0.18 Allowed Glycine 0 CA--C 1.479 -2.189 0 C-N-CA 118.148 -1.977 . . . . 0.0 113.925 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.14 -165.66 25.76 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.89 118.35 7.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 118.076 0.938 . . . . 0.0 109.04 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.44 -26.91 11.23 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.609 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -106.24 115.49 30.31 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -125.77 162.54 24.86 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.31 -117.68 4.18 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.901 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.32 97.85 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.673 2.248 . . . . 0.0 110.964 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.3 p -111.94 -18.85 12.56 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.685 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -80.55 114.01 20.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.516 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.03 165.11 19.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.07 154.7 41.62 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.344 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -62.71 120.18 10.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -6.34 30.67 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.3 p -123.15 148.44 45.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 p -121.94 137.3 54.84 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.144 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -70.18 103.52 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -109.8 130.23 55.54 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.954 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.29 110.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.676 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.65 -29.18 13.19 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 43.1 m-80 -145.53 165.63 20.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -55.81 -38.78 94.02 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.687 1.591 . . . . 0.0 112.424 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -100.12 -26.86 13.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.289 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 52.2 t80 -94.47 114.01 25.95 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -132.2 132.97 43.65 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.531 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.9 tt0 -130.62 143.56 50.83 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 117.731 0.241 . . . . 0.0 111.283 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.88 104.29 7.29 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.291 -1.978 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.047 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -89.69 158.27 17.63 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 113.38 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -61.35 132.96 55.2 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.537 1.135 . . . . 0.0 109.235 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.267 8.0 m-85 74.85 8.12 4.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.9 163.58 22.41 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -78.48 110.77 13.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.735 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.3 p -82.17 -35.02 28.8 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.53 84.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 118.686 -1.721 . . . . 0.0 112.971 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.51 -174.93 20.52 Favored Glycine 0 C--N 1.294 -1.79 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -62.12 122.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 118.061 0.93 . . . . 0.0 108.55 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.36 -6.8 42.61 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.038 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -125.08 136.09 53.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.5 m -150.04 101.41 3.02 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.549 1.14 . . . . 0.0 108.672 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.42 -134.73 1.78 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.19 99.32 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.775 2.317 . . . . 0.0 111.193 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.3 p -91.79 -17.17 25.75 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.16 109.98 10.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.702 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.0 m -85.12 159.02 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.917 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.91 152.44 10.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.471 0.708 . . . . 0.0 111.61 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -59.65 113.35 2.19 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.832 0.825 . . . . 0.0 111.774 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -11.55 29.33 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.282 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -112.56 136.87 51.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -116.06 137.62 51.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.586 0.231 . . . . 0.0 111.142 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.81 106.11 4.04 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.62 126.4 55.23 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.37 102.86 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.41 -44.98 15.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -132.9 166.03 32.25 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.45 -42.74 63.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.219 1.946 . . . . 0.0 113.593 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -97.88 -26.46 14.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.761 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.615 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 37.4 t80 -94.55 114.18 26.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.5 m -120.73 138.02 54.2 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.615 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.6 tt0 -133.61 142.03 47.92 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 123.037 0.21 . . . . 0.0 111.284 -173.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.92 105.21 7.85 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.781 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -92.45 173.97 7.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.65 0.738 . . . . 0.0 112.167 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -72.31 135.56 45.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.065 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.83 59.07 0.37 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.332 1.053 . . . . 0.0 112.366 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.0 153.63 24.89 Favored Glycine 0 C--O 1.254 1.394 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -68.05 116.12 8.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.179 0.489 . . . . 0.0 110.608 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.677 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.9 p -82.85 -46.01 13.57 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.677 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.89 107.55 0.24 Allowed Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.371 -1.395 . . . . 0.0 113.45 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.27 -160.5 17.86 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.482 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 74.2 mt -66.39 122.79 18.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 117.706 0.753 . . . . 0.0 109.167 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.34 63.53 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.559 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -116.17 139.24 50.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.779 0.79 . . . . 0.0 110.348 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -138.87 145.98 40.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.81 -137.31 5.9 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.7 91.56 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.678 2.252 . . . . 0.0 110.876 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -93.94 -5.43 47.82 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.252 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.33 113.78 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.2 m -80.62 162.96 23.98 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 152.09 42.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 111.09 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 m -60.75 116.74 4.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.394 0.616 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -15.05 29.4 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.6 p -109.64 146.55 34.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.2 p -118.2 135.32 54.32 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.966 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 51.0 t -74.01 98.13 3.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -99.62 130.05 45.82 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.03 94.29 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.2 -46.65 22.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.976 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -126.98 168.64 14.09 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.46 -34.31 93.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.421 1.414 . . . . 0.0 112.216 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.482 ' HD2' ' O ' ' A' ' 11' ' ' ILE . 23.2 m-85 -106.76 -26.39 11.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.139 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -93.0 114.69 27.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.463 0.649 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.8 m -129.53 134.9 48.01 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.29 141.7 47.04 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.693 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 34.5 m -73.36 105.53 4.79 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.479 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 m -66.29 159.8 25.85 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.619 1.168 . . . . 0.0 113.818 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -67.79 123.23 19.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 77.94 58.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.92 0.888 . . . . 0.0 112.552 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 34' ' ' GLN . . . -156.09 160.87 30.4 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.535 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 64.3 tt0 -78.61 116.21 18.83 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.802 0.801 . . . . 0.0 110.215 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.724 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.0 p -86.75 -44.35 11.85 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.45 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.88 84.49 0.06 OUTLIER Glycine 0 CA--C 1.481 -2.072 0 C-N-CA 119.278 -1.439 . . . . 0.0 112.01 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.95 -172.67 20.42 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 63.6 mt -66.85 113.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 117.307 0.553 . . . . 0.0 109.663 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -9.18 32.48 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.656 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -102.83 135.08 45.16 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.555 -0.379 . . . . 0.0 110.116 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -139.11 116.13 10.95 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.51 -147.21 10.76 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.98 95.49 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.115 2.543 . . . . 0.0 111.628 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.1 p -80.57 -26.61 37.82 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.244 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.4 117.8 20.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 110.052 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.0 m -81.04 167.53 19.66 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.2 40.46 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 117.7 4.51 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.965 0.506 . . . . 0.0 109.749 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.71 -0.29 34.28 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.673 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -128.77 142.87 50.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -116.12 136.52 52.94 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.875 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 48.1 t -76.84 103.21 6.66 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -119.75 142.86 48.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.921 0.391 . . . . 0.0 111.444 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 114.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.77 -43.89 8.4 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -134.76 165.6 35.5 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.54 -38.85 45.44 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 122.721 2.281 . . . . 0.0 114.513 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.44 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.8 m-85 -106.63 -24.86 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.32 0.581 . . . . 0.0 110.812 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' A' ' 7' ' ' GLN . 36.0 t80 -93.3 113.87 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.452 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -112.56 135.81 52.84 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 6' ' ' GLY . 28.4 tt0 -132.06 144.91 51.08 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.724 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.3 m -72.43 108.54 5.58 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.137 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.108 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -61.21 154.49 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.406 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.4 t-160 -63.94 132.83 51.9 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 71.06 11.8 6.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.66 166.88 19.63 Favored Glycine 0 C--O 1.251 1.194 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -76.85 109.14 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.764 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -83.7 -33.51 25.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.38 93.25 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 117.971 -2.061 . . . . 0.0 113.217 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.98 -169.88 19.19 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.03 119.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.39 -16.33 45.19 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.708 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -105.49 121.62 44.31 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -135.3 123.48 22.99 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.81 -126.08 1.66 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.312 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.36 96.28 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.545 2.163 . . . . 0.0 111.418 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.2 p -100.74 -10.48 20.78 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.6 t -90.25 114.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 80.3 m -75.34 159.69 31.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.788 -178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.96 170.19 3.71 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.194 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.0 t -61.62 120.3 10.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.976 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.62 -9.28 58.7 Favored Glycine 0 N--CA 1.423 -2.191 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.294 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -114.68 145.66 41.78 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.916 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 p -116.85 134.57 54.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 54.1 t -73.94 105.4 5.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.73 141.05 48.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.231 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.93 112.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.865 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -96.93 -34.64 11.15 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -143.13 166.23 21.46 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.98 -43.3 58.0 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.16 1.907 . . . . 0.0 112.977 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.5 m-85 -97.33 -26.18 14.98 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.245 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.65 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 33.0 t80 -93.74 114.18 26.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.686 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -122.3 137.26 54.91 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.65 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 30.0 tt0 -131.73 141.14 49.45 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 123.097 0.248 . . . . 0.0 111.155 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.5 m -77.26 108.32 10.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.991 176.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.615 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 121.092 0.472 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -63.35 165.56 7.49 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 125.496 1.518 . . . . 0.0 113.589 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.47 139.42 51.71 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 72.18 23.13 3.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.776 0.798 . . . . 0.0 112.124 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.76 148.15 17.27 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -70.49 109.71 4.97 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.1 p -71.25 -47.28 58.07 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.17 88.16 0.07 OUTLIER Glycine 0 N--CA 1.417 -2.602 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.284 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.75 177.58 19.41 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 64.8 mt -66.14 118.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -11.92 30.47 Favored Glycine 0 C--N 1.306 -1.119 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.838 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -96.01 132.92 40.84 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -134.78 95.74 3.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.8 8.94 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.983 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.52 107.87 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.271 2.648 . . . . 0.0 112.318 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 43.0 p -87.17 -13.93 42.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.261 0.553 . . . . 0.0 111.227 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.79 116.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -85.51 153.35 22.51 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.044 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.2 149.01 5.71 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.661 1.184 . . . . 0.0 111.934 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -54.56 112.29 0.98 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.431 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.22 -1.21 29.72 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.2 p -129.35 143.95 51.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -120.74 148.73 43.57 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.742 0.306 . . . . 0.0 111.718 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -74.26 118.8 17.64 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.12 126.96 49.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.285 0.564 . . . . 0.0 110.558 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -79.46 103.42 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.097 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.75 -48.6 8.11 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -129.23 171.37 8.88 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.12 -43.91 43.75 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 121.671 1.581 . . . . 0.0 112.319 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.1 m-85 -98.93 -25.81 14.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.247 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.607 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 26.6 t80 -93.35 114.66 27.14 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.491 0.662 . . . . 0.0 111.773 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.9 m -135.81 127.68 29.39 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.607 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 34.2 tt0 -129.84 148.4 51.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.07 0.396 . . . . 0.0 111.99 -172.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 41.6 m -76.57 112.64 13.32 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.076 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 8' ' ' CYS . 7.0 tt0 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 120.999 0.428 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.461 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 9.8 m -64.77 165.4 10.57 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.142 1.777 . . . . 0.0 112.985 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -80.94 134.8 35.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 71.98 59.44 0.15 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.162 0.982 . . . . 0.0 112.324 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.09 156.4 26.7 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.9 tt0 -76.38 110.58 11.02 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 117.321 0.561 . . . . 0.0 109.645 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.753 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -70.39 -49.34 50.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.759 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.73 87.87 0.07 OUTLIER Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.96 172.4 15.75 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.05 113.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -11.13 37.55 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.741 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -104.25 132.92 49.98 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -127.57 129.28 47.05 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.95 -153.38 23.74 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.565 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.44 99.36 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.17 2.58 . . . . 0.0 111.688 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -81.94 -21.8 37.05 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.626 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -87.29 122.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -90.09 165.23 14.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 158.41 7.75 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 123.353 0.661 . . . . 0.0 111.331 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -59.51 118.28 5.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 -20.29 25.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.6 p -109.96 141.58 42.53 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 28.1 p -124.55 147.24 48.55 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.0 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.52 109.32 8.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -118.02 132.13 56.41 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.02 109.39 11.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.07 -43.63 8.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.557 0.694 . . . . 0.0 109.893 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -130.31 166.0 29.95 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.18 -42.25 47.28 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.714 2.276 . . . . 0.0 113.542 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.7 m-85 -104.32 -25.08 13.0 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.042 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 32.1 t80 -92.57 115.32 28.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.591 -0.843 . . . . 0.0 112.718 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.86 131.12 53.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.547 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.3 tt0 -128.73 148.24 50.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 118.116 0.417 . . . . 0.0 111.977 -171.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.0 m -77.47 106.52 9.29 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.317 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.405 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.242 0.673 0 CA-C-O 121.205 0.526 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -74.79 165.78 24.68 Favored 'General case' 0 C--O 1.248 1.005 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -64.09 139.74 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.043 1.337 . . . . 0.0 107.61 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 75.61 7.76 3.83 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.295 1.038 . . . . 0.0 113.683 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.32 154.84 21.2 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.815 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.6 tt0 -70.28 107.68 3.85 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.1 p -75.97 -38.03 57.91 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -175.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.01 96.07 0.11 Allowed Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 118.39 -1.862 . . . . 0.0 112.923 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.7 -169.83 19.4 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 62.9 mt -66.22 119.1 10.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.39 -1.82 58.94 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -97.84 130.49 44.75 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 122.006 -0.702 . . . . 0.0 109.114 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -135.7 133.21 37.84 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.23 -141.07 8.17 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.25 98.94 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.392 2.061 . . . . 0.0 111.343 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.5 p -89.42 -11.95 41.66 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.48 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.15 121.79 45.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.6 m -86.29 162.68 18.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.31 143.92 56.33 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -60.31 128.19 35.49 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -14.07 28.66 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.65 144.17 49.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 p -122.25 138.65 54.42 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.522 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.5 t -70.31 107.96 3.99 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.9 mt-30 -117.96 129.17 55.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.39 119.49 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.704 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.78 -49.99 3.99 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 108.943 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -126.02 166.08 23.55 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.52 -43.0 52.99 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.553 2.169 . . . . 0.0 112.71 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.0 m-85 -101.39 -26.63 13.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.214 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.3 t80 -93.58 114.86 27.3 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.259 -0.976 . . . . 0.0 113.128 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.5 138.48 54.34 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' HD22 ' A' ' 36' ' ' LEU . 35.6 tt0 -129.18 143.15 50.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 118.861 0.755 . . . . 0.0 111.813 -172.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 55.6 m -76.08 106.52 7.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.457 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.7 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -71.33 166.95 20.55 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -66.98 130.04 41.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.797 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 75.22 13.87 3.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.549 1.14 . . . . 0.0 113.358 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.44 166.38 20.76 Favored Glycine 0 C--N 1.308 -0.997 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.8 tt0 -76.33 118.98 19.59 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 117.491 0.646 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.0 p -85.16 -37.19 20.46 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.41 68.6 0.04 OUTLIER Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 118.902 -1.618 . . . . 0.0 112.713 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -101.57 176.2 26.17 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.5 mt -60.42 117.85 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 117.372 0.586 . . . . 0.0 110.19 -178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -25.44 13.7 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.532 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.23 134.5 35.29 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 m -135.54 103.11 5.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.76 -156.4 24.87 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.867 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.28 123.18 8.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.271 2.647 . . . . 0.0 111.59 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -92.92 -5.06 51.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.861 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.6 t -74.75 116.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -84.73 165.61 17.7 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.32 162.68 14.39 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.574 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -57.03 119.63 6.64 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.242 1.017 . . . . 0.0 110.712 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.76 65.21 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.855 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -110.23 143.19 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.16 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -116.29 141.0 48.73 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.316 0.246 . . . . 0.0 111.274 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.86 108.24 9.75 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.14 140.62 49.29 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.95 113.6 25.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.74 -30.85 12.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.78 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -148.2 167.75 12.62 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.05 -43.44 48.02 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.404 2.069 . . . . 0.0 113.391 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 59.0 m-85 -99.68 -25.08 14.51 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.618 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 19.2 t80 -93.64 114.33 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.4 129.74 48.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 174.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.618 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.7 tt0 -131.11 145.4 51.98 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 -172.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.6 m -78.22 105.52 9.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.649 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.554 1.108 0 CA-C-O 120.916 0.389 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -61.96 153.79 28.31 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.544 1.938 . . . . 0.0 115.489 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.59 132.28 50.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.281 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 72.31 9.05 5.87 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.94 166.87 19.32 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.493 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -79.46 114.45 18.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.781 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -78.56 -52.56 8.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.012 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.6 78.15 0.09 OUTLIER Glycine 0 CA--C 1.47 -2.753 0 C-N-CA 119.282 -1.437 . . . . 0.0 111.18 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.41 173.79 16.71 Favored Glycine 0 N--CA 1.412 -2.939 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.86 115.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.28 37.34 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.937 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -97.11 136.58 37.45 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 109.88 11.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.27 -148.59 16.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.309 -1.424 . . . . 0.0 112.377 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.93 110.06 2.49 Favored 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.389 2.726 . . . . 0.0 111.643 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.4 p -89.17 -17.81 28.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.91 124.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -76.22 161.25 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 172.55 2.49 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -56.91 112.35 1.3 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.31 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.74 -2.95 67.44 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.525 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.0 p -110.04 146.47 35.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.788 0.794 . . . . 0.0 110.928 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 p -118.35 143.48 46.59 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.37 106.63 11.54 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -113.07 130.05 56.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.135 0.493 . . . . 0.0 110.6 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -77.88 112.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.54 -45.71 6.96 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.523 0.678 . . . . 0.0 110.178 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.1 m-20 -125.85 173.38 5.1 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -53.39 -43.53 56.63 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.377 2.052 . . . . 0.0 113.161 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.441 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.8 m-85 -105.43 -24.46 12.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.2 t80 -92.72 115.58 28.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -119.09 133.72 55.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -126.98 146.68 50.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.784 0.266 . . . . 0.0 111.316 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -82.09 108.81 15.86 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.2 0.524 . . . . 0.0 111.477 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.001 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.294 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -76.0 158.19 32.21 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.78 0.8 . . . . 0.0 112.794 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -63.71 134.82 56.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 72.19 18.67 4.69 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.08 169.36 13.07 Favored Glycine 0 C--O 1.249 1.041 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -77.56 122.03 24.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 117.401 0.6 . . . . 0.0 109.901 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.722 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -99.96 7.65 44.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 119.0 91.03 1.35 Allowed Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 118.236 -1.935 . . . . 0.0 113.146 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.9 -170.66 19.37 Favored Glycine 0 N--CA 1.422 -2.266 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 172.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.531 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 45.4 mt -62.22 123.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.66 -26.2 25.49 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.466 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 36.3 t80 -79.41 129.7 34.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -128.87 98.82 5.08 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.98 -136.78 3.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.468 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -69.57 120.8 7.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.859 2.373 . . . . 0.0 112.179 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -110.7 -17.13 13.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.939 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.89 113.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.99 167.32 22.02 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.104 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.52 162.67 7.85 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.066 0.546 . . . . 0.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -60.29 121.64 12.5 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.613 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.18 -3.92 57.01 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.939 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -119.12 142.45 47.91 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -118.02 142.77 47.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.9 t -81.63 98.13 8.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -105.89 132.85 51.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.38 115.64 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.56 -56.11 2.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.582 0.706 . . . . 0.0 109.75 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.498 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -111.18 171.98 3.9 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.88 -40.45 85.29 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 121.998 1.798 . . . . 0.0 112.744 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.9 m-85 -107.11 -23.79 12.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -91.49 114.8 27.43 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.095 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.2 m -118.02 138.47 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.53 143.72 45.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 118.922 0.783 . . . . 0.0 112.121 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.5 m -75.07 112.41 11.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.85 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.07 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.41 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -80.05 135.37 36.34 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.199 0.523 . . . . 0.0 110.43 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -76.35 163.77 26.67 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.633 1.173 . . . . 0.0 114.157 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -65.02 129.18 38.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 74.93 17.94 2.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.502 1.121 . . . . 0.0 113.43 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.37 165.55 12.15 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.47 116.98 20.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.231 0.515 . . . . 0.0 110.315 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.9 p -81.53 -51.65 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.849 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.51 96.19 0.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 119.39 -1.386 . . . . 0.0 112.759 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.5 -176.85 20.77 Favored Glycine 0 C--N 1.291 -1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.1 mt -61.1 115.32 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 117.181 0.491 . . . . 0.0 109.718 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 -13.93 56.36 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.379 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.657 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 52.4 t80 -89.98 114.23 26.03 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.3 m -108.97 121.75 45.8 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.94 -157.15 28.89 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.36 102.92 1.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.68 2.254 . . . . 0.0 110.748 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -87.68 -10.52 51.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.441 0.638 . . . . 0.0 111.653 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -82.42 123.73 38.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.5 m -85.46 167.74 15.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 122.618 0.367 . . . . 0.0 110.357 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.45 155.63 39.51 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.246 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.69 119.89 4.66 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.462 0.705 . . . . 0.0 112.16 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.17 -13.11 57.31 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.768 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -110.09 137.86 47.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.296 0.548 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.9 p -108.92 136.68 48.06 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -76.07 97.79 4.16 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -102.87 125.73 49.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.006 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.1 t -78.81 104.94 7.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 mt -87.45 -44.29 11.43 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.579 0.704 . . . . 0.0 109.67 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -127.83 167.27 19.0 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.68 -38.1 76.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.644 2.229 . . . . 0.0 113.197 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.41 -25.23 10.63 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.788 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -92.52 115.3 27.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.431 0.634 . . . . 0.0 111.714 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -124.0 136.07 54.05 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.408 ' OE1' HD23 ' A' ' 36' ' ' LEU . 35.4 tt0 -129.04 142.39 50.92 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 117.926 0.33 . . . . 0.0 111.458 -171.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -80.17 108.33 13.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.408 HD23 ' OE1' ' A' ' 34' ' ' GLN . 92.7 mt . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 123.596 0.758 . . . . 0.0 109.365 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.657 ' H5 ' ' O ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.95 134.93 35.8 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.351 0.596 . . . . 0.0 110.644 -173.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 m -61.32 155.83 20.34 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.069 1.747 . . . . 0.0 114.876 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.433 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.1 t-160 -68.23 132.71 47.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 74.32 7.3 4.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.06 0.944 . . . . 0.0 112.861 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.42 160.78 23.82 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.622 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -72.75 113.5 9.85 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.821 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 p -88.05 -38.72 15.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.22 75.08 0.05 OUTLIER Glycine 0 CA--C 1.476 -2.391 0 C-N-CA 117.177 -2.44 . . . . 0.0 113.79 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 171.93 15.2 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.36 122.87 10.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.15 -26.47 12.21 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.782 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -102.14 148.27 25.61 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 p -158.81 156.18 29.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.686 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.22 -121.95 4.77 Favored Glycine 0 C--N 1.308 -1.018 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.43 100.69 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 121.964 1.776 . . . . 0.0 109.841 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.7 p -99.21 -20.39 16.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.796 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -87.11 124.73 40.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.834 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.0 m -79.02 167.29 21.3 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.541 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 148.64 51.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -54.23 123.24 12.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.032 0.444 . . . . 0.0 110.707 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -14.58 31.01 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.3 p -117.0 142.25 47.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 31.5 p -115.72 141.29 48.28 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.134 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.53 102.46 9.75 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -105.16 119.56 39.34 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.535 0.683 . . . . 0.0 110.92 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.85 106.98 6.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.089 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 mt -91.37 -44.2 9.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -128.0 166.23 25.19 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -57.12 -33.87 96.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.661 1.574 . . . . 0.0 111.911 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 9.7 m-85 -102.23 -27.63 12.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.92 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.551 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 25.9 t80 -94.65 114.92 26.92 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.119 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -133.66 130.51 38.33 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.551 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.2 tt0 -126.86 140.18 52.54 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 123.032 0.207 . . . . 0.0 110.986 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.821 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.1 m -76.2 111.29 11.47 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.287 -2.121 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.539 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.87 145.61 30.28 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -81.61 165.35 21.16 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.811 0.844 . . . . 0.0 112.863 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.3 136.02 44.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 73.11 21.21 3.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.525 0.73 . . . . 0.0 112.41 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.66 151.6 18.34 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.08 121.08 15.96 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.699 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -87.1 -42.36 13.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.97 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 168.97 98.18 0.12 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.592 -1.765 . . . . 0.0 113.531 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.88 -179.72 20.83 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 174.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.97 116.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 117.655 0.728 . . . . 0.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.43 -18.19 48.8 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.44 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 64.2 t80 -80.97 136.08 35.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.762 0.281 . . . . 0.0 111.417 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -124.66 113.82 18.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.63 -161.56 30.47 Favored Glycine 0 C--N 1.306 -1.105 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.2 114.87 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.89 2.393 . . . . 0.0 110.459 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p -90.04 -23.68 21.39 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.17 120.6 36.74 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.83 164.41 19.51 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.174 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 141.31 57.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.7 120.67 7.08 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.418 0.448 . . . . 0.0 109.824 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.51 -10.46 28.29 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.8 p -121.7 140.49 52.24 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -113.87 135.3 54.12 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.875 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.91 98.05 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.54 145.06 30.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.286 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.2 t -87.98 111.73 22.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' C ' HD21 ' A' ' 29' ' ' ASN . 6.7 mp -88.26 -43.59 11.46 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.392 0.615 . . . . 0.0 109.687 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.496 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -138.82 169.55 12.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.57 -29.17 89.24 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.245 1.48 . . . . 0.0 111.622 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.494 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.4 m-85 -102.53 -25.57 13.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.23 114.18 26.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.5 m -138.04 129.37 27.66 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -137.01 147.31 46.17 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.385 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.4 m -76.39 107.77 8.88 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.431 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -87.31 145.03 26.51 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.105 -176.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -72.31 160.91 31.6 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -68.68 131.85 45.88 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 71.73 17.52 5.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.029 0.932 . . . . 0.0 112.403 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.04 164.68 12.3 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.7 tt0 -82.14 110.22 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 122.586 0.354 . . . . 0.0 110.241 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -73.32 -41.87 63.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.97 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.95 96.97 0.13 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.947 -1.597 . . . . 0.0 113.833 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.63 -152.58 13.09 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.413 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.5 mt -70.54 125.97 29.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.7 -21.18 37.23 Favored Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.616 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.15 121.08 30.39 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.421 -0.458 . . . . 0.0 109.842 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -141.22 111.99 7.1 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.1 -116.95 0.39 Allowed Glycine 0 C--N 1.304 -1.222 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 2.6 Cg_endo -77.65 90.16 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 CA-C-N 119.587 1.694 . . . . 0.0 108.631 173.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -82.83 -20.68 35.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.344 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.4 t -84.76 128.28 39.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -82.16 163.46 21.94 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.388 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.3 152.49 43.65 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.316 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -53.56 122.78 10.47 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.973 0.909 . . . . 0.0 111.349 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -19.92 25.59 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.734 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 p -118.77 147.94 43.35 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.481 -0.423 . . . . 0.0 111.686 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 20.5 p -115.81 146.44 41.96 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.012 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -81.24 99.54 8.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.8 127.48 49.95 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.069 0.461 . . . . 0.0 110.366 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.71 106.64 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.91 -52.99 4.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.13 163.36 30.38 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.86 -41.58 62.25 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.688 2.259 . . . . 0.0 113.458 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.413 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 45.5 m-85 -99.15 -26.59 14.15 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.012 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 26.1 t80 -94.05 114.6 26.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -120.35 133.19 55.49 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -129.26 144.27 51.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 117.785 0.266 . . . . 0.0 110.956 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.0 m -79.41 110.65 14.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.061 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.93 33.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -94.11 176.49 6.31 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.09 129.03 39.76 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.778 0.831 . . . . 0.0 110.087 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.26 13.3 m-85 71.58 59.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -157.42 155.11 26.12 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.6 tt0 -72.87 115.1 11.76 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 117.541 0.67 . . . . 0.0 109.648 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.2 p -90.74 -36.42 14.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.889 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.56 88.43 0.07 OUTLIER Glycine 0 CA--C 1.488 -1.655 0 C-N-CA 118.835 -1.65 . . . . 0.0 112.662 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.64 178.96 20.06 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 175.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 59.4 mt -64.2 116.71 3.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.68 -10.22 55.88 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.416 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -84.88 144.17 28.56 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.7 m -138.73 99.12 3.72 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.97 -142.38 4.62 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.945 -1.122 . . . . 0.0 112.467 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 106.91 1.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.332 2.688 . . . . 0.0 111.302 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.3 p -88.9 -9.58 51.04 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.781 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -89.32 121.88 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.41 154.8 19.77 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.31 148.18 19.31 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.912 0.758 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -57.84 119.84 7.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.518 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.83 27.86 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.84 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -116.33 140.23 49.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -114.45 141.78 47.24 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.204 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.28 97.61 7.06 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -103.47 135.52 44.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.52 99.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -46.16 19.7 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.74 164.24 39.79 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.52 -35.25 65.79 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.642 2.228 . . . . 0.0 113.503 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.635 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 80.5 m-85 -110.21 -24.98 10.4 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.163 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 57.1 t80 -93.38 114.68 27.16 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.1 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -116.38 138.43 51.35 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.0 tt0 -131.39 143.36 50.41 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 117.977 0.353 . . . . 0.0 110.873 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.4 m -77.6 105.98 9.1 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.412 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 144.35 42.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -82.95 160.26 22.09 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -65.44 133.14 50.67 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.103 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 77.18 7.34 3.0 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.581 1.153 . . . . 0.0 112.355 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 161.14 18.34 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.483 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -74.7 120.0 19.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.195 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.7 p -82.91 -52.82 6.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.468 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.94 85.68 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.0 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.23 179.35 20.4 Favored Glycine 0 C--N 1.293 -1.825 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.457 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.9 mt -62.42 112.9 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 117.668 0.734 . . . . 0.0 109.508 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.51 -17.1 26.2 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.378 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -94.07 138.81 31.73 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.653 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -136.34 136.01 39.34 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.5 -142.13 11.02 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.66 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.91 101.74 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.734 2.289 . . . . 0.0 111.757 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 p -90.93 -0.57 57.77 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.24 0.543 . . . . 0.0 112.315 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.48 113.41 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.0 m -77.36 167.41 21.73 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.678 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.28 154.12 24.58 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.968 0.507 . . . . 0.0 110.844 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -57.6 112.43 1.44 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.312 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.88 -9.71 29.69 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -113.86 139.31 49.28 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.477 -0.425 . . . . 0.0 109.855 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.8 p -113.1 145.13 41.44 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.49 100.83 7.89 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -105.49 131.97 52.24 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.48 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.92 100.25 7.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.02 -58.15 3.29 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.856 0.836 . . . . 0.0 108.818 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.18 165.75 13.0 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -38.28 94.83 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.184 1.922 . . . . 0.0 112.621 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.8 m-85 -104.45 -26.11 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.0 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -93.35 114.89 27.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.93 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.69 131.05 53.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -125.73 145.1 50.33 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.604 0.184 . . . . 0.0 110.989 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -79.55 104.45 10.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--N 1.293 -1.871 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.443 -0.817 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.425 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -90.15 134.16 34.44 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -78.94 171.64 14.91 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -65.38 132.9 50.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.65 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 76.95 7.43 3.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.975 1.31 . . . . 0.0 113.747 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -96.16 171.03 27.93 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.7 tt0 -85.35 120.17 26.53 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.6 p -81.09 -50.7 9.32 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.262 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.94 87.48 0.07 OUTLIER Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.267 -1.444 . . . . 0.0 111.877 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 -176.28 20.83 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 174.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.2 mt -64.6 125.87 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 117.52 0.66 . . . . 0.0 109.26 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.69 60.03 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.307 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -107.65 142.61 37.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -145.31 139.98 27.43 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.81 -134.49 4.75 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.951 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.01 97.12 0.98 Allowed 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.324 2.016 . . . . 0.0 110.885 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 38.9 p -82.05 -19.11 40.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.295 0.569 . . . . 0.0 111.459 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -82.14 122.15 36.46 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -85.53 163.68 18.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.352 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 150.6 39.91 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 p -57.32 122.82 13.44 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.666 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.82 26.86 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.373 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -110.46 143.17 41.17 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -116.63 141.21 48.49 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 121.994 0.117 . . . . 0.0 111.164 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.61 104.84 5.44 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -110.51 127.75 55.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.255 0.55 . . . . 0.0 110.916 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -81.29 109.1 15.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.55 -48.46 7.29 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -122.77 164.63 25.68 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.27 -36.22 77.26 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.296 1.998 . . . . 0.0 113.087 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -102.98 -25.73 13.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.553 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 39.2 t80 -94.36 114.74 26.84 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -124.87 129.03 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.6 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.6 tt0 -127.38 142.9 51.31 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.637 0.256 . . . . 0.0 111.57 -173.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -78.49 107.41 11.12 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.297 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.434 -1.274 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 135.28 33.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -74.06 162.33 29.12 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -64.03 135.54 56.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.133 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 71.54 17.78 5.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.792 0.837 . . . . 0.0 112.522 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -110.5 165.41 12.25 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.187 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.9 tt0 -76.42 111.94 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.4 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.0 p -89.98 -30.78 17.56 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.73 75.8 0.05 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 118.882 -1.628 . . . . 0.0 112.534 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.49 179.45 29.33 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.91 113.46 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 117.585 0.692 . . . . 0.0 110.028 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.66 -17.31 36.35 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.018 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -86.5 137.74 32.29 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -140.96 130.22 23.59 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.54 -126.97 3.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.521 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.14 98.59 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.84 2.36 . . . . 0.0 112.254 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.9 p -96.68 -17.31 20.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.314 0.578 . . . . 0.0 111.792 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.41 121.57 37.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -84.3 167.43 16.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 167.62 11.84 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 122.966 0.506 . . . . 0.0 111.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -54.8 113.55 1.37 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.057 0.943 . . . . 0.0 111.881 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -0.59 60.38 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.975 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.9 p -112.94 141.61 46.57 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.136 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.2 p -114.47 142.46 46.36 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.327 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.74 111.66 18.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -122.94 139.55 53.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.66 120.34 21.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -97.51 -44.57 6.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -134.71 166.8 26.49 Favored Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.46 -43.5 22.08 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.95 2.434 . . . . 0.0 114.034 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.627 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 77.8 m-85 -101.91 -24.97 13.95 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.293 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 46.1 t80 -93.8 114.45 26.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.909 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.2 m -113.72 136.17 53.14 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.97 142.71 50.84 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 117.93 0.332 . . . . 0.0 111.298 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.7 m -77.83 117.91 19.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 124.213 1.005 . . . . 0.0 108.627 178.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 134.72 35.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 161.5 27.54 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.478 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 23.3 t-160 -66.14 134.82 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.51 5.98 2.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.555 1.542 . . . . 0.0 112.532 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.06 163.95 27.05 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.3 tt0 -79.99 116.69 20.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.793 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -80.92 -43.73 19.34 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.806 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.501 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 163.36 97.18 0.12 Allowed Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.11 -170.53 19.95 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.9 121.6 12.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.39 -9.85 59.35 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.167 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.501 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 23.5 t80 -98.81 136.52 38.72 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 13.9 m -141.05 106.09 4.97 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.61 -149.4 8.63 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.419 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.16 104.24 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.975 2.45 . . . . 0.0 111.557 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 p -85.33 -15.38 43.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.338 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.8 109.85 2.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.494 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -83.42 164.51 19.88 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.714 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.04 154.04 27.93 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.425 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 m -60.28 118.78 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.12 0.486 . . . . 0.0 110.567 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.68 -9.8 55.66 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.08 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -110.16 136.66 49.04 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.8 p -116.2 134.61 54.73 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.728 0.299 . . . . 0.0 111.685 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -67.37 112.17 4.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -122.5 135.36 54.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.111 0.481 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.1 102.86 4.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.359 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.28 -44.93 14.39 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -129.31 164.3 40.42 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.92 -40.14 86.31 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 121.559 1.506 . . . . 0.0 112.026 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -97.72 -27.83 14.17 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 118.894 -1.123 . . . . 0.0 111.089 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.17 114.12 25.88 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.313 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.1 m -120.42 133.59 55.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -125.59 143.04 51.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 120.437 0.16 . . . . 0.0 111.284 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -78.62 108.02 11.72 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.6 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.401 ' H2 ' ' HB2' ' A' ' 14' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.412 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -90.59 136.21 33.21 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -87.45 169.82 11.89 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -60.0 130.87 48.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.191 1.396 . . . . 0.0 109.848 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 78.76 7.2 2.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.807 1.243 . . . . 0.0 112.988 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -98.75 158.41 20.26 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.0 tt0 -76.54 113.19 13.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.9 p -82.48 -21.35 35.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.03 87.17 0.18 Allowed Glycine 0 CA--C 1.479 -2.189 0 C-N-CA 118.148 -1.977 . . . . 0.0 113.925 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.14 -165.66 25.76 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.89 118.35 7.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 118.076 0.938 . . . . 0.0 109.04 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.44 -26.91 11.23 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.609 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.8 ' C ' ' H1 ' ' A' ' 101' ' ' MAN . 36.7 t80 -106.24 115.49 30.31 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.526 ' N ' ' H1 ' ' A' ' 101' ' ' MAN . 17.3 m -125.77 162.54 24.86 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.31 -117.68 4.18 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.901 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.32 97.85 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.673 2.248 . . . . 0.0 110.964 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.3 p -111.94 -18.85 12.56 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.685 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -80.55 114.01 20.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.516 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.03 165.11 19.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.07 154.7 41.62 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.344 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -62.71 120.18 10.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -6.34 30.67 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.3 p -123.15 148.44 45.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 p -121.94 137.3 54.84 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.144 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -70.18 103.52 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -109.8 130.23 55.54 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.954 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.29 110.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.676 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.65 -29.18 13.19 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 43.1 m-80 -145.53 165.63 20.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -55.81 -38.78 94.02 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.687 1.591 . . . . 0.0 112.424 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -100.12 -26.86 13.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.289 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 52.2 t80 -94.47 114.01 25.95 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -132.2 132.97 43.65 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.531 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.9 tt0 -130.62 143.56 50.83 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 117.731 0.241 . . . . 0.0 111.283 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.88 104.29 7.29 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.291 -1.978 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.772 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.8 ' H1 ' ' C ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.84 147.37 27.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -89.69 158.27 17.63 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 113.38 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -61.35 132.96 55.2 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.537 1.135 . . . . 0.0 109.235 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.267 8.0 m-85 74.85 8.12 4.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.9 163.58 22.41 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -78.48 110.77 13.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.735 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.3 p -82.17 -35.02 28.8 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.53 84.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 118.686 -1.721 . . . . 0.0 112.971 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.51 -174.93 20.52 Favored Glycine 0 C--N 1.294 -1.79 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -62.12 122.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 118.061 0.93 . . . . 0.0 108.55 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.36 -6.8 42.61 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.038 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -125.08 136.09 53.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.5 m -150.04 101.41 3.02 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.549 1.14 . . . . 0.0 108.672 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.42 -134.73 1.78 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.19 99.32 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.775 2.317 . . . . 0.0 111.193 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.3 p -91.79 -17.17 25.75 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.16 109.98 10.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.702 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.0 m -85.12 159.02 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.917 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.91 152.44 10.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.471 0.708 . . . . 0.0 111.61 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -59.65 113.35 2.19 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.832 0.825 . . . . 0.0 111.774 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -11.55 29.33 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.282 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -112.56 136.87 51.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -116.06 137.62 51.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.586 0.231 . . . . 0.0 111.142 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.81 106.11 4.04 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.62 126.4 55.23 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.37 102.86 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.41 -44.98 15.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -132.9 166.03 32.25 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.45 -42.74 63.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.219 1.946 . . . . 0.0 113.593 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -97.88 -26.46 14.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.761 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.615 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 37.4 t80 -94.55 114.18 26.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.5 m -120.73 138.02 54.2 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.615 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.6 tt0 -133.61 142.03 47.92 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 123.037 0.21 . . . . 0.0 111.284 -173.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.92 105.21 7.85 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 153.66 20.16 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -92.45 173.97 7.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.65 0.738 . . . . 0.0 112.167 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -72.31 135.56 45.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.065 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.83 59.07 0.37 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.332 1.053 . . . . 0.0 112.366 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.0 153.63 24.89 Favored Glycine 0 C--O 1.254 1.394 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -68.05 116.12 8.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.179 0.489 . . . . 0.0 110.608 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.677 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.9 p -82.85 -46.01 13.57 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.677 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.89 107.55 0.24 Allowed Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.371 -1.395 . . . . 0.0 113.45 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.27 -160.5 17.86 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.482 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 74.2 mt -66.39 122.79 18.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 117.706 0.753 . . . . 0.0 109.167 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.34 63.53 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.559 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -116.17 139.24 50.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.779 0.79 . . . . 0.0 110.348 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -138.87 145.98 40.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.81 -137.31 5.9 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.7 91.56 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.678 2.252 . . . . 0.0 110.876 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -93.94 -5.43 47.82 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.252 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.33 113.78 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.2 m -80.62 162.96 23.98 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 152.09 42.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 111.09 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 m -60.75 116.74 4.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.394 0.616 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -15.05 29.4 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.6 p -109.64 146.55 34.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.2 p -118.2 135.32 54.32 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.966 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 51.0 t -74.01 98.13 3.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -99.62 130.05 45.82 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.03 94.29 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.2 -46.65 22.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.976 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -126.98 168.64 14.09 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.46 -34.31 93.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.421 1.414 . . . . 0.0 112.216 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.482 ' HD2' ' O ' ' A' ' 11' ' ' ILE . 23.2 m-85 -106.76 -26.39 11.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.139 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -93.0 114.69 27.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.463 0.649 . . . . 0.0 110.758 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.8 m -129.53 134.9 48.01 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.29 141.7 47.04 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.693 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 34.5 m -73.36 105.53 4.79 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.479 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 132.2 44.01 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 m -66.29 159.8 25.85 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.619 1.168 . . . . 0.0 113.818 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -67.79 123.23 19.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 77.94 58.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.92 0.888 . . . . 0.0 112.552 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 34' ' ' GLN . . . -156.09 160.87 30.4 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.535 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 64.3 tt0 -78.61 116.21 18.83 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.802 0.801 . . . . 0.0 110.215 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.724 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.0 p -86.75 -44.35 11.85 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.45 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.88 84.49 0.06 OUTLIER Glycine 0 CA--C 1.481 -2.072 0 C-N-CA 119.278 -1.439 . . . . 0.0 112.01 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.95 -172.67 20.42 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 63.6 mt -66.85 113.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 117.307 0.553 . . . . 0.0 109.663 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -9.18 32.48 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.656 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -102.83 135.08 45.16 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.555 -0.379 . . . . 0.0 110.116 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -139.11 116.13 10.95 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.51 -147.21 10.76 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.98 95.49 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.115 2.543 . . . . 0.0 111.628 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.1 p -80.57 -26.61 37.82 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.244 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.4 117.8 20.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 110.052 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.0 m -81.04 167.53 19.66 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.2 40.46 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 117.7 4.51 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.965 0.506 . . . . 0.0 109.749 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.71 -0.29 34.28 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.673 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -128.77 142.87 50.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -116.12 136.52 52.94 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.875 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 48.1 t -76.84 103.21 6.66 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -119.75 142.86 48.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.921 0.391 . . . . 0.0 111.444 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 114.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.77 -43.89 8.4 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -134.76 165.6 35.5 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.54 -38.85 45.44 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 122.721 2.281 . . . . 0.0 114.513 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.44 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.8 m-85 -106.63 -24.86 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.32 0.581 . . . . 0.0 110.812 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' A' ' 7' ' ' GLN . 36.0 t80 -93.3 113.87 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.452 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -112.56 135.81 52.84 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 6' ' ' GLY . 28.4 tt0 -132.06 144.91 51.08 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.724 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.3 m -72.43 108.54 5.58 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.137 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.108 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 9.5 m . . . . . 0 N--CA 1.437 -1.101 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.07 140.0 53.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -61.21 154.49 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.406 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.4 t-160 -63.94 132.83 51.9 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 71.06 11.8 6.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.66 166.88 19.63 Favored Glycine 0 C--O 1.251 1.194 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -76.85 109.14 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.764 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -83.7 -33.51 25.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.38 93.25 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 117.971 -2.061 . . . . 0.0 113.217 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.98 -169.88 19.19 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.03 119.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.39 -16.33 45.19 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.708 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -105.49 121.62 44.31 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -135.3 123.48 22.99 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.81 -126.08 1.66 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.312 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.36 96.28 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.545 2.163 . . . . 0.0 111.418 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.2 p -100.74 -10.48 20.78 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 1' ' ' THR . 64.6 t -90.25 114.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 80.3 m -75.34 159.69 31.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.788 -178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.96 170.19 3.71 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.194 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.0 t -61.62 120.3 10.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.976 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.62 -9.28 58.7 Favored Glycine 0 N--CA 1.423 -2.191 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.294 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -114.68 145.66 41.78 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.916 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 p -116.85 134.57 54.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 54.1 t -73.94 105.4 5.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.73 141.05 48.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.231 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.93 112.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.865 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -96.93 -34.64 11.15 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -143.13 166.23 21.46 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.98 -43.3 58.0 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.16 1.907 . . . . 0.0 112.977 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.5 m-85 -97.33 -26.18 14.98 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.245 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.65 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 33.0 t80 -93.74 114.18 26.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.686 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -122.3 137.26 54.91 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.65 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 30.0 tt0 -131.73 141.14 49.45 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 123.097 0.248 . . . . 0.0 111.155 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.5 m -77.26 108.32 10.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.991 176.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.615 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -83.37 146.54 28.41 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.999 0.818 . . . . 0.0 111.85 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -63.35 165.56 7.49 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 125.496 1.518 . . . . 0.0 113.589 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.47 139.42 51.71 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 72.18 23.13 3.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.776 0.798 . . . . 0.0 112.124 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.76 148.15 17.27 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -70.49 109.71 4.97 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.1 p -71.25 -47.28 58.07 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.17 88.16 0.07 OUTLIER Glycine 0 N--CA 1.417 -2.602 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.284 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.75 177.58 19.41 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 64.8 mt -66.14 118.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' O ' ' H62' ' A' ' 101' ' ' MAN . . . 110.54 -11.92 30.47 Favored Glycine 0 C--N 1.306 -1.119 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.838 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -96.01 132.92 40.84 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -134.78 95.74 3.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.8 8.94 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.983 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.52 107.87 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.271 2.648 . . . . 0.0 112.318 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 43.0 p -87.17 -13.93 42.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.261 0.553 . . . . 0.0 111.227 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.79 116.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -85.51 153.35 22.51 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.044 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.2 149.01 5.71 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.661 1.184 . . . . 0.0 111.934 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -54.56 112.29 0.98 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.431 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.22 -1.21 29.72 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.2 p -129.35 143.95 51.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -120.74 148.73 43.57 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.742 0.306 . . . . 0.0 111.718 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -74.26 118.8 17.64 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.12 126.96 49.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.285 0.564 . . . . 0.0 110.558 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -79.46 103.42 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.097 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.75 -48.6 8.11 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -129.23 171.37 8.88 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.12 -43.91 43.75 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 121.671 1.581 . . . . 0.0 112.319 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.1 m-85 -98.93 -25.81 14.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.247 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 26.6 t80 -93.35 114.66 27.14 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.491 0.662 . . . . 0.0 111.773 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.9 m -135.81 127.68 29.39 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.607 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 34.2 tt0 -129.84 148.4 51.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.07 0.396 . . . . 0.0 111.99 -172.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 41.6 m -76.57 112.64 13.32 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.45 ' H62' ' O ' ' A' ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 8' ' ' CYS . 7.0 tt0 -95.64 157.8 15.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.999 0.428 . . . . 0.0 111.122 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.461 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 9.8 m -64.77 165.4 10.57 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.142 1.777 . . . . 0.0 112.985 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -80.94 134.8 35.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 71.98 59.44 0.15 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.162 0.982 . . . . 0.0 112.324 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.09 156.4 26.7 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.9 tt0 -76.38 110.58 11.02 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 117.321 0.561 . . . . 0.0 109.645 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.753 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -70.39 -49.34 50.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.759 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.73 87.87 0.07 OUTLIER Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.96 172.4 15.75 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.05 113.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -11.13 37.55 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.741 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.759 ' O ' ' H1 ' ' A' ' 101' ' ' MAN . 62.9 t80 -104.25 132.92 49.98 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -127.57 129.28 47.05 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.95 -153.38 23.74 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.565 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.44 99.36 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.17 2.58 . . . . 0.0 111.688 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -81.94 -21.8 37.05 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.626 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -87.29 122.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -90.09 165.23 14.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 158.41 7.75 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 123.353 0.661 . . . . 0.0 111.331 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -59.51 118.28 5.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 -20.29 25.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.6 p -109.96 141.58 42.53 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 28.1 p -124.55 147.24 48.55 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.0 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.52 109.32 8.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -118.02 132.13 56.41 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.02 109.39 11.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.07 -43.63 8.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.557 0.694 . . . . 0.0 109.893 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -130.31 166.0 29.95 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.18 -42.25 47.28 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.714 2.276 . . . . 0.0 113.542 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.7 m-85 -104.32 -25.08 13.0 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.042 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 32.1 t80 -92.57 115.32 28.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.591 -0.843 . . . . 0.0 112.718 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.86 131.12 53.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.547 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.3 tt0 -128.73 148.24 50.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 118.116 0.417 . . . . 0.0 111.977 -171.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.0 m -77.47 106.52 9.29 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.317 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.405 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.759 ' H1 ' ' O ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.22 157.81 16.12 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.138 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -74.79 165.78 24.68 Favored 'General case' 0 C--O 1.248 1.005 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -64.09 139.74 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.043 1.337 . . . . 0.0 107.61 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 75.61 7.76 3.83 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.295 1.038 . . . . 0.0 113.683 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.32 154.84 21.2 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.815 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.6 tt0 -70.28 107.68 3.85 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.1 p -75.97 -38.03 57.91 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -175.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.01 96.07 0.11 Allowed Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 118.39 -1.862 . . . . 0.0 112.923 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.7 -169.83 19.4 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 62.9 mt -66.22 119.1 10.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.39 -1.82 58.94 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -97.84 130.49 44.75 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 122.006 -0.702 . . . . 0.0 109.114 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -135.7 133.21 37.84 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.23 -141.07 8.17 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.25 98.94 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.392 2.061 . . . . 0.0 111.343 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.5 p -89.42 -11.95 41.66 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.48 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.15 121.79 45.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.6 m -86.29 162.68 18.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.31 143.92 56.33 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -60.31 128.19 35.49 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -14.07 28.66 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.65 144.17 49.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 p -122.25 138.65 54.42 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.522 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.5 t -70.31 107.96 3.99 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.9 mt-30 -117.96 129.17 55.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.39 119.49 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.704 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.78 -49.99 3.99 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 108.943 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -126.02 166.08 23.55 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.52 -43.0 52.99 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.553 2.169 . . . . 0.0 112.71 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.0 m-85 -101.39 -26.63 13.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.214 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.3 t80 -93.58 114.86 27.3 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.259 -0.976 . . . . 0.0 113.128 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.5 138.48 54.34 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' HD22 ' A' ' 36' ' ' LEU . 35.6 tt0 -129.18 143.15 50.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 118.861 0.755 . . . . 0.0 111.813 -172.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 55.6 m -76.08 106.52 7.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.457 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.7 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.87 133.31 34.31 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.367 -172.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -71.33 166.95 20.55 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -66.98 130.04 41.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.797 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 75.22 13.87 3.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.549 1.14 . . . . 0.0 113.358 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.44 166.38 20.76 Favored Glycine 0 C--N 1.308 -0.997 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.8 tt0 -76.33 118.98 19.59 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 117.491 0.646 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.0 p -85.16 -37.19 20.46 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.41 68.6 0.04 OUTLIER Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 118.902 -1.618 . . . . 0.0 112.713 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -101.57 176.2 26.17 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.5 mt -60.42 117.85 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 117.372 0.586 . . . . 0.0 110.19 -178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -25.44 13.7 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.532 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.23 134.5 35.29 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 m -135.54 103.11 5.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.76 -156.4 24.87 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.867 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.28 123.18 8.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.271 2.647 . . . . 0.0 111.59 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -92.92 -5.06 51.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.861 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.6 t -74.75 116.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -84.73 165.61 17.7 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.32 162.68 14.39 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.574 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -57.03 119.63 6.64 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.242 1.017 . . . . 0.0 110.712 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.76 65.21 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.855 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -110.23 143.19 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.16 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -116.29 141.0 48.73 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.316 0.246 . . . . 0.0 111.274 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.86 108.24 9.75 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.14 140.62 49.29 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.95 113.6 25.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.74 -30.85 12.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.78 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -148.2 167.75 12.62 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.05 -43.44 48.02 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.404 2.069 . . . . 0.0 113.391 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 59.0 m-85 -99.68 -25.08 14.51 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.618 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 19.2 t80 -93.64 114.33 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.4 129.74 48.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 174.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.618 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.7 tt0 -131.11 145.4 51.98 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 -172.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.6 m -78.22 105.52 9.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.93 140.96 30.72 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 120.916 0.389 . . . . 0.0 111.348 -171.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -61.96 153.79 28.31 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.544 1.938 . . . . 0.0 115.489 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.59 132.28 50.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.281 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 72.31 9.05 5.87 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.94 166.87 19.32 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.493 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -79.46 114.45 18.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.781 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -78.56 -52.56 8.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.012 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.6 78.15 0.09 OUTLIER Glycine 0 CA--C 1.47 -2.753 0 C-N-CA 119.282 -1.437 . . . . 0.0 111.18 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.41 173.79 16.71 Favored Glycine 0 N--CA 1.412 -2.939 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.86 115.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.28 37.34 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.937 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -97.11 136.58 37.45 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 109.88 11.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.27 -148.59 16.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.309 -1.424 . . . . 0.0 112.377 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.93 110.06 2.49 Favored 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.389 2.726 . . . . 0.0 111.643 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.4 p -89.17 -17.81 28.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.91 124.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -76.22 161.25 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 172.55 2.49 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -56.91 112.35 1.3 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.31 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.74 -2.95 67.44 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.525 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.0 p -110.04 146.47 35.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.788 0.794 . . . . 0.0 110.928 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 p -118.35 143.48 46.59 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.37 106.63 11.54 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -113.07 130.05 56.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.135 0.493 . . . . 0.0 110.6 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -77.88 112.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.54 -45.71 6.96 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.523 0.678 . . . . 0.0 110.178 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.1 m-20 -125.85 173.38 5.1 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -53.39 -43.53 56.63 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.377 2.052 . . . . 0.0 113.161 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.8 m-85 -105.43 -24.46 12.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.2 t80 -92.72 115.58 28.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -119.09 133.72 55.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -126.98 146.68 50.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.784 0.266 . . . . 0.0 111.316 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -82.09 108.81 15.86 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.2 0.524 . . . . 0.0 111.477 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.001 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.38 141.58 43.24 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -76.0 158.19 32.21 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.78 0.8 . . . . 0.0 112.794 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -63.71 134.82 56.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 72.19 18.67 4.69 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.08 169.36 13.07 Favored Glycine 0 C--O 1.249 1.041 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -77.56 122.03 24.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 117.401 0.6 . . . . 0.0 109.901 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.722 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -99.96 7.65 44.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 119.0 91.03 1.35 Allowed Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 118.236 -1.935 . . . . 0.0 113.146 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.9 -170.66 19.37 Favored Glycine 0 N--CA 1.422 -2.266 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 172.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.531 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 45.4 mt -62.22 123.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.585 ' O ' ' H2 ' ' A' ' 101' ' ' MAN . . . 100.66 -26.2 25.49 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.466 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 36.3 t80 -79.41 129.7 34.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -128.87 98.82 5.08 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.98 -136.78 3.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.468 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -69.57 120.8 7.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.859 2.373 . . . . 0.0 112.179 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -110.7 -17.13 13.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.939 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.89 113.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.99 167.32 22.02 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.104 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.52 162.67 7.85 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.066 0.546 . . . . 0.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -60.29 121.64 12.5 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.613 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.18 -3.92 57.01 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.939 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -119.12 142.45 47.91 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -118.02 142.77 47.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.9 t -81.63 98.13 8.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -105.89 132.85 51.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.38 115.64 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.56 -56.11 2.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.582 0.706 . . . . 0.0 109.75 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.498 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -111.18 171.98 3.9 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.88 -40.45 85.29 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 121.998 1.798 . . . . 0.0 112.744 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.9 m-85 -107.11 -23.79 12.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -91.49 114.8 27.43 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.095 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.2 m -118.02 138.47 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -135.53 143.72 45.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 118.922 0.783 . . . . 0.0 112.121 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.5 m -75.07 112.41 11.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.85 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.07 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.585 ' H2 ' ' O ' ' A' ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 tm0? . . . . . 0 N--CA 1.435 -1.225 0 CA-C-O 121.199 0.523 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -76.35 163.77 26.67 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.633 1.173 . . . . 0.0 114.157 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -65.02 129.18 38.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 74.93 17.94 2.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.502 1.121 . . . . 0.0 113.43 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.37 165.55 12.15 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.47 116.98 20.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.231 0.515 . . . . 0.0 110.315 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.9 p -81.53 -51.65 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.849 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 177.51 96.19 0.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 119.39 -1.386 . . . . 0.0 112.759 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.5 -176.85 20.77 Favored Glycine 0 C--N 1.291 -1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.1 mt -61.1 115.32 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 117.181 0.491 . . . . 0.0 109.718 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 -13.93 56.36 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.379 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -89.98 114.23 26.03 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.3 m -108.97 121.75 45.8 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.94 -157.15 28.89 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.36 102.92 1.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.68 2.254 . . . . 0.0 110.748 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA3' ' A' ' 9' ' ' GLY . 17.5 p -87.68 -10.52 51.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.441 0.638 . . . . 0.0 111.653 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -82.42 123.73 38.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.5 m -85.46 167.74 15.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 122.618 0.367 . . . . 0.0 110.357 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.45 155.63 39.51 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.246 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.69 119.89 4.66 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.462 0.705 . . . . 0.0 112.16 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.17 -13.11 57.31 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.768 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -110.09 137.86 47.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.296 0.548 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.9 p -108.92 136.68 48.06 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -76.07 97.79 4.16 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -102.87 125.73 49.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.006 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.1 t -78.81 104.94 7.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 mt -87.45 -44.29 11.43 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.579 0.704 . . . . 0.0 109.67 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -127.83 167.27 19.0 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.68 -38.1 76.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.644 2.229 . . . . 0.0 113.197 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.41 -25.23 10.63 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.788 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -92.52 115.3 27.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.431 0.634 . . . . 0.0 111.714 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -124.0 136.07 54.05 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.4 tt0 -129.04 142.39 50.92 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 117.926 0.33 . . . . 0.0 111.458 -171.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -80.17 108.33 13.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' OE1' ' A' ' 34' ' ' GLN . 92.7 mt . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 123.596 0.758 . . . . 0.0 109.365 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 121.351 0.596 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 m -61.32 155.83 20.34 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.069 1.747 . . . . 0.0 114.876 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.432 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.1 t-160 -68.23 132.71 47.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 74.32 7.3 4.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.06 0.944 . . . . 0.0 112.861 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.42 160.78 23.82 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.622 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -72.75 113.5 9.85 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 p -88.05 -38.72 15.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.22 75.08 0.05 OUTLIER Glycine 0 CA--C 1.476 -2.391 0 C-N-CA 117.177 -2.44 . . . . 0.0 113.79 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 171.93 15.2 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.36 122.87 10.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.15 -26.47 12.21 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.782 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -102.14 148.27 25.61 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 p -158.81 156.18 29.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.686 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.22 -121.95 4.77 Favored Glycine 0 C--N 1.308 -1.018 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.43 100.69 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 121.964 1.776 . . . . 0.0 109.841 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.7 p -99.21 -20.39 16.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.796 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -87.11 124.73 40.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.834 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.0 m -79.02 167.29 21.3 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.541 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 148.64 51.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -54.23 123.24 12.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.032 0.444 . . . . 0.0 110.707 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -14.58 31.01 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.3 p -117.0 142.25 47.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 31.5 p -115.72 141.29 48.28 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.134 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.53 102.46 9.75 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -105.16 119.56 39.34 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.535 0.683 . . . . 0.0 110.92 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.85 106.98 6.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.089 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 mt -91.37 -44.2 9.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -128.0 166.23 25.19 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -57.12 -33.87 96.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.661 1.574 . . . . 0.0 111.911 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 9.7 m-85 -102.23 -27.63 12.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.92 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -94.65 114.92 26.92 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.119 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -133.66 130.51 38.33 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.86 140.18 52.54 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 123.032 0.207 . . . . 0.0 110.986 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.1 m -76.2 111.29 11.47 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.287 -2.121 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.539 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -81.61 165.35 21.16 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.811 0.844 . . . . 0.0 112.863 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.3 136.02 44.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 73.11 21.21 3.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.525 0.73 . . . . 0.0 112.41 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.66 151.6 18.34 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.08 121.08 15.96 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -87.1 -42.36 13.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.97 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 168.97 98.18 0.12 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.592 -1.765 . . . . 0.0 113.531 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.88 -179.72 20.83 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 174.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.97 116.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 117.655 0.728 . . . . 0.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.43 -18.19 48.8 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.44 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 64.2 t80 -80.97 136.08 35.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.762 0.281 . . . . 0.0 111.417 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -124.66 113.82 18.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.63 -161.56 30.47 Favored Glycine 0 C--N 1.306 -1.105 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.2 114.87 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.89 2.393 . . . . 0.0 110.459 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p -90.04 -23.68 21.39 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.17 120.6 36.74 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.83 164.41 19.51 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.174 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 141.31 57.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.7 120.67 7.08 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.418 0.448 . . . . 0.0 109.824 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.51 -10.46 28.29 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.8 p -121.7 140.49 52.24 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -113.87 135.3 54.12 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.875 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.91 98.05 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.54 145.06 30.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.286 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.2 t -87.98 111.73 22.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.26 -43.59 11.46 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.392 0.615 . . . . 0.0 109.687 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -138.82 169.55 12.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.57 -29.17 89.24 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.245 1.48 . . . . 0.0 111.622 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.4 m-85 -102.53 -25.57 13.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.23 114.18 26.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.5 m -138.04 129.37 27.66 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -137.01 147.31 46.17 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.385 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.4 m -76.39 107.77 8.88 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.431 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.28 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.105 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -72.31 160.91 31.6 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.68 131.85 45.88 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 71.73 17.52 5.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.029 0.932 . . . . 0.0 112.403 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.04 164.68 12.3 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.7 tt0 -82.14 110.22 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 122.586 0.354 . . . . 0.0 110.241 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -73.32 -41.87 63.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.97 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 154.95 96.97 0.13 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.947 -1.597 . . . . 0.0 113.833 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.63 -152.58 13.09 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.5 mt -70.54 125.97 29.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.7 -21.18 37.23 Favored Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.616 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.15 121.08 30.39 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.421 -0.458 . . . . 0.0 109.842 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -141.22 111.99 7.1 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.1 -116.95 0.39 Allowed Glycine 0 C--N 1.304 -1.222 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 2.6 Cg_endo -77.65 90.16 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 CA-C-N 119.587 1.694 . . . . 0.0 108.631 173.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.403 HG22 ' HA3' ' A' ' 9' ' ' GLY . 7.7 p -82.83 -20.68 35.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.344 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.4 t -84.76 128.28 39.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -82.16 163.46 21.94 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.388 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.3 152.49 43.65 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.316 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -53.56 122.78 10.47 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.973 0.909 . . . . 0.0 111.349 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -19.92 25.59 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.734 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 p -118.77 147.94 43.35 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.481 -0.423 . . . . 0.0 111.686 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 20.5 p -115.81 146.44 41.96 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.012 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -81.24 99.54 8.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.8 127.48 49.95 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.069 0.461 . . . . 0.0 110.366 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.71 106.64 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.91 -52.99 4.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.13 163.36 30.38 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.86 -41.58 62.25 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.688 2.259 . . . . 0.0 113.458 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 45.5 m-85 -99.15 -26.59 14.15 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.012 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 26.1 t80 -94.05 114.6 26.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -120.35 133.19 55.49 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -129.26 144.27 51.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 117.785 0.266 . . . . 0.0 110.956 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.0 m -79.41 110.65 14.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.061 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -94.11 176.49 6.31 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.09 129.03 39.76 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.778 0.831 . . . . 0.0 110.087 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.26 13.3 m-85 71.58 59.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -157.42 155.11 26.12 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.6 tt0 -72.87 115.1 11.76 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 117.541 0.67 . . . . 0.0 109.648 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.2 p -90.74 -36.42 14.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.889 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.56 88.43 0.07 OUTLIER Glycine 0 CA--C 1.488 -1.655 0 C-N-CA 118.835 -1.65 . . . . 0.0 112.662 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.64 178.96 20.06 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 175.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 59.4 mt -64.2 116.71 3.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.68 -10.22 55.88 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.416 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -84.88 144.17 28.56 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.7 m -138.73 99.12 3.72 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.97 -142.38 4.62 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.945 -1.122 . . . . 0.0 112.467 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 106.91 1.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.332 2.688 . . . . 0.0 111.302 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.3 p -88.9 -9.58 51.04 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.781 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -89.32 121.88 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.41 154.8 19.77 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.31 148.18 19.31 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.912 0.758 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -57.84 119.84 7.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.518 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.83 27.86 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.84 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -116.33 140.23 49.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -114.45 141.78 47.24 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.204 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.28 97.61 7.06 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -103.47 135.52 44.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.52 99.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -46.16 19.7 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -128.74 164.24 39.79 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.52 -35.25 65.79 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.642 2.228 . . . . 0.0 113.503 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.645 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 80.5 m-85 -110.21 -24.98 10.4 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.163 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 57.1 t80 -93.38 114.68 27.16 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.1 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -116.38 138.43 51.35 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.0 tt0 -131.39 143.36 50.41 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 117.977 0.353 . . . . 0.0 110.873 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.4 m -77.6 105.98 9.1 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.412 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -82.95 160.26 22.09 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -65.44 133.14 50.67 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.103 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 77.18 7.34 3.0 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.581 1.153 . . . . 0.0 112.355 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 161.14 18.34 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.483 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -74.7 120.0 19.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.195 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.7 p -82.91 -52.82 6.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.468 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.94 85.68 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.0 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.23 179.35 20.4 Favored Glycine 0 C--N 1.293 -1.825 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.9 mt -62.42 112.9 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 117.668 0.734 . . . . 0.0 109.508 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.51 -17.1 26.2 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.378 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -94.07 138.81 31.73 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.653 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -136.34 136.01 39.34 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.5 -142.13 11.02 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.66 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.91 101.74 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.734 2.289 . . . . 0.0 111.757 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 p -90.93 -0.57 57.77 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.24 0.543 . . . . 0.0 112.315 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.48 113.41 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.0 m -77.36 167.41 21.73 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.678 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.28 154.12 24.58 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.968 0.507 . . . . 0.0 110.844 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -57.6 112.43 1.44 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.312 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.88 -9.71 29.69 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -113.86 139.31 49.28 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.477 -0.425 . . . . 0.0 109.855 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.8 p -113.1 145.13 41.44 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.49 100.83 7.89 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -105.49 131.97 52.24 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.48 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.92 100.25 7.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.02 -58.15 3.29 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.856 0.836 . . . . 0.0 108.818 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.1 m-20 -114.18 165.75 13.0 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -38.28 94.83 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.184 1.922 . . . . 0.0 112.621 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.8 m-85 -104.45 -26.11 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.0 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -93.35 114.89 27.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.93 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.69 131.05 53.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -125.73 145.1 50.33 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.604 0.184 . . . . 0.0 110.989 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -79.55 104.45 10.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--N 1.293 -1.871 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.427 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.969 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -78.94 171.64 14.91 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.38 132.9 50.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.65 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 76.95 7.43 3.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.975 1.31 . . . . 0.0 113.747 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -96.16 171.03 27.93 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.7 tt0 -85.35 120.17 26.53 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.748 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.6 p -81.09 -50.7 9.32 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.262 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.94 87.48 0.07 OUTLIER Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.267 -1.444 . . . . 0.0 111.877 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 -176.28 20.83 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 174.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.2 mt -64.6 125.87 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 117.52 0.66 . . . . 0.0 109.26 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.69 60.03 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.307 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -107.65 142.61 37.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -145.31 139.98 27.43 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.81 -134.49 4.75 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.951 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.01 97.12 0.98 Allowed 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.324 2.016 . . . . 0.0 110.885 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 38.9 p -82.05 -19.11 40.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.295 0.569 . . . . 0.0 111.459 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -82.14 122.15 36.46 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -85.53 163.68 18.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.352 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 150.6 39.91 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 p -57.32 122.82 13.44 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.666 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.82 26.86 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.373 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -110.46 143.17 41.17 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -116.63 141.21 48.49 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 121.994 0.117 . . . . 0.0 111.164 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.61 104.84 5.44 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -110.51 127.75 55.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.255 0.55 . . . . 0.0 110.916 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -81.29 109.1 15.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.55 -48.46 7.29 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -122.77 164.63 25.68 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.27 -36.22 77.26 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.296 1.998 . . . . 0.0 113.087 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -102.98 -25.73 13.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.553 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -94.36 114.74 26.84 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -124.87 129.03 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -127.38 142.9 51.31 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.637 0.256 . . . . 0.0 111.57 -173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -78.49 107.41 11.12 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.297 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -74.06 162.33 29.12 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -64.03 135.54 56.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.133 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 71.54 17.78 5.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.792 0.837 . . . . 0.0 112.522 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -110.5 165.41 12.25 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.187 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.9 tt0 -76.42 111.94 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.4 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.0 p -89.98 -30.78 17.56 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.73 75.8 0.05 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 118.882 -1.628 . . . . 0.0 112.534 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.49 179.45 29.33 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.91 113.46 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 117.585 0.692 . . . . 0.0 110.028 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.66 -17.31 36.35 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.018 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -86.5 137.74 32.29 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -140.96 130.22 23.59 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.54 -126.97 3.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.521 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.14 98.59 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.84 2.36 . . . . 0.0 112.254 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.9 p -96.68 -17.31 20.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.314 0.578 . . . . 0.0 111.792 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.41 121.57 37.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -84.3 167.43 16.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 167.62 11.84 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 122.966 0.506 . . . . 0.0 111.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -54.8 113.55 1.37 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.057 0.943 . . . . 0.0 111.881 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -0.59 60.38 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.975 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.9 p -112.94 141.61 46.57 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.136 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.2 p -114.47 142.46 46.36 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.327 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.74 111.66 18.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -122.94 139.55 53.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.66 120.34 21.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -97.51 -44.57 6.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -134.71 166.8 26.49 Favored Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.46 -43.5 22.08 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.95 2.434 . . . . 0.0 114.034 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.633 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 77.8 m-85 -101.91 -24.97 13.95 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.293 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 46.1 t80 -93.8 114.45 26.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.909 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.2 m -113.72 136.17 53.14 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.472 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.97 142.71 50.84 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 117.93 0.332 . . . . 0.0 111.298 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.7 m -77.83 117.91 19.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 124.213 1.005 . . . . 0.0 108.627 178.819 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 161.5 27.54 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -66.14 134.82 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.51 5.98 2.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.555 1.542 . . . . 0.0 112.532 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.06 163.95 27.05 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.3 tt0 -79.99 116.69 20.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -80.92 -43.73 19.34 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.806 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 163.36 97.18 0.12 Allowed Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.11 -170.53 19.95 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.9 121.6 12.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.39 -9.85 59.35 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.167 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 23.5 t80 -98.81 136.52 38.72 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -141.05 106.09 4.97 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.61 -149.4 8.63 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.419 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.16 104.24 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.975 2.45 . . . . 0.0 111.557 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 p -85.33 -15.38 43.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.338 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.8 109.85 2.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.494 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -83.42 164.51 19.88 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.714 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.04 154.04 27.93 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.425 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 m -60.28 118.78 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.12 0.486 . . . . 0.0 110.567 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.68 -9.8 55.66 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.08 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -110.16 136.66 49.04 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.8 p -116.2 134.61 54.73 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.728 0.299 . . . . 0.0 111.685 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -67.37 112.17 4.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -122.5 135.36 54.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.111 0.481 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.1 102.86 4.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.359 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.28 -44.93 14.39 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -129.31 164.3 40.42 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.92 -40.14 86.31 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 121.559 1.506 . . . . 0.0 112.026 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -97.72 -27.83 14.17 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 118.894 -1.123 . . . . 0.0 111.089 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.17 114.12 25.88 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.313 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.1 m -120.42 133.59 55.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -125.59 143.04 51.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 120.437 0.16 . . . . 0.0 111.284 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -78.62 108.02 11.72 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.6 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -87.45 169.82 11.89 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -60.0 130.87 48.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.191 1.396 . . . . 0.0 109.848 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 78.76 7.2 2.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.807 1.243 . . . . 0.0 112.988 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -98.75 158.41 20.26 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.0 tt0 -76.54 113.19 13.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.9 p -82.48 -21.35 35.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.03 87.17 0.18 Allowed Glycine 0 CA--C 1.479 -2.189 0 C-N-CA 118.148 -1.977 . . . . 0.0 113.925 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.14 -165.66 25.76 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.89 118.35 7.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 118.076 0.938 . . . . 0.0 109.04 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.44 -26.91 11.23 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.609 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -106.24 115.49 30.31 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -125.77 162.54 24.86 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.426 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 114.31 -117.68 4.18 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.901 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 23.5 Cg_exo -66.32 97.85 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.673 2.248 . . . . 0.0 110.964 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.3 p -111.94 -18.85 12.56 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.685 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -80.55 114.01 20.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.516 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.03 165.11 19.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.07 154.7 41.62 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.344 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -62.71 120.18 10.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -6.34 30.67 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.3 p -123.15 148.44 45.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 p -121.94 137.3 54.84 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.144 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -70.18 103.52 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -109.8 130.23 55.54 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.954 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.29 110.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.676 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.65 -29.18 13.19 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.7 m120 -145.53 165.63 20.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -55.81 -38.78 94.02 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.687 1.591 . . . . 0.0 112.424 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -100.12 -26.86 13.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.289 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 52.2 t80 -94.47 114.01 25.95 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -132.2 132.97 43.65 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -130.62 143.56 50.83 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 117.731 0.241 . . . . 0.0 111.283 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.88 104.29 7.29 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.291 -1.978 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.047 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -89.69 158.27 17.63 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 113.38 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -61.35 132.96 55.2 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.537 1.135 . . . . 0.0 109.235 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.267 8.0 m-85 74.85 8.12 4.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.9 163.58 22.41 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -78.48 110.77 13.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.741 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.3 p -82.17 -35.02 28.8 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.53 84.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 118.686 -1.721 . . . . 0.0 112.971 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.51 -174.93 20.52 Favored Glycine 0 C--N 1.294 -1.79 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -62.12 122.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 118.061 0.93 . . . . 0.0 108.55 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.36 -6.8 42.61 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.038 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -125.08 136.09 53.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.5 m -150.04 101.41 3.02 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.549 1.14 . . . . 0.0 108.672 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.42 -134.73 1.78 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.19 99.32 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.775 2.317 . . . . 0.0 111.193 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.3 p -91.79 -17.17 25.75 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.16 109.98 10.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.702 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.0 m -85.12 159.02 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.917 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.91 152.44 10.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.471 0.708 . . . . 0.0 111.61 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -59.65 113.35 2.19 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.832 0.825 . . . . 0.0 111.774 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -11.55 29.33 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.282 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -112.56 136.87 51.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -116.06 137.62 51.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.586 0.231 . . . . 0.0 111.142 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.81 106.11 4.04 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.62 126.4 55.23 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.37 102.86 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.41 -44.98 15.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 84.5 m-20 -132.9 166.03 32.25 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.45 -42.74 63.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.219 1.946 . . . . 0.0 113.593 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -97.88 -26.46 14.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.761 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 37.4 t80 -94.55 114.18 26.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.5 m -120.73 138.02 54.2 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -133.61 142.03 47.92 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 123.037 0.21 . . . . 0.0 111.284 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.92 105.21 7.85 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.781 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -92.45 173.97 7.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.65 0.738 . . . . 0.0 112.167 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -72.31 135.56 45.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.065 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.83 59.07 0.37 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.332 1.053 . . . . 0.0 112.366 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.0 153.63 24.89 Favored Glycine 0 C--O 1.254 1.394 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -68.05 116.12 8.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.179 0.489 . . . . 0.0 110.608 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.9 p -82.85 -46.01 13.57 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.677 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.89 107.55 0.24 Allowed Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.371 -1.395 . . . . 0.0 113.45 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.27 -160.5 17.86 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 74.2 mt -66.39 122.79 18.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 117.706 0.753 . . . . 0.0 109.167 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.34 63.53 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.559 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -116.17 139.24 50.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.779 0.79 . . . . 0.0 110.348 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -138.87 145.98 40.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.81 -137.31 5.9 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.7 91.56 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.678 2.252 . . . . 0.0 110.876 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -93.94 -5.43 47.82 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.252 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.33 113.78 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.2 m -80.62 162.96 23.98 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 152.09 42.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 111.09 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 m -60.75 116.74 4.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.394 0.616 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -15.05 29.4 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.6 p -109.64 146.55 34.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.2 p -118.2 135.32 54.32 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.966 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 51.0 t -74.01 98.13 3.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -99.62 130.05 45.82 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.03 94.29 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.2 -46.65 22.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.976 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 3.0 m-20 -126.98 168.64 14.09 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.46 -34.31 93.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.421 1.414 . . . . 0.0 112.216 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 11' ' ' ILE . 23.2 m-85 -106.76 -26.39 11.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.139 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 25.2 t80 -93.0 114.69 27.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.463 0.649 . . . . 0.0 110.758 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.8 m -129.53 134.9 48.01 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.485 HE21 HD21 ' A' ' 36' ' ' LEU . 29.5 tt0 -134.29 141.7 47.04 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.693 -172.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 34.5 m -73.36 105.53 4.79 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HE21 ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 m -66.29 159.8 25.85 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.619 1.168 . . . . 0.0 113.818 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -67.79 123.23 19.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 77.94 58.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.92 0.888 . . . . 0.0 112.552 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' GLN . . . -156.09 160.87 30.4 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 64.3 tt0 -78.61 116.21 18.83 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.802 0.801 . . . . 0.0 110.215 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.733 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.0 p -86.75 -44.35 11.85 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.45 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.88 84.49 0.06 OUTLIER Glycine 0 CA--C 1.481 -2.072 0 C-N-CA 119.278 -1.439 . . . . 0.0 112.01 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.95 -172.67 20.42 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 63.6 mt -66.85 113.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 117.307 0.553 . . . . 0.0 109.663 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -9.18 32.48 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.656 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -102.83 135.08 45.16 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.555 -0.379 . . . . 0.0 110.116 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -139.11 116.13 10.95 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.51 -147.21 10.76 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.98 95.49 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.115 2.543 . . . . 0.0 111.628 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.1 p -80.57 -26.61 37.82 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.244 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.4 117.8 20.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 110.052 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.0 m -81.04 167.53 19.66 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.2 40.46 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 117.7 4.51 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.965 0.506 . . . . 0.0 109.749 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.71 -0.29 34.28 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.673 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -128.77 142.87 50.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -116.12 136.52 52.94 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.875 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 48.1 t -76.84 103.21 6.66 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -119.75 142.86 48.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.921 0.391 . . . . 0.0 111.444 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 114.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.77 -43.89 8.4 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -134.76 165.6 35.5 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.54 -38.85 45.44 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 122.721 2.281 . . . . 0.0 114.513 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.8 m-85 -106.63 -24.86 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.32 0.581 . . . . 0.0 110.812 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 7' ' ' GLN . 36.0 t80 -93.3 113.87 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.452 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -112.56 135.81 52.84 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.456 HE21 HD21 ' A' ' 36' ' ' LEU . 28.4 tt0 -132.06 144.91 51.08 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.3 m -72.43 108.54 5.58 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.137 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.456 HD21 HE21 ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -61.21 154.49 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.452 ' CE1' ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -63.94 132.83 51.9 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 71.06 11.8 6.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.66 166.88 19.63 Favored Glycine 0 C--O 1.251 1.194 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -76.85 109.14 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -83.7 -33.51 25.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.38 93.25 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 117.971 -2.061 . . . . 0.0 113.217 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.98 -169.88 19.19 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.03 119.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.39 -16.33 45.19 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.708 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -105.49 121.62 44.31 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -135.3 123.48 22.99 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 157.81 -126.08 1.66 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.312 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 7.0 Cg_exo -72.36 96.28 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.545 2.163 . . . . 0.0 111.418 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.2 p -100.74 -10.48 20.78 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.6 t -90.25 114.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 80.3 m -75.34 159.69 31.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.788 -178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.96 170.19 3.71 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.194 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.0 t -61.62 120.3 10.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.976 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.62 -9.28 58.7 Favored Glycine 0 N--CA 1.423 -2.191 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.294 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -114.68 145.66 41.78 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.916 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 p -116.85 134.57 54.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 54.1 t -73.94 105.4 5.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.73 141.05 48.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.231 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.93 112.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.865 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -96.93 -34.64 11.15 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 24.6 m120 -143.13 166.23 21.46 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.98 -43.3 58.0 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.16 1.907 . . . . 0.0 112.977 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.5 m-85 -97.33 -26.18 14.98 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.245 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.0 t80 -93.74 114.18 26.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.686 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -122.3 137.26 54.91 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.73 141.14 49.45 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 123.097 0.248 . . . . 0.0 111.155 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.5 m -77.26 108.32 10.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.991 176.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.452 ' O ' ' CE1' ' A' ' 4' ' ' HIS . 96.5 mt . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 121.092 0.472 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -63.35 165.56 7.49 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 125.496 1.518 . . . . 0.0 113.589 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.47 139.42 51.71 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 72.18 23.13 3.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.776 0.798 . . . . 0.0 112.124 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.76 148.15 17.27 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 13' ' ' TYR . 50.2 tt0 -70.49 109.71 4.97 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.732 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.1 p -71.25 -47.28 58.07 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.17 88.16 0.07 OUTLIER Glycine 0 N--CA 1.417 -2.602 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.284 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.75 177.58 19.41 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.14 118.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -11.92 30.47 Favored Glycine 0 C--N 1.306 -1.119 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.838 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' HE21 ' A' ' 7' ' ' GLN . 60.7 t80 -96.01 132.92 40.84 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -134.78 95.74 3.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.8 8.94 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.983 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.52 107.87 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.271 2.648 . . . . 0.0 112.318 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 43.0 p -87.17 -13.93 42.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.261 0.553 . . . . 0.0 111.227 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.79 116.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -85.51 153.35 22.51 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.044 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.2 149.01 5.71 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.661 1.184 . . . . 0.0 111.934 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -54.56 112.29 0.98 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.431 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.22 -1.21 29.72 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.2 p -129.35 143.95 51.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -120.74 148.73 43.57 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.742 0.306 . . . . 0.0 111.718 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -74.26 118.8 17.64 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.12 126.96 49.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.285 0.564 . . . . 0.0 110.558 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -79.46 103.42 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.097 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.75 -48.6 8.11 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 74.0 m-20 -129.23 171.37 8.88 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.12 -43.91 43.75 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 121.671 1.581 . . . . 0.0 112.319 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.1 m-85 -98.93 -25.81 14.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.247 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 26.6 t80 -93.35 114.66 27.14 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.491 0.662 . . . . 0.0 111.773 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.9 m -135.81 127.68 29.39 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -129.84 148.4 51.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.07 0.396 . . . . 0.0 111.99 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 41.6 m -76.57 112.64 13.32 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.076 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 8' ' ' CYS . 7.0 tt0 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 120.999 0.428 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.477 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 9.8 m -64.77 165.4 10.57 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.142 1.777 . . . . 0.0 112.985 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -80.94 134.8 35.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 71.98 59.44 0.15 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.162 0.982 . . . . 0.0 112.324 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.09 156.4 26.7 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.9 tt0 -76.38 110.58 11.02 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 117.321 0.561 . . . . 0.0 109.645 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -70.39 -49.34 50.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.759 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.73 87.87 0.07 OUTLIER Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.96 172.4 15.75 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.05 113.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -11.13 37.55 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.741 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -104.25 132.92 49.98 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -127.57 129.28 47.05 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.95 -153.38 23.74 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.565 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.44 99.36 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.17 2.58 . . . . 0.0 111.688 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -81.94 -21.8 37.05 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.626 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -87.29 122.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -90.09 165.23 14.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 158.41 7.75 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 123.353 0.661 . . . . 0.0 111.331 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -59.51 118.28 5.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 -20.29 25.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.6 p -109.96 141.58 42.53 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 28.1 p -124.55 147.24 48.55 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.0 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.52 109.32 8.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -118.02 132.13 56.41 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.02 109.39 11.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.07 -43.63 8.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.557 0.694 . . . . 0.0 109.893 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -130.31 166.0 29.95 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.18 -42.25 47.28 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.714 2.276 . . . . 0.0 113.542 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.7 m-85 -104.32 -25.08 13.0 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.042 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 32.1 t80 -92.57 115.32 28.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.591 -0.843 . . . . 0.0 112.718 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.86 131.12 53.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.3 tt0 -128.73 148.24 50.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 118.116 0.417 . . . . 0.0 111.977 -171.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.0 m -77.47 106.52 9.29 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.317 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.405 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.242 0.673 0 CA-C-O 121.205 0.526 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -74.79 165.78 24.68 Favored 'General case' 0 C--O 1.248 1.005 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -64.09 139.74 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.043 1.337 . . . . 0.0 107.61 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 75.61 7.76 3.83 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.295 1.038 . . . . 0.0 113.683 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.32 154.84 21.2 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.815 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.6 tt0 -70.28 107.68 3.85 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.1 p -75.97 -38.03 57.91 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -175.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.01 96.07 0.11 Allowed Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 118.39 -1.862 . . . . 0.0 112.923 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.7 -169.83 19.4 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 62.9 mt -66.22 119.1 10.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.39 -1.82 58.94 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -97.84 130.49 44.75 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 122.006 -0.702 . . . . 0.0 109.114 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -135.7 133.21 37.84 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.23 -141.07 8.17 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.25 98.94 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.392 2.061 . . . . 0.0 111.343 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.5 p -89.42 -11.95 41.66 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.48 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.15 121.79 45.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.6 m -86.29 162.68 18.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.31 143.92 56.33 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -60.31 128.19 35.49 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -14.07 28.66 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.65 144.17 49.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 p -122.25 138.65 54.42 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.522 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.5 t -70.31 107.96 3.99 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -117.96 129.17 55.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.543 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.39 119.49 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.704 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.78 -49.99 3.99 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 108.943 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -126.02 166.08 23.55 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.52 -43.0 52.99 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.553 2.169 . . . . 0.0 112.71 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.0 m-85 -101.39 -26.63 13.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.214 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.3 t80 -93.58 114.86 27.3 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.259 -0.976 . . . . 0.0 113.128 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.5 138.48 54.34 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.6 tt0 -129.18 143.15 50.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 118.861 0.755 . . . . 0.0 111.813 -172.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 55.6 m -76.08 106.52 7.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.43 HD21 ' OE1' ' A' ' 34' ' ' GLN . 94.7 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -71.33 166.95 20.55 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -66.98 130.04 41.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.797 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 75.22 13.87 3.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.549 1.14 . . . . 0.0 113.358 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.44 166.38 20.76 Favored Glycine 0 C--N 1.308 -0.997 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.8 tt0 -76.33 118.98 19.59 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 117.491 0.646 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.0 p -85.16 -37.19 20.46 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.41 68.6 0.04 OUTLIER Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 118.902 -1.618 . . . . 0.0 112.713 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -101.57 176.2 26.17 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.465 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.5 mt -60.42 117.85 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 117.372 0.586 . . . . 0.0 110.19 -178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -25.44 13.7 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.532 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.23 134.5 35.29 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 m -135.54 103.11 5.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.76 -156.4 24.87 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.867 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.28 123.18 8.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.271 2.647 . . . . 0.0 111.59 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -92.92 -5.06 51.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.861 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.6 t -74.75 116.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -84.73 165.61 17.7 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.32 162.68 14.39 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.574 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -57.03 119.63 6.64 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.242 1.017 . . . . 0.0 110.712 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.76 65.21 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.855 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -110.23 143.19 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.16 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -116.29 141.0 48.73 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.316 0.246 . . . . 0.0 111.274 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.86 108.24 9.75 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.14 140.62 49.29 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.95 113.6 25.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.74 -30.85 12.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.78 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -148.2 167.75 12.62 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.05 -43.44 48.02 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.404 2.069 . . . . 0.0 113.391 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 59.0 m-85 -99.68 -25.08 14.51 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -93.64 114.33 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.4 129.74 48.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 174.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -131.11 145.4 51.98 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.6 m -78.22 105.52 9.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.649 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.554 1.108 0 CA-C-O 120.916 0.389 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -61.96 153.79 28.31 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.544 1.938 . . . . 0.0 115.489 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.59 132.28 50.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.281 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 72.31 9.05 5.87 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.94 166.87 19.32 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.493 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -79.46 114.45 18.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -78.56 -52.56 8.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.012 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.6 78.15 0.09 OUTLIER Glycine 0 CA--C 1.47 -2.753 0 C-N-CA 119.282 -1.437 . . . . 0.0 111.18 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.41 173.79 16.71 Favored Glycine 0 N--CA 1.412 -2.939 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.86 115.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.28 37.34 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.937 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -97.11 136.58 37.45 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 109.88 11.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.27 -148.59 16.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.309 -1.424 . . . . 0.0 112.377 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.93 110.06 2.49 Favored 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.389 2.726 . . . . 0.0 111.643 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.4 p -89.17 -17.81 28.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.91 124.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -76.22 161.25 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 172.55 2.49 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -56.91 112.35 1.3 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.31 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.74 -2.95 67.44 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.525 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.0 p -110.04 146.47 35.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.788 0.794 . . . . 0.0 110.928 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 p -118.35 143.48 46.59 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.37 106.63 11.54 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -113.07 130.05 56.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.135 0.493 . . . . 0.0 110.6 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -77.88 112.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.54 -45.71 6.96 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.523 0.678 . . . . 0.0 110.178 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.1 m-20 -125.85 173.38 5.1 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -53.39 -43.53 56.63 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.377 2.052 . . . . 0.0 113.161 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.8 m-85 -105.43 -24.46 12.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.2 t80 -92.72 115.58 28.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -119.09 133.72 55.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -126.98 146.68 50.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.784 0.266 . . . . 0.0 111.316 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -82.09 108.81 15.86 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.2 0.524 . . . . 0.0 111.477 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.001 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.294 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -76.0 158.19 32.21 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.78 0.8 . . . . 0.0 112.794 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -63.71 134.82 56.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 72.19 18.67 4.69 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.08 169.36 13.07 Favored Glycine 0 C--O 1.249 1.041 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -77.56 122.03 24.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 117.401 0.6 . . . . 0.0 109.901 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -99.96 7.65 44.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 119.0 91.03 1.35 Allowed Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 118.236 -1.935 . . . . 0.0 113.146 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.9 -170.66 19.37 Favored Glycine 0 N--CA 1.422 -2.266 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 172.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 45.4 mt -62.22 123.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.66 -26.2 25.49 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.466 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 36.3 t80 -79.41 129.7 34.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -128.87 98.82 5.08 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.98 -136.78 3.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.468 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -69.57 120.8 7.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.859 2.373 . . . . 0.0 112.179 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -110.7 -17.13 13.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.939 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.89 113.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.99 167.32 22.02 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.104 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.52 162.67 7.85 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.066 0.546 . . . . 0.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -60.29 121.64 12.5 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.613 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.18 -3.92 57.01 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.939 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -119.12 142.45 47.91 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -118.02 142.77 47.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.9 t -81.63 98.13 8.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -105.89 132.85 51.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.38 115.64 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.56 -56.11 2.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.582 0.706 . . . . 0.0 109.75 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -111.18 171.98 3.9 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.88 -40.45 85.29 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 121.998 1.798 . . . . 0.0 112.744 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.601 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.9 m-85 -107.11 -23.79 12.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -91.49 114.8 27.43 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.095 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.2 m -118.02 138.47 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.419 HE21 HD21 ' A' ' 36' ' ' LEU . 30.4 tt0 -135.53 143.72 45.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 118.922 0.783 . . . . 0.0 112.121 -174.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.5 m -75.07 112.41 11.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.85 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.419 HD21 HE21 ' A' ' 34' ' ' GLN . 95.8 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.3 tm0? -80.05 135.37 36.34 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.199 0.523 . . . . 0.0 110.43 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -76.35 163.77 26.67 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.633 1.173 . . . . 0.0 114.157 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -65.02 129.18 38.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 74.93 17.94 2.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.502 1.121 . . . . 0.0 113.43 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.37 165.55 12.15 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.47 116.98 20.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.231 0.515 . . . . 0.0 110.315 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.9 p -81.53 -51.65 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.849 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 177.51 96.19 0.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 119.39 -1.386 . . . . 0.0 112.759 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.5 -176.85 20.77 Favored Glycine 0 C--N 1.291 -1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.1 mt -61.1 115.32 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 117.181 0.491 . . . . 0.0 109.718 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 -13.93 56.36 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.379 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.623 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 52.4 t80 -89.98 114.23 26.03 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.3 m -108.97 121.75 45.8 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.94 -157.15 28.89 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.36 102.92 1.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.68 2.254 . . . . 0.0 110.748 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA3' ' A' ' 9' ' ' GLY . 17.5 p -87.68 -10.52 51.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.441 0.638 . . . . 0.0 111.653 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -82.42 123.73 38.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.5 m -85.46 167.74 15.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 122.618 0.367 . . . . 0.0 110.357 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.45 155.63 39.51 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.246 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.69 119.89 4.66 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.462 0.705 . . . . 0.0 112.16 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.17 -13.11 57.31 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.768 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -110.09 137.86 47.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.296 0.548 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.9 p -108.92 136.68 48.06 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -76.07 97.79 4.16 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -102.87 125.73 49.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.006 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.1 t -78.81 104.94 7.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 mt -87.45 -44.29 11.43 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.579 0.704 . . . . 0.0 109.67 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -127.83 167.27 19.0 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.68 -38.1 76.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.644 2.229 . . . . 0.0 113.197 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.41 -25.23 10.63 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.788 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -92.52 115.3 27.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.431 0.634 . . . . 0.0 111.714 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -124.0 136.07 54.05 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.4 tt0 -129.04 142.39 50.92 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 117.926 0.33 . . . . 0.0 111.458 -171.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -80.17 108.33 13.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' OE1' ' A' ' 34' ' ' GLN . 92.7 mt . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 123.596 0.758 . . . . 0.0 109.365 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.623 ' H5 ' ' O ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.95 134.93 35.8 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.351 0.596 . . . . 0.0 110.644 -173.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 m -61.32 155.83 20.34 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.069 1.747 . . . . 0.0 114.876 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.432 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.1 t-160 -68.23 132.71 47.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 74.32 7.3 4.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.06 0.944 . . . . 0.0 112.861 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.42 160.78 23.82 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.622 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -72.75 113.5 9.85 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 p -88.05 -38.72 15.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.22 75.08 0.05 OUTLIER Glycine 0 CA--C 1.476 -2.391 0 C-N-CA 117.177 -2.44 . . . . 0.0 113.79 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 171.93 15.2 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.36 122.87 10.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.15 -26.47 12.21 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.782 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -102.14 148.27 25.61 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 p -158.81 156.18 29.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.686 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.22 -121.95 4.77 Favored Glycine 0 C--N 1.308 -1.018 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.43 100.69 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 121.964 1.776 . . . . 0.0 109.841 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.7 p -99.21 -20.39 16.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.796 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -87.11 124.73 40.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.834 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.0 m -79.02 167.29 21.3 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.541 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 148.64 51.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -54.23 123.24 12.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.032 0.444 . . . . 0.0 110.707 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -14.58 31.01 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.3 p -117.0 142.25 47.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 31.5 p -115.72 141.29 48.28 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.134 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.53 102.46 9.75 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -105.16 119.56 39.34 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.535 0.683 . . . . 0.0 110.92 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.85 106.98 6.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.089 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 mt -91.37 -44.2 9.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -128.0 166.23 25.19 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -57.12 -33.87 96.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.661 1.574 . . . . 0.0 111.911 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 9.7 m-85 -102.23 -27.63 12.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.92 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -94.65 114.92 26.92 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.119 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -133.66 130.51 38.33 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.86 140.18 52.54 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 123.032 0.207 . . . . 0.0 110.986 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.1 m -76.2 111.29 11.47 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.287 -2.121 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.539 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.87 145.61 30.28 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -81.61 165.35 21.16 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.811 0.844 . . . . 0.0 112.863 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.3 136.02 44.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 73.11 21.21 3.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.525 0.73 . . . . 0.0 112.41 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.66 151.6 18.34 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.08 121.08 15.96 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -87.1 -42.36 13.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.97 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 168.97 98.18 0.12 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.592 -1.765 . . . . 0.0 113.531 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.88 -179.72 20.83 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 174.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.97 116.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 117.655 0.728 . . . . 0.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.43 -18.19 48.8 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.44 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 64.2 t80 -80.97 136.08 35.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.762 0.281 . . . . 0.0 111.417 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -124.66 113.82 18.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.63 -161.56 30.47 Favored Glycine 0 C--N 1.306 -1.105 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.2 114.87 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.89 2.393 . . . . 0.0 110.459 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p -90.04 -23.68 21.39 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.17 120.6 36.74 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.83 164.41 19.51 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.174 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 141.31 57.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.7 120.67 7.08 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.418 0.448 . . . . 0.0 109.824 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.51 -10.46 28.29 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.8 p -121.7 140.49 52.24 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -113.87 135.3 54.12 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.875 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.91 98.05 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.54 145.06 30.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.286 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.2 t -87.98 111.73 22.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.26 -43.59 11.46 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.392 0.615 . . . . 0.0 109.687 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -138.82 169.55 12.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.57 -29.17 89.24 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.245 1.48 . . . . 0.0 111.622 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.4 m-85 -102.53 -25.57 13.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.23 114.18 26.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.5 m -138.04 129.37 27.66 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -137.01 147.31 46.17 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.385 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.4 m -76.39 107.77 8.88 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.431 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -87.31 145.03 26.51 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.105 -176.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -72.31 160.91 31.6 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.68 131.85 45.88 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 71.73 17.52 5.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.029 0.932 . . . . 0.0 112.403 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.04 164.68 12.3 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.7 tt0 -82.14 110.22 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 122.586 0.354 . . . . 0.0 110.241 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -73.32 -41.87 63.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.97 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 154.95 96.97 0.13 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.947 -1.597 . . . . 0.0 113.833 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.63 -152.58 13.09 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.5 mt -70.54 125.97 29.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.7 -21.18 37.23 Favored Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.616 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.15 121.08 30.39 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.421 -0.458 . . . . 0.0 109.842 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -141.22 111.99 7.1 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.1 -116.95 0.39 Allowed Glycine 0 C--N 1.304 -1.222 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 2.6 Cg_endo -77.65 90.16 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 CA-C-N 119.587 1.694 . . . . 0.0 108.631 173.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.403 HG22 ' HA3' ' A' ' 9' ' ' GLY . 7.7 p -82.83 -20.68 35.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.344 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.4 t -84.76 128.28 39.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -82.16 163.46 21.94 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.388 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.3 152.49 43.65 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.316 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -53.56 122.78 10.47 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.973 0.909 . . . . 0.0 111.349 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -19.92 25.59 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.734 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 p -118.77 147.94 43.35 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.481 -0.423 . . . . 0.0 111.686 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 20.5 p -115.81 146.44 41.96 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.012 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -81.24 99.54 8.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.8 127.48 49.95 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.069 0.461 . . . . 0.0 110.366 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.71 106.64 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.91 -52.99 4.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.13 163.36 30.38 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.86 -41.58 62.25 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.688 2.259 . . . . 0.0 113.458 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 45.5 m-85 -99.15 -26.59 14.15 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.012 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 26.1 t80 -94.05 114.6 26.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -120.35 133.19 55.49 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -129.26 144.27 51.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 117.785 0.266 . . . . 0.0 110.956 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.0 m -79.41 110.65 14.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.061 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.93 33.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -94.11 176.49 6.31 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.09 129.03 39.76 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.778 0.831 . . . . 0.0 110.087 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.26 13.3 m-85 71.58 59.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -157.42 155.11 26.12 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.6 tt0 -72.87 115.1 11.76 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 117.541 0.67 . . . . 0.0 109.648 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.2 p -90.74 -36.42 14.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.889 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.56 88.43 0.07 OUTLIER Glycine 0 CA--C 1.488 -1.655 0 C-N-CA 118.835 -1.65 . . . . 0.0 112.662 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.64 178.96 20.06 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 175.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 59.4 mt -64.2 116.71 3.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.68 -10.22 55.88 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.416 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -84.88 144.17 28.56 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.7 m -138.73 99.12 3.72 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.97 -142.38 4.62 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.945 -1.122 . . . . 0.0 112.467 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 106.91 1.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.332 2.688 . . . . 0.0 111.302 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.3 p -88.9 -9.58 51.04 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.781 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -89.32 121.88 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.41 154.8 19.77 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.31 148.18 19.31 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.912 0.758 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -57.84 119.84 7.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.518 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.83 27.86 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.84 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -116.33 140.23 49.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -114.45 141.78 47.24 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.204 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.28 97.61 7.06 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -103.47 135.52 44.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.52 99.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -46.16 19.7 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -128.74 164.24 39.79 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.52 -35.25 65.79 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.642 2.228 . . . . 0.0 113.503 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.645 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 80.5 m-85 -110.21 -24.98 10.4 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.163 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 57.1 t80 -93.38 114.68 27.16 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.1 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -116.38 138.43 51.35 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.0 tt0 -131.39 143.36 50.41 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 117.977 0.353 . . . . 0.0 110.873 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.4 m -77.6 105.98 9.1 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.412 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 144.35 42.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -82.95 160.26 22.09 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -65.44 133.14 50.67 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.103 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 77.18 7.34 3.0 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.581 1.153 . . . . 0.0 112.355 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 161.14 18.34 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.483 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -74.7 120.0 19.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.195 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.7 p -82.91 -52.82 6.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.468 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.94 85.68 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.0 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.23 179.35 20.4 Favored Glycine 0 C--N 1.293 -1.825 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.9 mt -62.42 112.9 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 117.668 0.734 . . . . 0.0 109.508 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.51 -17.1 26.2 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.378 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -94.07 138.81 31.73 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.653 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -136.34 136.01 39.34 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.5 -142.13 11.02 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.66 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.91 101.74 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.734 2.289 . . . . 0.0 111.757 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 p -90.93 -0.57 57.77 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.24 0.543 . . . . 0.0 112.315 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.48 113.41 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.0 m -77.36 167.41 21.73 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.678 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.28 154.12 24.58 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.968 0.507 . . . . 0.0 110.844 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -57.6 112.43 1.44 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.312 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.88 -9.71 29.69 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -113.86 139.31 49.28 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.477 -0.425 . . . . 0.0 109.855 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.8 p -113.1 145.13 41.44 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.49 100.83 7.89 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -105.49 131.97 52.24 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.48 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.92 100.25 7.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.02 -58.15 3.29 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.856 0.836 . . . . 0.0 108.818 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.1 m-20 -114.18 165.75 13.0 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -38.28 94.83 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.184 1.922 . . . . 0.0 112.621 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.8 m-85 -104.45 -26.11 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.0 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -93.35 114.89 27.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.93 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.69 131.05 53.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -125.73 145.1 50.33 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.604 0.184 . . . . 0.0 110.989 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -79.55 104.45 10.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--N 1.293 -1.871 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.96 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.443 -0.817 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -90.15 134.16 34.44 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -78.94 171.64 14.91 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.38 132.9 50.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.65 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 76.95 7.43 3.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.975 1.31 . . . . 0.0 113.747 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -96.16 171.03 27.93 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.7 tt0 -85.35 120.17 26.53 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.748 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.6 p -81.09 -50.7 9.32 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.262 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.94 87.48 0.07 OUTLIER Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.267 -1.444 . . . . 0.0 111.877 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 -176.28 20.83 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 174.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.2 mt -64.6 125.87 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 117.52 0.66 . . . . 0.0 109.26 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.69 60.03 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.307 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -107.65 142.61 37.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -145.31 139.98 27.43 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.81 -134.49 4.75 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.951 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.01 97.12 0.98 Allowed 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.324 2.016 . . . . 0.0 110.885 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 38.9 p -82.05 -19.11 40.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.295 0.569 . . . . 0.0 111.459 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -82.14 122.15 36.46 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -85.53 163.68 18.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.352 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 150.6 39.91 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 p -57.32 122.82 13.44 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.666 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.82 26.86 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.373 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -110.46 143.17 41.17 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -116.63 141.21 48.49 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 121.994 0.117 . . . . 0.0 111.164 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.61 104.84 5.44 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -110.51 127.75 55.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.255 0.55 . . . . 0.0 110.916 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -81.29 109.1 15.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.55 -48.46 7.29 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -122.77 164.63 25.68 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.27 -36.22 77.26 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.296 1.998 . . . . 0.0 113.087 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -102.98 -25.73 13.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.553 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -94.36 114.74 26.84 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -124.87 129.03 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -127.38 142.9 51.31 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.637 0.256 . . . . 0.0 111.57 -173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -78.49 107.41 11.12 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.297 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.434 -1.274 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 135.28 33.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -74.06 162.33 29.12 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -64.03 135.54 56.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.133 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 71.54 17.78 5.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.792 0.837 . . . . 0.0 112.522 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -110.5 165.41 12.25 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.187 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.9 tt0 -76.42 111.94 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.4 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.0 p -89.98 -30.78 17.56 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.73 75.8 0.05 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 118.882 -1.628 . . . . 0.0 112.534 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.49 179.45 29.33 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.91 113.46 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 117.585 0.692 . . . . 0.0 110.028 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.66 -17.31 36.35 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.018 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -86.5 137.74 32.29 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -140.96 130.22 23.59 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.54 -126.97 3.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.521 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.14 98.59 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.84 2.36 . . . . 0.0 112.254 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.9 p -96.68 -17.31 20.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.314 0.578 . . . . 0.0 111.792 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.41 121.57 37.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -84.3 167.43 16.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 167.62 11.84 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 122.966 0.506 . . . . 0.0 111.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -54.8 113.55 1.37 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.057 0.943 . . . . 0.0 111.881 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -0.59 60.38 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.975 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.9 p -112.94 141.61 46.57 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.136 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.2 p -114.47 142.46 46.36 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.327 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.74 111.66 18.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -122.94 139.55 53.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.66 120.34 21.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -97.51 -44.57 6.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -134.71 166.8 26.49 Favored Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.46 -43.5 22.08 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.95 2.434 . . . . 0.0 114.034 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.633 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 77.8 m-85 -101.91 -24.97 13.95 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.293 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 46.1 t80 -93.8 114.45 26.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.909 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.2 m -113.72 136.17 53.14 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.472 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.97 142.71 50.84 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 117.93 0.332 . . . . 0.0 111.298 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.7 m -77.83 117.91 19.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 124.213 1.005 . . . . 0.0 108.627 178.819 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 134.72 35.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 161.5 27.54 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -66.14 134.82 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.51 5.98 2.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.555 1.542 . . . . 0.0 112.532 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.06 163.95 27.05 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.3 tt0 -79.99 116.69 20.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -80.92 -43.73 19.34 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.806 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 163.36 97.18 0.12 Allowed Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.11 -170.53 19.95 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.9 121.6 12.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.39 -9.85 59.35 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.167 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 23.5 t80 -98.81 136.52 38.72 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 13.9 m -141.05 106.09 4.97 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.61 -149.4 8.63 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.419 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.16 104.24 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.975 2.45 . . . . 0.0 111.557 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 p -85.33 -15.38 43.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.338 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.8 109.85 2.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.494 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -83.42 164.51 19.88 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.714 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.04 154.04 27.93 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.425 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 m -60.28 118.78 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.12 0.486 . . . . 0.0 110.567 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.68 -9.8 55.66 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.08 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -110.16 136.66 49.04 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.8 p -116.2 134.61 54.73 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.728 0.299 . . . . 0.0 111.685 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -67.37 112.17 4.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -122.5 135.36 54.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.111 0.481 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.1 102.86 4.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.359 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.28 -44.93 14.39 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -129.31 164.3 40.42 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.92 -40.14 86.31 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 121.559 1.506 . . . . 0.0 112.026 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -97.72 -27.83 14.17 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 118.894 -1.123 . . . . 0.0 111.089 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.17 114.12 25.88 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.313 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.1 m -120.42 133.59 55.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -125.59 143.04 51.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 120.437 0.16 . . . . 0.0 111.284 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -78.62 108.02 11.72 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.6 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.475 ' H2 ' ' HB2' ' A' ' 14' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -90.59 136.21 33.21 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -87.45 169.82 11.89 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -60.0 130.87 48.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.191 1.396 . . . . 0.0 109.848 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 78.76 7.2 2.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.807 1.243 . . . . 0.0 112.988 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -98.75 158.41 20.26 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.0 tt0 -76.54 113.19 13.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.9 p -82.48 -21.35 35.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.03 87.17 0.18 Allowed Glycine 0 CA--C 1.479 -2.189 0 C-N-CA 118.148 -1.977 . . . . 0.0 113.925 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.14 -165.66 25.76 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.89 118.35 7.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 118.076 0.938 . . . . 0.0 109.04 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.44 -26.91 11.23 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.609 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -106.24 115.49 30.31 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -125.77 162.54 24.86 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 114.31 -117.68 4.18 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.901 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 23.5 Cg_exo -66.32 97.85 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.673 2.248 . . . . 0.0 110.964 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.3 p -111.94 -18.85 12.56 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.685 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -80.55 114.01 20.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.516 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.03 165.11 19.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.07 154.7 41.62 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.344 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -62.71 120.18 10.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -6.34 30.67 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.3 p -123.15 148.44 45.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 p -121.94 137.3 54.84 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.144 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -70.18 103.52 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -109.8 130.23 55.54 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.954 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.29 110.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.676 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.65 -29.18 13.19 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 20.7 m120 -145.53 165.63 20.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -55.81 -38.78 94.02 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.687 1.591 . . . . 0.0 112.424 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -100.12 -26.86 13.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.289 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 52.2 t80 -94.47 114.01 25.95 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -132.2 132.97 43.65 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -130.62 143.56 50.83 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 117.731 0.241 . . . . 0.0 111.283 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.88 104.29 7.29 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.291 -1.978 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.772 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.84 147.37 27.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -89.69 158.27 17.63 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 113.38 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -61.35 132.96 55.2 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.537 1.135 . . . . 0.0 109.235 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.267 8.0 m-85 74.85 8.12 4.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.9 163.58 22.41 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -78.48 110.77 13.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.741 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.3 p -82.17 -35.02 28.8 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.53 84.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 118.686 -1.721 . . . . 0.0 112.971 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.51 -174.93 20.52 Favored Glycine 0 C--N 1.294 -1.79 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -62.12 122.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 118.061 0.93 . . . . 0.0 108.55 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.36 -6.8 42.61 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.038 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -125.08 136.09 53.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.5 m -150.04 101.41 3.02 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.549 1.14 . . . . 0.0 108.672 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.42 -134.73 1.78 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.19 99.32 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.775 2.317 . . . . 0.0 111.193 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.3 p -91.79 -17.17 25.75 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.16 109.98 10.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.702 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.0 m -85.12 159.02 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.917 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.91 152.44 10.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.471 0.708 . . . . 0.0 111.61 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -59.65 113.35 2.19 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.832 0.825 . . . . 0.0 111.774 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -11.55 29.33 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.282 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -112.56 136.87 51.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -116.06 137.62 51.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.586 0.231 . . . . 0.0 111.142 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.81 106.11 4.04 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.62 126.4 55.23 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.37 102.86 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.41 -44.98 15.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 84.5 m-20 -132.9 166.03 32.25 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.45 -42.74 63.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.219 1.946 . . . . 0.0 113.593 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -97.88 -26.46 14.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.761 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 37.4 t80 -94.55 114.18 26.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.5 m -120.73 138.02 54.2 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -133.61 142.03 47.92 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 123.037 0.21 . . . . 0.0 111.284 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.92 105.21 7.85 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.781 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 153.66 20.16 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -92.45 173.97 7.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.65 0.738 . . . . 0.0 112.167 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -72.31 135.56 45.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.065 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.83 59.07 0.37 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.332 1.053 . . . . 0.0 112.366 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.0 153.63 24.89 Favored Glycine 0 C--O 1.254 1.394 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -68.05 116.12 8.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.179 0.489 . . . . 0.0 110.608 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.9 p -82.85 -46.01 13.57 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.677 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.89 107.55 0.24 Allowed Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.371 -1.395 . . . . 0.0 113.45 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.27 -160.5 17.86 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 74.2 mt -66.39 122.79 18.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 117.706 0.753 . . . . 0.0 109.167 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.34 63.53 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.559 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -116.17 139.24 50.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.779 0.79 . . . . 0.0 110.348 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -138.87 145.98 40.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.81 -137.31 5.9 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.7 91.56 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.678 2.252 . . . . 0.0 110.876 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -93.94 -5.43 47.82 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.252 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.33 113.78 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.2 m -80.62 162.96 23.98 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 152.09 42.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 111.09 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 m -60.75 116.74 4.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.394 0.616 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -15.05 29.4 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.6 p -109.64 146.55 34.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.2 p -118.2 135.32 54.32 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.966 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 51.0 t -74.01 98.13 3.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -99.62 130.05 45.82 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.03 94.29 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.2 -46.65 22.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.976 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 3.0 m-20 -126.98 168.64 14.09 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.46 -34.31 93.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.421 1.414 . . . . 0.0 112.216 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 11' ' ' ILE . 23.2 m-85 -106.76 -26.39 11.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.139 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 25.2 t80 -93.0 114.69 27.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.463 0.649 . . . . 0.0 110.758 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.8 m -129.53 134.9 48.01 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.485 HE21 HD21 ' A' ' 36' ' ' LEU . 29.5 tt0 -134.29 141.7 47.04 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.693 -172.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 34.5 m -73.36 105.53 4.79 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HE21 ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 132.2 44.01 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 m -66.29 159.8 25.85 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.619 1.168 . . . . 0.0 113.818 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -67.79 123.23 19.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 77.94 58.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.92 0.888 . . . . 0.0 112.552 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' GLN . . . -156.09 160.87 30.4 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 64.3 tt0 -78.61 116.21 18.83 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.802 0.801 . . . . 0.0 110.215 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.733 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.0 p -86.75 -44.35 11.85 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.45 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.88 84.49 0.06 OUTLIER Glycine 0 CA--C 1.481 -2.072 0 C-N-CA 119.278 -1.439 . . . . 0.0 112.01 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.95 -172.67 20.42 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 63.6 mt -66.85 113.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 117.307 0.553 . . . . 0.0 109.663 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -9.18 32.48 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.656 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -102.83 135.08 45.16 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.555 -0.379 . . . . 0.0 110.116 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -139.11 116.13 10.95 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.51 -147.21 10.76 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.98 95.49 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.115 2.543 . . . . 0.0 111.628 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.1 p -80.57 -26.61 37.82 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.244 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.4 117.8 20.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 110.052 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.0 m -81.04 167.53 19.66 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.2 40.46 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 117.7 4.51 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.965 0.506 . . . . 0.0 109.749 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.71 -0.29 34.28 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.673 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -128.77 142.87 50.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -116.12 136.52 52.94 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.875 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 48.1 t -76.84 103.21 6.66 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -119.75 142.86 48.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.921 0.391 . . . . 0.0 111.444 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 114.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.77 -43.89 8.4 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -134.76 165.6 35.5 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.54 -38.85 45.44 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 122.721 2.281 . . . . 0.0 114.513 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.8 m-85 -106.63 -24.86 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.32 0.581 . . . . 0.0 110.812 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 7' ' ' GLN . 36.0 t80 -93.3 113.87 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.452 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -112.56 135.81 52.84 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.456 HE21 HD21 ' A' ' 36' ' ' LEU . 28.4 tt0 -132.06 144.91 51.08 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.3 m -72.43 108.54 5.58 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.137 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.456 HD21 HE21 ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 9.5 m . . . . . 0 N--CA 1.437 -1.101 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.07 140.0 53.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -61.21 154.49 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.452 ' CE1' ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -63.94 132.83 51.9 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 71.06 11.8 6.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.66 166.88 19.63 Favored Glycine 0 C--O 1.251 1.194 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -76.85 109.14 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -83.7 -33.51 25.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.38 93.25 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 117.971 -2.061 . . . . 0.0 113.217 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.98 -169.88 19.19 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.03 119.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.39 -16.33 45.19 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.708 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -105.49 121.62 44.31 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -135.3 123.48 22.99 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 157.81 -126.08 1.66 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.312 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 7.0 Cg_exo -72.36 96.28 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.545 2.163 . . . . 0.0 111.418 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.2 p -100.74 -10.48 20.78 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 1' ' ' THR . 64.6 t -90.25 114.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 80.3 m -75.34 159.69 31.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.788 -178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.96 170.19 3.71 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.194 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.0 t -61.62 120.3 10.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.976 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.62 -9.28 58.7 Favored Glycine 0 N--CA 1.423 -2.191 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.294 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -114.68 145.66 41.78 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.916 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 p -116.85 134.57 54.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 54.1 t -73.94 105.4 5.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.73 141.05 48.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.231 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.93 112.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.865 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -96.93 -34.64 11.15 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 24.6 m120 -143.13 166.23 21.46 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.98 -43.3 58.0 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.16 1.907 . . . . 0.0 112.977 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.5 m-85 -97.33 -26.18 14.98 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.245 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.0 t80 -93.74 114.18 26.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.686 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -122.3 137.26 54.91 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.73 141.14 49.45 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 123.097 0.248 . . . . 0.0 111.155 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.5 m -77.26 108.32 10.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.991 176.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.452 ' O ' ' CE1' ' A' ' 4' ' ' HIS . 96.5 mt . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -83.37 146.54 28.41 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.999 0.818 . . . . 0.0 111.85 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -63.35 165.56 7.49 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 125.496 1.518 . . . . 0.0 113.589 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.47 139.42 51.71 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 72.18 23.13 3.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.776 0.798 . . . . 0.0 112.124 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.76 148.15 17.27 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 13' ' ' TYR . 50.2 tt0 -70.49 109.71 4.97 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.732 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.1 p -71.25 -47.28 58.07 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.17 88.16 0.07 OUTLIER Glycine 0 N--CA 1.417 -2.602 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.284 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.75 177.58 19.41 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.14 118.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' H62' ' A' ' 101' ' ' MAN . . . 110.54 -11.92 30.47 Favored Glycine 0 C--N 1.306 -1.119 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.838 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' HE21 ' A' ' 7' ' ' GLN . 60.7 t80 -96.01 132.92 40.84 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -134.78 95.74 3.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.8 8.94 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.983 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.52 107.87 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.271 2.648 . . . . 0.0 112.318 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 43.0 p -87.17 -13.93 42.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.261 0.553 . . . . 0.0 111.227 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.79 116.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -85.51 153.35 22.51 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.044 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.2 149.01 5.71 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.661 1.184 . . . . 0.0 111.934 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -54.56 112.29 0.98 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.431 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.22 -1.21 29.72 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.2 p -129.35 143.95 51.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -120.74 148.73 43.57 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.742 0.306 . . . . 0.0 111.718 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -74.26 118.8 17.64 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.12 126.96 49.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.285 0.564 . . . . 0.0 110.558 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -79.46 103.42 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.097 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.75 -48.6 8.11 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 74.0 m-20 -129.23 171.37 8.88 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.12 -43.91 43.75 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 121.671 1.581 . . . . 0.0 112.319 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.1 m-85 -98.93 -25.81 14.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.247 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 26.6 t80 -93.35 114.66 27.14 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.491 0.662 . . . . 0.0 111.773 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.9 m -135.81 127.68 29.39 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -129.84 148.4 51.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.07 0.396 . . . . 0.0 111.99 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 41.6 m -76.57 112.64 13.32 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.43 ' H62' ' O ' ' A' ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 8' ' ' CYS . 7.0 tt0 -95.64 157.8 15.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.999 0.428 . . . . 0.0 111.122 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.477 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 9.8 m -64.77 165.4 10.57 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.142 1.777 . . . . 0.0 112.985 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -80.94 134.8 35.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 71.98 59.44 0.15 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.162 0.982 . . . . 0.0 112.324 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.09 156.4 26.7 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.9 tt0 -76.38 110.58 11.02 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 117.321 0.561 . . . . 0.0 109.645 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -70.39 -49.34 50.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.759 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.73 87.87 0.07 OUTLIER Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.96 172.4 15.75 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.05 113.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -11.13 37.55 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.741 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -104.25 132.92 49.98 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -127.57 129.28 47.05 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.95 -153.38 23.74 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.565 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.44 99.36 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.17 2.58 . . . . 0.0 111.688 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -81.94 -21.8 37.05 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.626 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -87.29 122.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -90.09 165.23 14.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 158.41 7.75 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 123.353 0.661 . . . . 0.0 111.331 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -59.51 118.28 5.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 -20.29 25.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.6 p -109.96 141.58 42.53 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 28.1 p -124.55 147.24 48.55 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.0 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.52 109.32 8.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -118.02 132.13 56.41 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.02 109.39 11.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.07 -43.63 8.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.557 0.694 . . . . 0.0 109.893 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -130.31 166.0 29.95 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.18 -42.25 47.28 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.714 2.276 . . . . 0.0 113.542 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.7 m-85 -104.32 -25.08 13.0 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.042 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 32.1 t80 -92.57 115.32 28.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.591 -0.843 . . . . 0.0 112.718 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.86 131.12 53.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.3 tt0 -128.73 148.24 50.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 118.116 0.417 . . . . 0.0 111.977 -171.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.0 m -77.47 106.52 9.29 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.317 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.405 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -99.22 157.81 16.12 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.138 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -74.79 165.78 24.68 Favored 'General case' 0 C--O 1.248 1.005 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -64.09 139.74 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.043 1.337 . . . . 0.0 107.61 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 75.61 7.76 3.83 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.295 1.038 . . . . 0.0 113.683 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.32 154.84 21.2 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.815 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.6 tt0 -70.28 107.68 3.85 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.1 p -75.97 -38.03 57.91 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -175.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.01 96.07 0.11 Allowed Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 118.39 -1.862 . . . . 0.0 112.923 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.7 -169.83 19.4 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 62.9 mt -66.22 119.1 10.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.39 -1.82 58.94 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -97.84 130.49 44.75 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 122.006 -0.702 . . . . 0.0 109.114 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -135.7 133.21 37.84 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.23 -141.07 8.17 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.25 98.94 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.392 2.061 . . . . 0.0 111.343 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.5 p -89.42 -11.95 41.66 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.48 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.15 121.79 45.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.6 m -86.29 162.68 18.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.31 143.92 56.33 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -60.31 128.19 35.49 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -14.07 28.66 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.65 144.17 49.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 p -122.25 138.65 54.42 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.522 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.5 t -70.31 107.96 3.99 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -117.96 129.17 55.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.543 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.39 119.49 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.704 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.78 -49.99 3.99 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 108.943 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -126.02 166.08 23.55 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.52 -43.0 52.99 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.553 2.169 . . . . 0.0 112.71 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.0 m-85 -101.39 -26.63 13.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.214 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.3 t80 -93.58 114.86 27.3 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.259 -0.976 . . . . 0.0 113.128 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.5 138.48 54.34 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.6 tt0 -129.18 143.15 50.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 118.861 0.755 . . . . 0.0 111.813 -172.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 55.6 m -76.08 106.52 7.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.43 HD21 ' OE1' ' A' ' 34' ' ' GLN . 94.7 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.87 133.31 34.31 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.367 -172.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -71.33 166.95 20.55 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -66.98 130.04 41.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.797 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 75.22 13.87 3.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.549 1.14 . . . . 0.0 113.358 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.44 166.38 20.76 Favored Glycine 0 C--N 1.308 -0.997 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.8 tt0 -76.33 118.98 19.59 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 117.491 0.646 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.0 p -85.16 -37.19 20.46 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.41 68.6 0.04 OUTLIER Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 118.902 -1.618 . . . . 0.0 112.713 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -101.57 176.2 26.17 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.465 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.5 mt -60.42 117.85 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 117.372 0.586 . . . . 0.0 110.19 -178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -25.44 13.7 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.532 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.23 134.5 35.29 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 m -135.54 103.11 5.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.76 -156.4 24.87 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.867 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.28 123.18 8.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.271 2.647 . . . . 0.0 111.59 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -92.92 -5.06 51.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.861 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.6 t -74.75 116.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -84.73 165.61 17.7 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.32 162.68 14.39 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.574 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -57.03 119.63 6.64 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.242 1.017 . . . . 0.0 110.712 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.76 65.21 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.855 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -110.23 143.19 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.16 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -116.29 141.0 48.73 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.316 0.246 . . . . 0.0 111.274 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.86 108.24 9.75 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.14 140.62 49.29 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.95 113.6 25.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.74 -30.85 12.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.78 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -148.2 167.75 12.62 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.05 -43.44 48.02 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.404 2.069 . . . . 0.0 113.391 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 59.0 m-85 -99.68 -25.08 14.51 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -93.64 114.33 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.4 129.74 48.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 174.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -131.11 145.4 51.98 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.6 m -78.22 105.52 9.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.649 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 20' ' ' ALA . 4.3 m . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.93 140.96 30.72 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 120.916 0.389 . . . . 0.0 111.348 -171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -61.96 153.79 28.31 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.544 1.938 . . . . 0.0 115.489 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.59 132.28 50.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.281 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 72.31 9.05 5.87 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.94 166.87 19.32 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.493 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -79.46 114.45 18.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -78.56 -52.56 8.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.012 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.6 78.15 0.09 OUTLIER Glycine 0 CA--C 1.47 -2.753 0 C-N-CA 119.282 -1.437 . . . . 0.0 111.18 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.41 173.79 16.71 Favored Glycine 0 N--CA 1.412 -2.939 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.86 115.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.28 37.34 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.937 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -97.11 136.58 37.45 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 109.88 11.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.27 -148.59 16.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.309 -1.424 . . . . 0.0 112.377 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.93 110.06 2.49 Favored 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.389 2.726 . . . . 0.0 111.643 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.4 p -89.17 -17.81 28.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.91 124.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -76.22 161.25 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 1' ' ' THR . . . -64.38 172.55 2.49 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.519 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -56.91 112.35 1.3 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.31 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.74 -2.95 67.44 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.525 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.0 p -110.04 146.47 35.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.788 0.794 . . . . 0.0 110.928 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 p -118.35 143.48 46.59 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.37 106.63 11.54 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -113.07 130.05 56.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.135 0.493 . . . . 0.0 110.6 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -77.88 112.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.54 -45.71 6.96 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.523 0.678 . . . . 0.0 110.178 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.1 m-20 -125.85 173.38 5.1 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -53.39 -43.53 56.63 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.377 2.052 . . . . 0.0 113.161 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.8 m-85 -105.43 -24.46 12.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.2 t80 -92.72 115.58 28.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -119.09 133.72 55.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -126.98 146.68 50.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.784 0.266 . . . . 0.0 111.316 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -82.09 108.81 15.86 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.2 0.524 . . . . 0.0 111.477 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.001 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.38 141.58 43.24 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -76.0 158.19 32.21 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.78 0.8 . . . . 0.0 112.794 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -63.71 134.82 56.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 72.19 18.67 4.69 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.08 169.36 13.07 Favored Glycine 0 C--O 1.249 1.041 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -77.56 122.03 24.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 117.401 0.6 . . . . 0.0 109.901 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -99.96 7.65 44.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 119.0 91.03 1.35 Allowed Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 118.236 -1.935 . . . . 0.0 113.146 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.9 -170.66 19.37 Favored Glycine 0 N--CA 1.422 -2.266 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 172.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 45.4 mt -62.22 123.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.582 ' O ' ' H2 ' ' A' ' 101' ' ' MAN . . . 100.66 -26.2 25.49 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.466 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 36.3 t80 -79.41 129.7 34.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -128.87 98.82 5.08 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.98 -136.78 3.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.468 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -69.57 120.8 7.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.859 2.373 . . . . 0.0 112.179 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -110.7 -17.13 13.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.939 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.89 113.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.99 167.32 22.02 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.104 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.52 162.67 7.85 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.066 0.546 . . . . 0.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -60.29 121.64 12.5 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.613 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.18 -3.92 57.01 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.939 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -119.12 142.45 47.91 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -118.02 142.77 47.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.9 t -81.63 98.13 8.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -105.89 132.85 51.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.38 115.64 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.56 -56.11 2.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.582 0.706 . . . . 0.0 109.75 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -111.18 171.98 3.9 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.88 -40.45 85.29 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 121.998 1.798 . . . . 0.0 112.744 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.601 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.9 m-85 -107.11 -23.79 12.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -91.49 114.8 27.43 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.095 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.2 m -118.02 138.47 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.419 HE21 HD21 ' A' ' 36' ' ' LEU . 30.4 tt0 -135.53 143.72 45.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 118.922 0.783 . . . . 0.0 112.121 -174.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.5 m -75.07 112.41 11.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.85 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.419 HD21 HE21 ' A' ' 34' ' ' GLN . 95.8 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.582 ' H2 ' ' O ' ' A' ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.225 0 CA-C-O 121.199 0.523 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -76.35 163.77 26.67 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.633 1.173 . . . . 0.0 114.157 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -65.02 129.18 38.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 74.93 17.94 2.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.502 1.121 . . . . 0.0 113.43 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' HA3' HE22 ' A' ' 2' ' ' GLN . . . -111.37 165.55 12.15 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.47 116.98 20.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.231 0.515 . . . . 0.0 110.315 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.9 p -81.53 -51.65 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.849 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 177.51 96.19 0.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 119.39 -1.386 . . . . 0.0 112.759 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.5 -176.85 20.77 Favored Glycine 0 C--N 1.291 -1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.1 mt -61.1 115.32 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 117.181 0.491 . . . . 0.0 109.718 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 -13.93 56.36 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.379 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -89.98 114.23 26.03 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.3 m -108.97 121.75 45.8 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.94 -157.15 28.89 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.36 102.92 1.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.68 2.254 . . . . 0.0 110.748 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA3' ' A' ' 9' ' ' GLY . 17.5 p -87.68 -10.52 51.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.441 0.638 . . . . 0.0 111.653 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -82.42 123.73 38.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.5 m -85.46 167.74 15.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 122.618 0.367 . . . . 0.0 110.357 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.45 155.63 39.51 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.246 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.69 119.89 4.66 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.462 0.705 . . . . 0.0 112.16 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.17 -13.11 57.31 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.768 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -110.09 137.86 47.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.296 0.548 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.9 p -108.92 136.68 48.06 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -76.07 97.79 4.16 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -102.87 125.73 49.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.006 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.1 t -78.81 104.94 7.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 mt -87.45 -44.29 11.43 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.579 0.704 . . . . 0.0 109.67 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -127.83 167.27 19.0 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.68 -38.1 76.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.644 2.229 . . . . 0.0 113.197 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.41 -25.23 10.63 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.788 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -92.52 115.3 27.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.431 0.634 . . . . 0.0 111.714 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -124.0 136.07 54.05 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.4 tt0 -129.04 142.39 50.92 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 117.926 0.33 . . . . 0.0 111.458 -171.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -80.17 108.33 13.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' OE1' ' A' ' 34' ' ' GLN . 92.7 mt . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 123.596 0.758 . . . . 0.0 109.365 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 121.351 0.596 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 m -61.32 155.83 20.34 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.069 1.747 . . . . 0.0 114.876 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.432 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.1 t-160 -68.23 132.71 47.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 74.32 7.3 4.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.06 0.944 . . . . 0.0 112.861 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.42 160.78 23.82 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.622 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -72.75 113.5 9.85 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 p -88.05 -38.72 15.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.22 75.08 0.05 OUTLIER Glycine 0 CA--C 1.476 -2.391 0 C-N-CA 117.177 -2.44 . . . . 0.0 113.79 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 171.93 15.2 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.36 122.87 10.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.15 -26.47 12.21 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.782 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -102.14 148.27 25.61 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 p -158.81 156.18 29.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.686 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.22 -121.95 4.77 Favored Glycine 0 C--N 1.308 -1.018 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.43 100.69 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 121.964 1.776 . . . . 0.0 109.841 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.7 p -99.21 -20.39 16.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.796 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -87.11 124.73 40.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.834 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.0 m -79.02 167.29 21.3 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.541 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 148.64 51.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -54.23 123.24 12.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.032 0.444 . . . . 0.0 110.707 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -14.58 31.01 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.3 p -117.0 142.25 47.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 31.5 p -115.72 141.29 48.28 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.134 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.53 102.46 9.75 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -105.16 119.56 39.34 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.535 0.683 . . . . 0.0 110.92 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.85 106.98 6.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.089 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 mt -91.37 -44.2 9.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -128.0 166.23 25.19 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -57.12 -33.87 96.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.661 1.574 . . . . 0.0 111.911 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 9.7 m-85 -102.23 -27.63 12.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.92 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -94.65 114.92 26.92 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.119 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -133.66 130.51 38.33 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.86 140.18 52.54 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 123.032 0.207 . . . . 0.0 110.986 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.1 m -76.2 111.29 11.47 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.287 -2.121 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.539 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -81.61 165.35 21.16 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.811 0.844 . . . . 0.0 112.863 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.3 136.02 44.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 73.11 21.21 3.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.525 0.73 . . . . 0.0 112.41 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.66 151.6 18.34 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.08 121.08 15.96 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -87.1 -42.36 13.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.97 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 168.97 98.18 0.12 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.592 -1.765 . . . . 0.0 113.531 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.88 -179.72 20.83 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 174.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.97 116.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 117.655 0.728 . . . . 0.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.43 -18.19 48.8 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.44 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 64.2 t80 -80.97 136.08 35.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.762 0.281 . . . . 0.0 111.417 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -124.66 113.82 18.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.63 -161.56 30.47 Favored Glycine 0 C--N 1.306 -1.105 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.2 114.87 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.89 2.393 . . . . 0.0 110.459 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p -90.04 -23.68 21.39 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.17 120.6 36.74 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.83 164.41 19.51 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.174 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 141.31 57.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.7 120.67 7.08 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.418 0.448 . . . . 0.0 109.824 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.51 -10.46 28.29 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.8 p -121.7 140.49 52.24 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -113.87 135.3 54.12 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.875 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.91 98.05 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.54 145.06 30.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.286 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.2 t -87.98 111.73 22.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.525 ' C ' HD22 ' A' ' 29' ' ' ASN . 6.7 mp -88.26 -43.59 11.46 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.392 0.615 . . . . 0.0 109.687 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.525 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -138.82 169.55 12.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.57 -29.17 89.24 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.245 1.48 . . . . 0.0 111.622 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.4 m-85 -102.53 -25.57 13.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.23 114.18 26.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.5 m -138.04 129.37 27.66 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -137.01 147.31 46.17 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.385 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.4 m -76.39 107.77 8.88 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.431 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.28 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.105 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -72.31 160.91 31.6 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -68.68 131.85 45.88 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 71.73 17.52 5.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.029 0.932 . . . . 0.0 112.403 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.04 164.68 12.3 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.7 tt0 -82.14 110.22 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 122.586 0.354 . . . . 0.0 110.241 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -73.32 -41.87 63.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.97 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 154.95 96.97 0.13 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.947 -1.597 . . . . 0.0 113.833 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.63 -152.58 13.09 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.5 mt -70.54 125.97 29.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.7 -21.18 37.23 Favored Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.616 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.15 121.08 30.39 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.421 -0.458 . . . . 0.0 109.842 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -141.22 111.99 7.1 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.1 -116.95 0.39 Allowed Glycine 0 C--N 1.304 -1.222 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 2.6 Cg_endo -77.65 90.16 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 CA-C-N 119.587 1.694 . . . . 0.0 108.631 173.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.403 HG22 ' HA3' ' A' ' 9' ' ' GLY . 7.7 p -82.83 -20.68 35.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.344 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.4 t -84.76 128.28 39.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -82.16 163.46 21.94 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.388 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.3 152.49 43.65 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.316 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -53.56 122.78 10.47 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.973 0.909 . . . . 0.0 111.349 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -19.92 25.59 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.734 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 p -118.77 147.94 43.35 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.481 -0.423 . . . . 0.0 111.686 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 20.5 p -115.81 146.44 41.96 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.012 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -81.24 99.54 8.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.8 127.48 49.95 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.069 0.461 . . . . 0.0 110.366 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.71 106.64 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.91 -52.99 4.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.13 163.36 30.38 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.86 -41.58 62.25 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.688 2.259 . . . . 0.0 113.458 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 45.5 m-85 -99.15 -26.59 14.15 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.012 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 26.1 t80 -94.05 114.6 26.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -120.35 133.19 55.49 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -129.26 144.27 51.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 117.785 0.266 . . . . 0.0 110.956 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.0 m -79.41 110.65 14.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.061 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -94.11 176.49 6.31 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.09 129.03 39.76 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.778 0.831 . . . . 0.0 110.087 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.26 13.3 m-85 71.58 59.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -157.42 155.11 26.12 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.6 tt0 -72.87 115.1 11.76 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 117.541 0.67 . . . . 0.0 109.648 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.2 p -90.74 -36.42 14.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.889 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.56 88.43 0.07 OUTLIER Glycine 0 CA--C 1.488 -1.655 0 C-N-CA 118.835 -1.65 . . . . 0.0 112.662 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.64 178.96 20.06 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 175.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 59.4 mt -64.2 116.71 3.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.68 -10.22 55.88 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.416 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -84.88 144.17 28.56 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.7 m -138.73 99.12 3.72 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.97 -142.38 4.62 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.945 -1.122 . . . . 0.0 112.467 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 106.91 1.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.332 2.688 . . . . 0.0 111.302 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.3 p -88.9 -9.58 51.04 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.781 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -89.32 121.88 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.41 154.8 19.77 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.31 148.18 19.31 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.912 0.758 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -57.84 119.84 7.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.518 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.83 27.86 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.84 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -116.33 140.23 49.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -114.45 141.78 47.24 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.204 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.28 97.61 7.06 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -103.47 135.52 44.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.52 99.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -46.16 19.7 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.413 HD22 ' HB3' ' A' ' 32' ' ' TYR . 44.9 m-80 -128.74 164.24 39.79 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.52 -35.25 65.79 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.642 2.228 . . . . 0.0 113.503 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.645 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 80.5 m-85 -110.21 -24.98 10.4 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.163 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 57.1 t80 -93.38 114.68 27.16 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.1 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -116.38 138.43 51.35 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.0 tt0 -131.39 143.36 50.41 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 117.977 0.353 . . . . 0.0 110.873 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.4 m -77.6 105.98 9.1 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.412 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -82.95 160.26 22.09 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -65.44 133.14 50.67 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.103 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 77.18 7.34 3.0 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.581 1.153 . . . . 0.0 112.355 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 161.14 18.34 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.483 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -74.7 120.0 19.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.195 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.7 p -82.91 -52.82 6.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.468 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.94 85.68 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.0 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.23 179.35 20.4 Favored Glycine 0 C--N 1.293 -1.825 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.9 mt -62.42 112.9 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 117.668 0.734 . . . . 0.0 109.508 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.51 -17.1 26.2 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.378 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -94.07 138.81 31.73 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.653 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -136.34 136.01 39.34 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.5 -142.13 11.02 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.66 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.91 101.74 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.734 2.289 . . . . 0.0 111.757 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 p -90.93 -0.57 57.77 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.24 0.543 . . . . 0.0 112.315 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.48 113.41 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.0 m -77.36 167.41 21.73 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.678 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.28 154.12 24.58 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.968 0.507 . . . . 0.0 110.844 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -57.6 112.43 1.44 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.312 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.88 -9.71 29.69 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -113.86 139.31 49.28 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.477 -0.425 . . . . 0.0 109.855 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.8 p -113.1 145.13 41.44 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.49 100.83 7.89 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -105.49 131.97 52.24 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.48 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.92 100.25 7.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.02 -58.15 3.29 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.856 0.836 . . . . 0.0 108.818 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.1 m-20 -114.18 165.75 13.0 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -38.28 94.83 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.184 1.922 . . . . 0.0 112.621 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.8 m-85 -104.45 -26.11 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.0 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -93.35 114.89 27.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.93 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.69 131.05 53.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -125.73 145.1 50.33 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.604 0.184 . . . . 0.0 110.989 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -79.55 104.45 10.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--N 1.293 -1.871 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.427 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.969 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -78.94 171.64 14.91 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -65.38 132.9 50.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.65 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 76.95 7.43 3.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.975 1.31 . . . . 0.0 113.747 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -96.16 171.03 27.93 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.7 tt0 -85.35 120.17 26.53 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.748 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.6 p -81.09 -50.7 9.32 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.262 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.94 87.48 0.07 OUTLIER Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.267 -1.444 . . . . 0.0 111.877 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 -176.28 20.83 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 174.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.2 mt -64.6 125.87 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 117.52 0.66 . . . . 0.0 109.26 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.69 60.03 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.307 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -107.65 142.61 37.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -145.31 139.98 27.43 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.81 -134.49 4.75 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.951 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.01 97.12 0.98 Allowed 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.324 2.016 . . . . 0.0 110.885 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 38.9 p -82.05 -19.11 40.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.295 0.569 . . . . 0.0 111.459 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -82.14 122.15 36.46 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -85.53 163.68 18.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.352 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 150.6 39.91 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 p -57.32 122.82 13.44 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.666 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.82 26.86 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.373 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -110.46 143.17 41.17 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -116.63 141.21 48.49 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 121.994 0.117 . . . . 0.0 111.164 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.61 104.84 5.44 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -110.51 127.75 55.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.255 0.55 . . . . 0.0 110.916 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -81.29 109.1 15.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.55 -48.46 7.29 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -122.77 164.63 25.68 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.27 -36.22 77.26 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.296 1.998 . . . . 0.0 113.087 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -102.98 -25.73 13.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.553 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -94.36 114.74 26.84 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -124.87 129.03 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -127.38 142.9 51.31 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.637 0.256 . . . . 0.0 111.57 -173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -78.49 107.41 11.12 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.297 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -74.06 162.33 29.12 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -64.03 135.54 56.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.133 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 71.54 17.78 5.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.792 0.837 . . . . 0.0 112.522 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -110.5 165.41 12.25 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.187 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.9 tt0 -76.42 111.94 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.4 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.0 p -89.98 -30.78 17.56 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.73 75.8 0.05 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 118.882 -1.628 . . . . 0.0 112.534 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.49 179.45 29.33 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.91 113.46 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 117.585 0.692 . . . . 0.0 110.028 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.66 -17.31 36.35 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.018 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -86.5 137.74 32.29 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -140.96 130.22 23.59 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.54 -126.97 3.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.521 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.14 98.59 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.84 2.36 . . . . 0.0 112.254 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.9 p -96.68 -17.31 20.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.314 0.578 . . . . 0.0 111.792 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.41 121.57 37.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -84.3 167.43 16.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 167.62 11.84 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 122.966 0.506 . . . . 0.0 111.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -54.8 113.55 1.37 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.057 0.943 . . . . 0.0 111.881 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -0.59 60.38 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.975 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.9 p -112.94 141.61 46.57 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.136 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.2 p -114.47 142.46 46.36 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.327 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.74 111.66 18.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -122.94 139.55 53.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.66 120.34 21.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -97.51 -44.57 6.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -134.71 166.8 26.49 Favored Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.46 -43.5 22.08 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.95 2.434 . . . . 0.0 114.034 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.633 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 77.8 m-85 -101.91 -24.97 13.95 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.293 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 46.1 t80 -93.8 114.45 26.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.909 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.2 m -113.72 136.17 53.14 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.472 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.97 142.71 50.84 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 117.93 0.332 . . . . 0.0 111.298 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.7 m -77.83 117.91 19.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 124.213 1.005 . . . . 0.0 108.627 178.819 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 161.5 27.54 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 23.3 t-160 -66.14 134.82 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.51 5.98 2.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.555 1.542 . . . . 0.0 112.532 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.06 163.95 27.05 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.3 tt0 -79.99 116.69 20.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -80.92 -43.73 19.34 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.806 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 163.36 97.18 0.12 Allowed Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.11 -170.53 19.95 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.9 121.6 12.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.39 -9.85 59.35 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.167 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 23.5 t80 -98.81 136.52 38.72 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -141.05 106.09 4.97 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.61 -149.4 8.63 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.419 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.16 104.24 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.975 2.45 . . . . 0.0 111.557 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 p -85.33 -15.38 43.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.338 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.8 109.85 2.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.494 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -83.42 164.51 19.88 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.714 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.04 154.04 27.93 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.425 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 m -60.28 118.78 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.12 0.486 . . . . 0.0 110.567 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.68 -9.8 55.66 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.08 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -110.16 136.66 49.04 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.8 p -116.2 134.61 54.73 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.728 0.299 . . . . 0.0 111.685 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -67.37 112.17 4.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -122.5 135.36 54.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.111 0.481 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.1 102.86 4.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.359 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.28 -44.93 14.39 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -129.31 164.3 40.42 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.92 -40.14 86.31 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 121.559 1.506 . . . . 0.0 112.026 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -97.72 -27.83 14.17 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 118.894 -1.123 . . . . 0.0 111.089 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.17 114.12 25.88 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.313 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.1 m -120.42 133.59 55.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -125.59 143.04 51.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 120.437 0.16 . . . . 0.0 111.284 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -78.62 108.02 11.72 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.6 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -87.45 169.82 11.89 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -60.0 130.87 48.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.191 1.396 . . . . 0.0 109.848 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 78.76 7.2 2.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.807 1.243 . . . . 0.0 112.988 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -98.75 158.41 20.26 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.0 tt0 -76.54 113.19 13.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.9 p -82.48 -21.35 35.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.03 87.17 0.18 Allowed Glycine 0 CA--C 1.479 -2.189 0 C-N-CA 118.148 -1.977 . . . . 0.0 113.925 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.14 -165.66 25.76 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.89 118.35 7.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 118.076 0.938 . . . . 0.0 109.04 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.44 -26.91 11.23 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.609 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -106.24 115.49 30.31 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -125.77 162.54 24.86 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.426 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 114.31 -117.68 4.18 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.901 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 23.5 Cg_exo -66.32 97.85 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.673 2.248 . . . . 0.0 110.964 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.3 p -111.94 -18.85 12.56 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.685 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -80.55 114.01 20.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.516 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.03 165.11 19.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.07 154.7 41.62 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.344 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -62.71 120.18 10.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -6.34 30.67 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.3 p -123.15 148.44 45.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 p -121.94 137.3 54.84 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.144 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -70.18 103.52 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 36' ' ' LEU . 50.9 mt-30 -109.8 130.23 55.54 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.954 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.29 110.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.676 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.65 -29.18 13.19 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 43.1 m-80 -145.53 165.63 20.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -55.81 -38.78 94.02 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.687 1.591 . . . . 0.0 112.424 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -100.12 -26.86 13.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.289 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 52.2 t80 -94.47 114.01 25.95 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -132.2 132.97 43.65 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -130.62 143.56 50.83 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 117.731 0.241 . . . . 0.0 111.283 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.88 104.29 7.29 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.43 ' HB2' HE21 ' A' ' 26' ' ' GLN . 85.3 mt . . . . . 0 C--N 1.291 -1.978 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.047 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -89.69 158.27 17.63 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 113.38 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -61.35 132.96 55.2 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.537 1.135 . . . . 0.0 109.235 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.267 8.0 m-85 74.85 8.12 4.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.9 163.58 22.41 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -78.48 110.77 13.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.741 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.3 p -82.17 -35.02 28.8 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.53 84.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 118.686 -1.721 . . . . 0.0 112.971 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.51 -174.93 20.52 Favored Glycine 0 C--N 1.294 -1.79 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -62.12 122.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 118.061 0.93 . . . . 0.0 108.55 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.36 -6.8 42.61 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.038 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -125.08 136.09 53.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.5 m -150.04 101.41 3.02 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.549 1.14 . . . . 0.0 108.672 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.42 -134.73 1.78 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.19 99.32 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.775 2.317 . . . . 0.0 111.193 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.3 p -91.79 -17.17 25.75 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.16 109.98 10.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.702 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.0 m -85.12 159.02 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.917 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.91 152.44 10.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.471 0.708 . . . . 0.0 111.61 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -59.65 113.35 2.19 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.832 0.825 . . . . 0.0 111.774 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -11.55 29.33 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.282 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -112.56 136.87 51.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -116.06 137.62 51.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.586 0.231 . . . . 0.0 111.142 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.81 106.11 4.04 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.62 126.4 55.23 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.37 102.86 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.41 -44.98 15.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 84.5 m-20 -132.9 166.03 32.25 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.45 -42.74 63.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.219 1.946 . . . . 0.0 113.593 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -97.88 -26.46 14.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.761 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 37.4 t80 -94.55 114.18 26.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.5 m -120.73 138.02 54.2 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -133.61 142.03 47.92 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 123.037 0.21 . . . . 0.0 111.284 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.92 105.21 7.85 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.781 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -92.45 173.97 7.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.65 0.738 . . . . 0.0 112.167 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -72.31 135.56 45.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.065 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.83 59.07 0.37 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.332 1.053 . . . . 0.0 112.366 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.0 153.63 24.89 Favored Glycine 0 C--O 1.254 1.394 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -68.05 116.12 8.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.179 0.489 . . . . 0.0 110.608 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.9 p -82.85 -46.01 13.57 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.677 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.89 107.55 0.24 Allowed Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.371 -1.395 . . . . 0.0 113.45 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.27 -160.5 17.86 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 74.2 mt -66.39 122.79 18.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 117.706 0.753 . . . . 0.0 109.167 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.34 63.53 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.559 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -116.17 139.24 50.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.779 0.79 . . . . 0.0 110.348 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -138.87 145.98 40.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.81 -137.31 5.9 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.7 91.56 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.678 2.252 . . . . 0.0 110.876 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -93.94 -5.43 47.82 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.252 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.33 113.78 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.2 m -80.62 162.96 23.98 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 152.09 42.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 111.09 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 m -60.75 116.74 4.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.394 0.616 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -15.05 29.4 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.6 p -109.64 146.55 34.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.2 p -118.2 135.32 54.32 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.966 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 51.0 t -74.01 98.13 3.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -99.62 130.05 45.82 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.03 94.29 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.2 -46.65 22.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.976 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 3.0 m-20 -126.98 168.64 14.09 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.46 -34.31 93.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.421 1.414 . . . . 0.0 112.216 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 11' ' ' ILE . 23.2 m-85 -106.76 -26.39 11.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.139 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 25.2 t80 -93.0 114.69 27.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.463 0.649 . . . . 0.0 110.758 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.8 m -129.53 134.9 48.01 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.485 HE21 HD21 ' A' ' 36' ' ' LEU . 29.5 tt0 -134.29 141.7 47.04 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.693 -172.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 34.5 m -73.36 105.53 4.79 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HE21 ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 m -66.29 159.8 25.85 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.619 1.168 . . . . 0.0 113.818 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -67.79 123.23 19.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 77.94 58.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.92 0.888 . . . . 0.0 112.552 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' GLN . . . -156.09 160.87 30.4 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 64.3 tt0 -78.61 116.21 18.83 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.802 0.801 . . . . 0.0 110.215 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.733 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.0 p -86.75 -44.35 11.85 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.45 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.88 84.49 0.06 OUTLIER Glycine 0 CA--C 1.481 -2.072 0 C-N-CA 119.278 -1.439 . . . . 0.0 112.01 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.95 -172.67 20.42 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 63.6 mt -66.85 113.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 117.307 0.553 . . . . 0.0 109.663 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -9.18 32.48 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.656 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -102.83 135.08 45.16 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.555 -0.379 . . . . 0.0 110.116 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -139.11 116.13 10.95 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.51 -147.21 10.76 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.98 95.49 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.115 2.543 . . . . 0.0 111.628 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.1 p -80.57 -26.61 37.82 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.244 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.4 117.8 20.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 110.052 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.0 m -81.04 167.53 19.66 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.2 40.46 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 117.7 4.51 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.965 0.506 . . . . 0.0 109.749 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.71 -0.29 34.28 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.673 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -128.77 142.87 50.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -116.12 136.52 52.94 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.875 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 48.1 t -76.84 103.21 6.66 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -119.75 142.86 48.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.921 0.391 . . . . 0.0 111.444 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 114.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.77 -43.89 8.4 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -134.76 165.6 35.5 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.54 -38.85 45.44 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 122.721 2.281 . . . . 0.0 114.513 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.8 m-85 -106.63 -24.86 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.32 0.581 . . . . 0.0 110.812 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 7' ' ' GLN . 36.0 t80 -93.3 113.87 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.452 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -112.56 135.81 52.84 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.456 HE21 HD21 ' A' ' 36' ' ' LEU . 28.4 tt0 -132.06 144.91 51.08 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.3 m -72.43 108.54 5.58 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.137 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.456 HD21 HE21 ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -61.21 154.49 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.4 t-160 -63.94 132.83 51.9 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 71.06 11.8 6.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.66 166.88 19.63 Favored Glycine 0 C--O 1.251 1.194 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -76.85 109.14 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -83.7 -33.51 25.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.38 93.25 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 117.971 -2.061 . . . . 0.0 113.217 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.98 -169.88 19.19 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.03 119.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.39 -16.33 45.19 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.708 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -105.49 121.62 44.31 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -135.3 123.48 22.99 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 157.81 -126.08 1.66 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.312 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 7.0 Cg_exo -72.36 96.28 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.545 2.163 . . . . 0.0 111.418 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.2 p -100.74 -10.48 20.78 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.6 t -90.25 114.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 80.3 m -75.34 159.69 31.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.788 -178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.96 170.19 3.71 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.194 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.0 t -61.62 120.3 10.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.976 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.62 -9.28 58.7 Favored Glycine 0 N--CA 1.423 -2.191 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.294 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -114.68 145.66 41.78 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.916 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 p -116.85 134.57 54.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 54.1 t -73.94 105.4 5.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.73 141.05 48.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.231 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.93 112.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.865 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -96.93 -34.64 11.15 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 51.5 m-80 -143.13 166.23 21.46 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.98 -43.3 58.0 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.16 1.907 . . . . 0.0 112.977 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.5 m-85 -97.33 -26.18 14.98 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.245 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.0 t80 -93.74 114.18 26.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.686 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -122.3 137.26 54.91 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.73 141.14 49.45 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 123.097 0.248 . . . . 0.0 111.155 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.5 m -77.26 108.32 10.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.991 176.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.615 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 121.092 0.472 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -63.35 165.56 7.49 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 125.496 1.518 . . . . 0.0 113.589 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.47 139.42 51.71 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 72.18 23.13 3.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.776 0.798 . . . . 0.0 112.124 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.76 148.15 17.27 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 13' ' ' TYR . 50.2 tt0 -70.49 109.71 4.97 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.732 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.1 p -71.25 -47.28 58.07 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.17 88.16 0.07 OUTLIER Glycine 0 N--CA 1.417 -2.602 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.284 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.75 177.58 19.41 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.14 118.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -11.92 30.47 Favored Glycine 0 C--N 1.306 -1.119 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.838 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' HE21 ' A' ' 7' ' ' GLN . 60.7 t80 -96.01 132.92 40.84 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -134.78 95.74 3.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.8 8.94 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.983 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.52 107.87 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.271 2.648 . . . . 0.0 112.318 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 43.0 p -87.17 -13.93 42.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.261 0.553 . . . . 0.0 111.227 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.79 116.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -85.51 153.35 22.51 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.044 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.2 149.01 5.71 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.661 1.184 . . . . 0.0 111.934 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -54.56 112.29 0.98 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.431 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.22 -1.21 29.72 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.2 p -129.35 143.95 51.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -120.74 148.73 43.57 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.742 0.306 . . . . 0.0 111.718 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -74.26 118.8 17.64 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.12 126.96 49.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.285 0.564 . . . . 0.0 110.558 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -79.46 103.42 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.097 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.75 -48.6 8.11 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 74.0 m-20 -129.23 171.37 8.88 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.12 -43.91 43.75 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 121.671 1.581 . . . . 0.0 112.319 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.1 m-85 -98.93 -25.81 14.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.247 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 26.6 t80 -93.35 114.66 27.14 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.491 0.662 . . . . 0.0 111.773 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.9 m -135.81 127.68 29.39 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -129.84 148.4 51.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.07 0.396 . . . . 0.0 111.99 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 41.6 m -76.57 112.64 13.32 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.076 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 8' ' ' CYS . 7.0 tt0 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 120.999 0.428 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.477 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 9.8 m -64.77 165.4 10.57 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.142 1.777 . . . . 0.0 112.985 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -80.94 134.8 35.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 71.98 59.44 0.15 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.162 0.982 . . . . 0.0 112.324 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.09 156.4 26.7 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.9 tt0 -76.38 110.58 11.02 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 117.321 0.561 . . . . 0.0 109.645 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -70.39 -49.34 50.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.759 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.73 87.87 0.07 OUTLIER Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.96 172.4 15.75 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.05 113.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -11.13 37.55 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.741 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -104.25 132.92 49.98 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -127.57 129.28 47.05 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.95 -153.38 23.74 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.565 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.44 99.36 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.17 2.58 . . . . 0.0 111.688 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -81.94 -21.8 37.05 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.626 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -87.29 122.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -90.09 165.23 14.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 158.41 7.75 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 123.353 0.661 . . . . 0.0 111.331 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -59.51 118.28 5.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 -20.29 25.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.6 p -109.96 141.58 42.53 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 28.1 p -124.55 147.24 48.55 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.0 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.52 109.32 8.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -118.02 132.13 56.41 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.02 109.39 11.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.07 -43.63 8.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.557 0.694 . . . . 0.0 109.893 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -130.31 166.0 29.95 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.18 -42.25 47.28 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.714 2.276 . . . . 0.0 113.542 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.7 m-85 -104.32 -25.08 13.0 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.042 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 32.1 t80 -92.57 115.32 28.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.591 -0.843 . . . . 0.0 112.718 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.86 131.12 53.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.3 tt0 -128.73 148.24 50.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 118.116 0.417 . . . . 0.0 111.977 -171.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.0 m -77.47 106.52 9.29 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.317 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.405 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.43 HE22 ' C ' ' A' ' 7' ' ' GLN . 5.9 tt0 . . . . . 0 C--O 1.242 0.673 0 CA-C-O 121.205 0.526 . . . . 0.0 112.138 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -74.79 165.78 24.68 Favored 'General case' 0 C--O 1.248 1.005 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -64.09 139.74 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.043 1.337 . . . . 0.0 107.61 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 75.61 7.76 3.83 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.295 1.038 . . . . 0.0 113.683 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.32 154.84 21.2 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.815 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.6 tt0 -70.28 107.68 3.85 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.1 p -75.97 -38.03 57.91 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -175.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.01 96.07 0.11 Allowed Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 118.39 -1.862 . . . . 0.0 112.923 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.7 -169.83 19.4 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 62.9 mt -66.22 119.1 10.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.39 -1.82 58.94 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -97.84 130.49 44.75 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 122.006 -0.702 . . . . 0.0 109.114 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -135.7 133.21 37.84 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.23 -141.07 8.17 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.25 98.94 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.392 2.061 . . . . 0.0 111.343 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.5 p -89.42 -11.95 41.66 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.48 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.15 121.79 45.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.6 m -86.29 162.68 18.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.31 143.92 56.33 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -60.31 128.19 35.49 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -14.07 28.66 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.65 144.17 49.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 p -122.25 138.65 54.42 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.522 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.5 t -70.31 107.96 3.99 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.9 mt-30 -117.96 129.17 55.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.39 119.49 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.704 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.78 -49.99 3.99 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 108.943 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -126.02 166.08 23.55 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.52 -43.0 52.99 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.553 2.169 . . . . 0.0 112.71 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.0 m-85 -101.39 -26.63 13.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.214 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.3 t80 -93.58 114.86 27.3 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.259 -0.976 . . . . 0.0 113.128 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.5 138.48 54.34 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.6 tt0 -129.18 143.15 50.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 118.861 0.755 . . . . 0.0 111.813 -172.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 55.6 m -76.08 106.52 7.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.7 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -71.33 166.95 20.55 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -66.98 130.04 41.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.797 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 75.22 13.87 3.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.549 1.14 . . . . 0.0 113.358 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.44 166.38 20.76 Favored Glycine 0 C--N 1.308 -0.997 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.8 tt0 -76.33 118.98 19.59 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 117.491 0.646 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.0 p -85.16 -37.19 20.46 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.41 68.6 0.04 OUTLIER Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 118.902 -1.618 . . . . 0.0 112.713 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -101.57 176.2 26.17 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.465 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.5 mt -60.42 117.85 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 117.372 0.586 . . . . 0.0 110.19 -178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -25.44 13.7 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.532 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.23 134.5 35.29 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 m -135.54 103.11 5.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.76 -156.4 24.87 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.867 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.28 123.18 8.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.271 2.647 . . . . 0.0 111.59 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -92.92 -5.06 51.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.861 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.6 t -74.75 116.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -84.73 165.61 17.7 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.32 162.68 14.39 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.574 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -57.03 119.63 6.64 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.242 1.017 . . . . 0.0 110.712 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.76 65.21 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.855 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -110.23 143.19 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.16 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -116.29 141.0 48.73 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.316 0.246 . . . . 0.0 111.274 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.86 108.24 9.75 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.14 140.62 49.29 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.95 113.6 25.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.74 -30.85 12.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.78 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -148.2 167.75 12.62 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.05 -43.44 48.02 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.404 2.069 . . . . 0.0 113.391 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 59.0 m-85 -99.68 -25.08 14.51 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -93.64 114.33 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.4 129.74 48.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 174.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -131.11 145.4 51.98 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.6 m -78.22 105.52 9.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.649 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.554 1.108 0 CA-C-O 120.916 0.389 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -61.96 153.79 28.31 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.544 1.938 . . . . 0.0 115.489 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.59 132.28 50.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.281 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 72.31 9.05 5.87 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.94 166.87 19.32 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.493 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -79.46 114.45 18.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -78.56 -52.56 8.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.012 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.6 78.15 0.09 OUTLIER Glycine 0 CA--C 1.47 -2.753 0 C-N-CA 119.282 -1.437 . . . . 0.0 111.18 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.41 173.79 16.71 Favored Glycine 0 N--CA 1.412 -2.939 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.86 115.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.28 37.34 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.937 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -97.11 136.58 37.45 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 109.88 11.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.27 -148.59 16.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.309 -1.424 . . . . 0.0 112.377 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.93 110.06 2.49 Favored 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.389 2.726 . . . . 0.0 111.643 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.4 p -89.17 -17.81 28.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.91 124.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -76.22 161.25 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 172.55 2.49 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -56.91 112.35 1.3 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.31 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.74 -2.95 67.44 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.525 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.0 p -110.04 146.47 35.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.788 0.794 . . . . 0.0 110.928 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 p -118.35 143.48 46.59 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.37 106.63 11.54 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -113.07 130.05 56.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.135 0.493 . . . . 0.0 110.6 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -77.88 112.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.54 -45.71 6.96 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.523 0.678 . . . . 0.0 110.178 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.1 m-20 -125.85 173.38 5.1 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -53.39 -43.53 56.63 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.377 2.052 . . . . 0.0 113.161 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.8 m-85 -105.43 -24.46 12.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.2 t80 -92.72 115.58 28.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -119.09 133.72 55.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -126.98 146.68 50.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.784 0.266 . . . . 0.0 111.316 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -82.09 108.81 15.86 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.2 0.524 . . . . 0.0 111.477 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.001 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.294 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -76.0 158.19 32.21 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.78 0.8 . . . . 0.0 112.794 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -63.71 134.82 56.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 72.19 18.67 4.69 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.08 169.36 13.07 Favored Glycine 0 C--O 1.249 1.041 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -77.56 122.03 24.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 117.401 0.6 . . . . 0.0 109.901 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -99.96 7.65 44.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 119.0 91.03 1.35 Allowed Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 118.236 -1.935 . . . . 0.0 113.146 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.9 -170.66 19.37 Favored Glycine 0 N--CA 1.422 -2.266 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 172.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 45.4 mt -62.22 123.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.66 -26.2 25.49 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.466 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 36.3 t80 -79.41 129.7 34.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -128.87 98.82 5.08 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.98 -136.78 3.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.468 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -69.57 120.8 7.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.859 2.373 . . . . 0.0 112.179 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -110.7 -17.13 13.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.939 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.89 113.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.99 167.32 22.02 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.104 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.52 162.67 7.85 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.066 0.546 . . . . 0.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -60.29 121.64 12.5 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.613 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.18 -3.92 57.01 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.939 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -119.12 142.45 47.91 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -118.02 142.77 47.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.9 t -81.63 98.13 8.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -105.89 132.85 51.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.38 115.64 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.56 -56.11 2.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.582 0.706 . . . . 0.0 109.75 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -111.18 171.98 3.9 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.88 -40.45 85.29 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 121.998 1.798 . . . . 0.0 112.744 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.601 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.9 m-85 -107.11 -23.79 12.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -91.49 114.8 27.43 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.095 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.2 m -118.02 138.47 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.419 HE21 HD21 ' A' ' 36' ' ' LEU . 30.4 tt0 -135.53 143.72 45.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 118.922 0.783 . . . . 0.0 112.121 -174.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.5 m -75.07 112.41 11.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.85 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 HD21 HE21 ' A' ' 34' ' ' GLN . 95.8 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -80.05 135.37 36.34 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.199 0.523 . . . . 0.0 110.43 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -76.35 163.77 26.67 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.633 1.173 . . . . 0.0 114.157 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -65.02 129.18 38.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 74.93 17.94 2.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.502 1.121 . . . . 0.0 113.43 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' HA3' HE22 ' A' ' 2' ' ' GLN . . . -111.37 165.55 12.15 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.47 116.98 20.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.231 0.515 . . . . 0.0 110.315 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.9 p -81.53 -51.65 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.849 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 177.51 96.19 0.1 Allowed Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 119.39 -1.386 . . . . 0.0 112.759 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.5 -176.85 20.77 Favored Glycine 0 C--N 1.291 -1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.1 mt -61.1 115.32 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 117.181 0.491 . . . . 0.0 109.718 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 -13.93 56.36 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.379 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.623 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 52.4 t80 -89.98 114.23 26.03 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.3 m -108.97 121.75 45.8 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.94 -157.15 28.89 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.36 102.92 1.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.68 2.254 . . . . 0.0 110.748 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA3' ' A' ' 9' ' ' GLY . 17.5 p -87.68 -10.52 51.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.441 0.638 . . . . 0.0 111.653 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -82.42 123.73 38.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.5 m -85.46 167.74 15.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 122.618 0.367 . . . . 0.0 110.357 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.45 155.63 39.51 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.246 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.69 119.89 4.66 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.462 0.705 . . . . 0.0 112.16 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.17 -13.11 57.31 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.768 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.8 p -110.09 137.86 47.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.296 0.548 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 32.9 p -108.92 136.68 48.06 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -76.07 97.79 4.16 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -102.87 125.73 49.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.006 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.1 t -78.81 104.94 7.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 mt -87.45 -44.29 11.43 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.579 0.704 . . . . 0.0 109.67 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -127.83 167.27 19.0 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.68 -38.1 76.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.644 2.229 . . . . 0.0 113.197 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.41 -25.23 10.63 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.788 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -92.52 115.3 27.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.431 0.634 . . . . 0.0 111.714 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -124.0 136.07 54.05 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.4 tt0 -129.04 142.39 50.92 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 117.926 0.33 . . . . 0.0 111.458 -171.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.8 m -80.17 108.33 13.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' OE1' ' A' ' 34' ' ' GLN . 92.7 mt . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 123.596 0.758 . . . . 0.0 109.365 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.623 ' H5 ' ' O ' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.95 134.93 35.8 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.351 0.596 . . . . 0.0 110.644 -173.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 m -61.32 155.83 20.34 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.069 1.747 . . . . 0.0 114.876 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.432 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 19.1 t-160 -68.23 132.71 47.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 74.32 7.3 4.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.06 0.944 . . . . 0.0 112.861 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.42 160.78 23.82 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.622 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.6 tt0 -72.75 113.5 9.85 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 p -88.05 -38.72 15.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.22 75.08 0.05 OUTLIER Glycine 0 CA--C 1.476 -2.391 0 C-N-CA 117.177 -2.44 . . . . 0.0 113.79 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 171.93 15.2 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.36 122.87 10.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.15 -26.47 12.21 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.782 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -102.14 148.27 25.61 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 p -158.81 156.18 29.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.686 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.22 -121.95 4.77 Favored Glycine 0 C--N 1.308 -1.018 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.43 100.69 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 121.964 1.776 . . . . 0.0 109.841 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.7 p -99.21 -20.39 16.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.796 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t -87.11 124.73 40.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.834 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.0 m -79.02 167.29 21.3 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.541 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 148.64 51.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -54.23 123.24 12.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.032 0.444 . . . . 0.0 110.707 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -14.58 31.01 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.3 p -117.0 142.25 47.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 31.5 p -115.72 141.29 48.28 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.134 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.53 102.46 9.75 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -105.16 119.56 39.34 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.535 0.683 . . . . 0.0 110.92 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.85 106.98 6.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.089 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.3 mt -91.37 -44.2 9.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -128.0 166.23 25.19 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -57.12 -33.87 96.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.661 1.574 . . . . 0.0 111.911 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 9.7 m-85 -102.23 -27.63 12.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.92 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -94.65 114.92 26.92 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.119 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.2 m -133.66 130.51 38.33 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.86 140.18 52.54 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 123.032 0.207 . . . . 0.0 110.986 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.1 m -76.2 111.29 11.47 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.287 -2.121 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.539 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.87 145.61 30.28 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 m -81.61 165.35 21.16 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.811 0.844 . . . . 0.0 112.863 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.3 136.02 44.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 73.11 21.21 3.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.525 0.73 . . . . 0.0 112.41 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.66 151.6 18.34 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.08 121.08 15.96 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -87.1 -42.36 13.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.97 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 168.97 98.18 0.12 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.592 -1.765 . . . . 0.0 113.531 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.88 -179.72 20.83 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 107.946 -2.062 . . . . 0.0 107.946 174.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.97 116.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 117.655 0.728 . . . . 0.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.43 -18.19 48.8 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.44 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 64.2 t80 -80.97 136.08 35.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.762 0.281 . . . . 0.0 111.417 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -124.66 113.82 18.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.63 -161.56 30.47 Favored Glycine 0 C--N 1.306 -1.105 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.2 114.87 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.89 2.393 . . . . 0.0 110.459 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p -90.04 -23.68 21.39 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.17 120.6 36.74 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.83 164.41 19.51 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.174 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 141.31 57.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.6 m -54.7 120.67 7.08 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.418 0.448 . . . . 0.0 109.824 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.51 -10.46 28.29 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.8 p -121.7 140.49 52.24 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -113.87 135.3 54.12 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.875 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.91 98.05 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.54 145.06 30.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.286 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.2 t -87.98 111.73 22.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' C ' HD22 ' A' ' 29' ' ' ASN . 6.7 mp -88.26 -43.59 11.46 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.392 0.615 . . . . 0.0 109.687 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.525 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -138.82 169.55 12.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 177.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.57 -29.17 89.24 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.245 1.48 . . . . 0.0 111.622 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.4 m-85 -102.53 -25.57 13.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.23 114.18 26.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.5 m -138.04 129.37 27.66 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -137.01 147.31 46.17 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.385 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 39.4 m -76.39 107.77 8.88 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.431 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -87.31 145.03 26.51 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.105 -176.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -72.31 160.91 31.6 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -68.68 131.85 45.88 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 71.73 17.52 5.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.029 0.932 . . . . 0.0 112.403 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.04 164.68 12.3 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.7 tt0 -82.14 110.22 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 122.586 0.354 . . . . 0.0 110.241 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -73.32 -41.87 63.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.97 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 154.95 96.97 0.13 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 118.947 -1.597 . . . . 0.0 113.833 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.63 -152.58 13.09 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 58.5 mt -70.54 125.97 29.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.7 -21.18 37.23 Favored Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.616 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.15 121.08 30.39 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 122.421 -0.458 . . . . 0.0 109.842 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -141.22 111.99 7.1 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.1 -116.95 0.39 Allowed Glycine 0 C--N 1.304 -1.222 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 2.6 Cg_endo -77.65 90.16 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 CA-C-N 119.587 1.694 . . . . 0.0 108.631 173.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.403 HG22 ' HA3' ' A' ' 9' ' ' GLY . 7.7 p -82.83 -20.68 35.19 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.344 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.4 t -84.76 128.28 39.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -82.16 163.46 21.94 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.388 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.3 152.49 43.65 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.316 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -53.56 122.78 10.47 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.973 0.909 . . . . 0.0 111.349 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.61 -19.92 25.59 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.734 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 p -118.77 147.94 43.35 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.481 -0.423 . . . . 0.0 111.686 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 20.5 p -115.81 146.44 41.96 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.012 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -81.24 99.54 8.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.8 127.48 49.95 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.069 0.461 . . . . 0.0 110.366 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.71 106.64 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.91 -52.99 4.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.13 163.36 30.38 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.86 -41.58 62.25 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.688 2.259 . . . . 0.0 113.458 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 45.5 m-85 -99.15 -26.59 14.15 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.012 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 26.1 t80 -94.05 114.6 26.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.1 m -120.35 133.19 55.49 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -129.26 144.27 51.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 117.785 0.266 . . . . 0.0 110.956 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.0 m -79.41 110.65 14.91 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.061 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.93 33.32 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p -94.11 176.49 6.31 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.09 129.03 39.76 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.778 0.831 . . . . 0.0 110.087 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.26 13.3 m-85 71.58 59.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -157.42 155.11 26.12 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.6 tt0 -72.87 115.1 11.76 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 117.541 0.67 . . . . 0.0 109.648 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.2 p -90.74 -36.42 14.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.889 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.56 88.43 0.07 OUTLIER Glycine 0 CA--C 1.488 -1.655 0 C-N-CA 118.835 -1.65 . . . . 0.0 112.662 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.64 178.96 20.06 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 175.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 59.4 mt -64.2 116.71 3.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.68 -10.22 55.88 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.416 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -84.88 144.17 28.56 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.7 m -138.73 99.12 3.72 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.97 -142.38 4.62 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.945 -1.122 . . . . 0.0 112.467 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 106.91 1.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.332 2.688 . . . . 0.0 111.302 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.3 p -88.9 -9.58 51.04 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.781 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -89.32 121.88 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.41 154.8 19.77 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.31 148.18 19.31 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.912 0.758 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 m -57.84 119.84 7.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.518 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.83 27.86 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.84 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -116.33 140.23 49.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -114.45 141.78 47.24 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.204 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.28 97.61 7.06 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -103.47 135.52 44.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.52 99.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -46.16 19.7 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.413 HD22 ' HB3' ' A' ' 32' ' ' TYR . 44.9 m-80 -128.74 164.24 39.79 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.52 -35.25 65.79 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.642 2.228 . . . . 0.0 113.503 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.645 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 80.5 m-85 -110.21 -24.98 10.4 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.163 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 57.1 t80 -93.38 114.68 27.16 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.1 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -116.38 138.43 51.35 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 36.0 tt0 -131.39 143.36 50.41 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 117.977 0.353 . . . . 0.0 110.873 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.4 m -77.6 105.98 9.1 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.412 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 144.35 42.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -82.95 160.26 22.09 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -65.44 133.14 50.67 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.103 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 77.18 7.34 3.0 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.581 1.153 . . . . 0.0 112.355 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 161.14 18.34 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.483 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.6 tt0 -74.7 120.0 19.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.195 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.7 p -82.91 -52.82 6.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.468 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.94 85.68 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.698 -1.239 . . . . 0.0 112.0 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.23 179.35 20.4 Favored Glycine 0 C--N 1.293 -1.825 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.9 mt -62.42 112.9 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 117.668 0.734 . . . . 0.0 109.508 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.51 -17.1 26.2 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.378 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -94.07 138.81 31.73 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.653 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -136.34 136.01 39.34 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.5 -142.13 11.02 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.66 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.91 101.74 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.734 2.289 . . . . 0.0 111.757 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 p -90.93 -0.57 57.77 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.24 0.543 . . . . 0.0 112.315 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.48 113.41 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.0 m -77.36 167.41 21.73 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.678 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.28 154.12 24.58 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.968 0.507 . . . . 0.0 110.844 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -57.6 112.43 1.44 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.312 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.88 -9.71 29.69 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -113.86 139.31 49.28 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.477 -0.425 . . . . 0.0 109.855 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.8 p -113.1 145.13 41.44 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.49 100.83 7.89 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -105.49 131.97 52.24 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.48 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.92 100.25 7.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.02 -58.15 3.29 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.856 0.836 . . . . 0.0 108.818 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.1 m-20 -114.18 165.75 13.0 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -38.28 94.83 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.184 1.922 . . . . 0.0 112.621 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 46.8 m-85 -104.45 -26.11 12.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.0 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.5 t80 -93.35 114.89 27.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.93 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.3 m -124.69 131.05 53.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -125.73 145.1 50.33 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.604 0.184 . . . . 0.0 110.989 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.1 m -79.55 104.45 10.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--N 1.293 -1.871 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.443 -0.817 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -90.15 134.16 34.44 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 m -78.94 171.64 14.91 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 16.5 t-160 -65.38 132.9 50.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.65 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 76.95 7.43 3.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.975 1.31 . . . . 0.0 113.747 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -96.16 171.03 27.93 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.7 tt0 -85.35 120.17 26.53 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.748 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.6 p -81.09 -50.7 9.32 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.262 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.94 87.48 0.07 OUTLIER Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.267 -1.444 . . . . 0.0 111.877 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.25 -176.28 20.83 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 174.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 62.2 mt -64.6 125.87 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 117.52 0.66 . . . . 0.0 109.26 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.69 60.03 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.307 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -107.65 142.61 37.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -145.31 139.98 27.43 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.81 -134.49 4.75 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.951 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.01 97.12 0.98 Allowed 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.324 2.016 . . . . 0.0 110.885 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 38.9 p -82.05 -19.11 40.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.295 0.569 . . . . 0.0 111.459 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -82.14 122.15 36.46 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -85.53 163.68 18.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.352 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 150.6 39.91 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 p -57.32 122.82 13.44 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.666 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.82 26.86 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.373 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -110.46 143.17 41.17 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -116.63 141.21 48.49 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 121.994 0.117 . . . . 0.0 111.164 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.61 104.84 5.44 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -110.51 127.75 55.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.255 0.55 . . . . 0.0 110.916 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.2 t -81.29 109.1 15.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.55 -48.46 7.29 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -122.77 164.63 25.68 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.27 -36.22 77.26 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.296 1.998 . . . . 0.0 113.087 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -102.98 -25.73 13.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.553 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -94.36 114.74 26.84 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -124.87 129.03 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -127.38 142.9 51.31 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.637 0.256 . . . . 0.0 111.57 -173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -78.49 107.41 11.12 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.297 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.434 -1.274 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 135.28 33.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -74.06 162.33 29.12 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -64.03 135.54 56.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.133 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 71.54 17.78 5.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.792 0.837 . . . . 0.0 112.522 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -110.5 165.41 12.25 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.187 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.9 tt0 -76.42 111.94 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.4 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.0 p -89.98 -30.78 17.56 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.73 75.8 0.05 OUTLIER Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 118.882 -1.628 . . . . 0.0 112.534 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.49 179.45 29.33 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.91 113.46 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 117.585 0.692 . . . . 0.0 110.028 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.66 -17.31 36.35 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.018 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -86.5 137.74 32.29 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -140.96 130.22 23.59 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.54 -126.97 3.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.521 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.14 98.59 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.84 2.36 . . . . 0.0 112.254 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.9 p -96.68 -17.31 20.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.314 0.578 . . . . 0.0 111.792 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.41 121.57 37.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -84.3 167.43 16.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 167.62 11.84 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 122.966 0.506 . . . . 0.0 111.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -54.8 113.55 1.37 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.057 0.943 . . . . 0.0 111.881 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -0.59 60.38 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.975 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.9 p -112.94 141.61 46.57 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.136 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 24.2 p -114.47 142.46 46.36 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.327 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.74 111.66 18.2 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -122.94 139.55 53.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.66 120.34 21.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 tt -97.51 -44.57 6.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -134.71 166.8 26.49 Favored Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.46 -43.5 22.08 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.95 2.434 . . . . 0.0 114.034 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.633 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 77.8 m-85 -101.91 -24.97 13.95 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.293 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 46.1 t80 -93.8 114.45 26.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.909 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.2 m -113.72 136.17 53.14 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.472 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.97 142.71 50.84 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 117.93 0.332 . . . . 0.0 111.298 -172.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.7 m -77.83 117.91 19.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 124.213 1.005 . . . . 0.0 108.627 178.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 134.72 35.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 161.5 27.54 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 23.3 t-160 -66.14 134.82 53.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 77.51 5.98 2.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.555 1.542 . . . . 0.0 112.532 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.06 163.95 27.05 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.3 tt0 -79.99 116.69 20.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -80.92 -43.73 19.34 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.806 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 163.36 97.18 0.12 Allowed Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.11 -170.53 19.95 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.9 121.6 12.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.39 -9.85 59.35 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.167 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 23.5 t80 -98.81 136.52 38.72 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 13.9 m -141.05 106.09 4.97 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.61 -149.4 8.63 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.419 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.16 104.24 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.975 2.45 . . . . 0.0 111.557 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 p -85.33 -15.38 43.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.338 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.8 109.85 2.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.494 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -83.42 164.51 19.88 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.714 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.04 154.04 27.93 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.425 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 m -60.28 118.78 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.12 0.486 . . . . 0.0 110.567 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.68 -9.8 55.66 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.08 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -110.16 136.66 49.04 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.8 p -116.2 134.61 54.73 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.728 0.299 . . . . 0.0 111.685 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -67.37 112.17 4.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -122.5 135.36 54.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.111 0.481 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.1 102.86 4.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.359 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.28 -44.93 14.39 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -129.31 164.3 40.42 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.92 -40.14 86.31 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 121.559 1.506 . . . . 0.0 112.026 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -97.72 -27.83 14.17 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 118.894 -1.123 . . . . 0.0 111.089 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -95.17 114.12 25.88 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.313 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.1 m -120.42 133.59 55.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -125.59 143.04 51.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 120.437 0.16 . . . . 0.0 111.284 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -78.62 108.02 11.72 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.6 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.475 ' H2 ' ' HB2' ' A' ' 14' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -90.59 136.21 33.21 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -87.45 169.82 11.89 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -60.0 130.87 48.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.191 1.396 . . . . 0.0 109.848 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 78.76 7.2 2.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.807 1.243 . . . . 0.0 112.988 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' OE1' ' A' ' 2' ' ' GLN . . . -98.75 158.41 20.26 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.0 tt0 -76.54 113.19 13.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.9 p -82.48 -21.35 35.6 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.03 87.17 0.18 Allowed Glycine 0 CA--C 1.479 -2.189 0 C-N-CA 118.148 -1.977 . . . . 0.0 113.925 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.14 -165.66 25.76 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.89 118.35 7.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 118.076 0.938 . . . . 0.0 109.04 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.44 -26.91 11.23 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.609 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -106.24 115.49 30.31 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -125.77 162.54 24.86 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 114.31 -117.68 4.18 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.901 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 23.5 Cg_exo -66.32 97.85 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.673 2.248 . . . . 0.0 110.964 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.3 p -111.94 -18.85 12.56 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.685 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -80.55 114.01 20.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.516 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.03 165.11 19.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.07 154.7 41.62 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.344 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -62.71 120.18 10.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -6.34 30.67 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.3 p -123.15 148.44 45.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 p -121.94 137.3 54.84 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.144 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -70.18 103.52 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 36' ' ' LEU . 50.9 mt-30 -109.8 130.23 55.54 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.954 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.29 110.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.676 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.65 -29.18 13.19 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 43.1 m-80 -145.53 165.63 20.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -55.81 -38.78 94.02 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.687 1.591 . . . . 0.0 112.424 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -100.12 -26.86 13.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.289 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 52.2 t80 -94.47 114.01 25.95 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.8 m -132.2 132.97 43.65 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -130.62 143.56 50.83 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 117.731 0.241 . . . . 0.0 111.283 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.88 104.29 7.29 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.43 ' HB2' HE21 ' A' ' 26' ' ' GLN . 85.3 mt . . . . . 0 C--N 1.291 -1.978 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.84 147.37 27.59 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -89.69 158.27 17.63 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 113.38 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -61.35 132.96 55.2 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.537 1.135 . . . . 0.0 109.235 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . 0.267 8.0 m-85 74.85 8.12 4.23 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.9 163.58 22.41 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -78.48 110.77 13.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.741 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.3 p -82.17 -35.02 28.8 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.53 84.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 118.686 -1.721 . . . . 0.0 112.971 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.51 -174.93 20.52 Favored Glycine 0 C--N 1.294 -1.79 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -62.12 122.71 13.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 118.061 0.93 . . . . 0.0 108.55 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.36 -6.8 42.61 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.038 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -125.08 136.09 53.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.5 m -150.04 101.41 3.02 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.549 1.14 . . . . 0.0 108.672 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.42 -134.73 1.78 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.19 99.32 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.775 2.317 . . . . 0.0 111.193 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.3 p -91.79 -17.17 25.75 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.16 109.98 10.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.702 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.0 m -85.12 159.02 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.917 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.91 152.44 10.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.471 0.708 . . . . 0.0 111.61 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -59.65 113.35 2.19 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.832 0.825 . . . . 0.0 111.774 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.01 -11.55 29.33 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.282 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -112.56 136.87 51.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.6 p -116.06 137.62 51.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.586 0.231 . . . . 0.0 111.142 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.81 106.11 4.04 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.62 126.4 55.23 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.37 102.86 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.41 -44.98 15.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 84.5 m-20 -132.9 166.03 32.25 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.45 -42.74 63.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.219 1.946 . . . . 0.0 113.593 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -97.88 -26.46 14.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.761 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 37.4 t80 -94.55 114.18 26.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.5 m -120.73 138.02 54.2 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -133.61 142.03 47.92 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 123.037 0.21 . . . . 0.0 111.284 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.4 m -76.92 105.21 7.85 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 153.66 20.16 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -92.45 173.97 7.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.65 0.738 . . . . 0.0 112.167 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -72.31 135.56 45.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.065 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.83 59.07 0.37 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.332 1.053 . . . . 0.0 112.366 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.0 153.63 24.89 Favored Glycine 0 C--O 1.254 1.394 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.4 tt0 -68.05 116.12 8.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.179 0.489 . . . . 0.0 110.608 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.9 p -82.85 -46.01 13.57 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.677 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.89 107.55 0.24 Allowed Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.371 -1.395 . . . . 0.0 113.45 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.27 -160.5 17.86 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.48 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 74.2 mt -66.39 122.79 18.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 117.706 0.753 . . . . 0.0 109.167 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.34 63.53 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.559 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -116.17 139.24 50.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.779 0.79 . . . . 0.0 110.348 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -138.87 145.98 40.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.81 -137.31 5.9 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.7 91.56 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.678 2.252 . . . . 0.0 110.876 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -93.94 -5.43 47.82 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.252 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.33 113.78 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.2 m -80.62 162.96 23.98 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 152.09 42.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 111.09 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 m -60.75 116.74 4.64 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.394 0.616 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.7 -15.05 29.4 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.6 p -109.64 146.55 34.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.2 p -118.2 135.32 54.32 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.966 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 51.0 t -74.01 98.13 3.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -99.62 130.05 45.82 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.086 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.03 94.29 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.2 -46.65 22.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.976 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 3.0 m-20 -126.98 168.64 14.09 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.46 -34.31 93.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.421 1.414 . . . . 0.0 112.216 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 11' ' ' ILE . 23.2 m-85 -106.76 -26.39 11.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.139 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 25.2 t80 -93.0 114.69 27.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.463 0.649 . . . . 0.0 110.758 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.8 m -129.53 134.9 48.01 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.485 HE21 HD21 ' A' ' 36' ' ' LEU . 29.5 tt0 -134.29 141.7 47.04 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.693 -172.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 34.5 m -73.36 105.53 4.79 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HE21 ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 132.2 44.01 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 m -66.29 159.8 25.85 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.619 1.168 . . . . 0.0 113.818 -173.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -67.79 123.23 19.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 77.94 58.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.92 0.888 . . . . 0.0 112.552 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' GLN . . . -156.09 160.87 30.4 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 64.3 tt0 -78.61 116.21 18.83 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.802 0.801 . . . . 0.0 110.215 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.733 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.0 p -86.75 -44.35 11.85 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.45 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.88 84.49 0.06 OUTLIER Glycine 0 CA--C 1.481 -2.072 0 C-N-CA 119.278 -1.439 . . . . 0.0 112.01 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.95 -172.67 20.42 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 63.6 mt -66.85 113.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 117.307 0.553 . . . . 0.0 109.663 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -9.18 32.48 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.656 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -102.83 135.08 45.16 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.555 -0.379 . . . . 0.0 110.116 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -139.11 116.13 10.95 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.51 -147.21 10.76 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.98 95.49 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.115 2.543 . . . . 0.0 111.628 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.1 p -80.57 -26.61 37.82 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.244 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.4 117.8 20.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 110.052 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 67.0 m -81.04 167.53 19.66 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.2 40.46 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 117.7 4.51 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.965 0.506 . . . . 0.0 109.749 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.71 -0.29 34.28 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.673 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -128.77 142.87 50.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -116.12 136.52 52.94 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.875 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 48.1 t -76.84 103.21 6.66 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -119.75 142.86 48.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.921 0.391 . . . . 0.0 111.444 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 114.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.77 -43.89 8.4 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -134.76 165.6 35.5 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.54 -38.85 45.44 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 122.721 2.281 . . . . 0.0 114.513 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.8 m-85 -106.63 -24.86 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.32 0.581 . . . . 0.0 110.812 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 7' ' ' GLN . 36.0 t80 -93.3 113.87 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.452 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -112.56 135.81 52.84 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.456 HE21 HD21 ' A' ' 36' ' ' LEU . 28.4 tt0 -132.06 144.91 51.08 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.3 m -72.43 108.54 5.58 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.137 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.456 HD21 HE21 ' A' ' 34' ' ' GLN . 96.3 mt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 9.5 m . . . . . 0 N--CA 1.437 -1.101 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.07 140.0 53.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -61.21 154.49 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 15.4 t-160 -63.94 132.83 51.9 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 71.06 11.8 6.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.66 166.88 19.63 Favored Glycine 0 C--O 1.251 1.194 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.0 tt0 -76.85 109.14 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.6 p -83.7 -33.51 25.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.38 93.25 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 117.971 -2.061 . . . . 0.0 113.217 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.98 -169.88 19.19 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.03 119.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.39 -16.33 45.19 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.708 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -105.49 121.62 44.31 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -135.3 123.48 22.99 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 16' ' ' PRO . . . 157.81 -126.08 1.66 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.312 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 15' ' ' GLY . 7.0 Cg_exo -72.36 96.28 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.545 2.163 . . . . 0.0 111.418 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.2 p -100.74 -10.48 20.78 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 1' ' ' THR . 64.6 t -90.25 114.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 80.3 m -75.34 159.69 31.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.788 -178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.96 170.19 3.71 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.194 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.0 t -61.62 120.3 10.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.976 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.62 -9.28 58.7 Favored Glycine 0 N--CA 1.423 -2.191 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.294 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -114.68 145.66 41.78 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.916 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 p -116.85 134.57 54.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.035 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 54.1 t -73.94 105.4 5.18 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -114.73 141.05 48.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.231 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.93 112.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.865 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tt -96.93 -34.64 11.15 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 51.5 m-80 -143.13 166.23 21.46 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.98 -43.3 58.0 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.16 1.907 . . . . 0.0 112.977 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 17.5 m-85 -97.33 -26.18 14.98 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.245 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 33.0 t80 -93.74 114.18 26.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.686 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.1 m -122.3 137.26 54.91 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.73 141.14 49.45 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 123.097 0.248 . . . . 0.0 111.155 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.5 m -77.26 108.32 10.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.991 176.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.615 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -83.37 146.54 28.41 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.999 0.818 . . . . 0.0 111.85 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -63.35 165.56 7.49 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 125.496 1.518 . . . . 0.0 113.589 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.47 139.42 51.71 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 72.18 23.13 3.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.776 0.798 . . . . 0.0 112.124 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.76 148.15 17.27 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 13' ' ' TYR . 50.2 tt0 -70.49 109.71 4.97 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.732 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.1 p -71.25 -47.28 58.07 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.17 88.16 0.07 OUTLIER Glycine 0 N--CA 1.417 -2.602 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.284 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.75 177.58 19.41 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.14 118.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' H62' ' A' ' 101' ' ' MAN . . . 110.54 -11.92 30.47 Favored Glycine 0 C--N 1.306 -1.119 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.838 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' HE21 ' A' ' 7' ' ' GLN . 60.7 t80 -96.01 132.92 40.84 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.1 m -134.78 95.74 3.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.8 8.94 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.983 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.52 107.87 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.271 2.648 . . . . 0.0 112.318 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 43.0 p -87.17 -13.93 42.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.261 0.553 . . . . 0.0 111.227 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.79 116.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -85.51 153.35 22.51 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.044 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.2 149.01 5.71 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.661 1.184 . . . . 0.0 111.934 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -54.56 112.29 0.98 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.431 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.22 -1.21 29.72 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.2 p -129.35 143.95 51.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 17.3 p -120.74 148.73 43.57 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.742 0.306 . . . . 0.0 111.718 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -74.26 118.8 17.64 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.12 126.96 49.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.285 0.564 . . . . 0.0 110.558 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -79.46 103.42 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.097 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.75 -48.6 8.11 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 74.0 m-20 -129.23 171.37 8.88 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.12 -43.91 43.75 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 121.671 1.581 . . . . 0.0 112.319 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 53.1 m-85 -98.93 -25.81 14.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.247 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 26.6 t80 -93.35 114.66 27.14 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.491 0.662 . . . . 0.0 111.773 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.9 m -135.81 127.68 29.39 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -129.84 148.4 51.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.07 0.396 . . . . 0.0 111.99 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 41.6 m -76.57 112.64 13.32 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.43 ' H62' ' O ' ' A' ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 8' ' ' CYS . 7.0 tt0 -95.64 157.8 15.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.999 0.428 . . . . 0.0 111.122 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.477 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 9.8 m -64.77 165.4 10.57 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 126.142 1.777 . . . . 0.0 112.985 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -80.94 134.8 35.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 71.98 59.44 0.15 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.162 0.982 . . . . 0.0 112.324 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.09 156.4 26.7 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.9 tt0 -76.38 110.58 11.02 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 117.321 0.561 . . . . 0.0 109.645 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -70.39 -49.34 50.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.759 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.73 87.87 0.07 OUTLIER Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -109.96 172.4 15.75 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.05 113.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -11.13 37.55 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.741 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -104.25 132.92 49.98 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -127.57 129.28 47.05 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.95 -153.38 23.74 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.565 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.44 99.36 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.17 2.58 . . . . 0.0 111.688 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -81.94 -21.8 37.05 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.626 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -87.29 122.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -90.09 165.23 14.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 158.41 7.75 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 123.353 0.661 . . . . 0.0 111.331 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -59.51 118.28 5.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 -20.29 25.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.6 p -109.96 141.58 42.53 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 28.1 p -124.55 147.24 48.55 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.0 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.0 t -75.52 109.32 8.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -118.02 132.13 56.41 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.02 109.39 11.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.07 -43.63 8.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.557 0.694 . . . . 0.0 109.893 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -130.31 166.0 29.95 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.18 -42.25 47.28 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.714 2.276 . . . . 0.0 113.542 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 68.7 m-85 -104.32 -25.08 13.0 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.042 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 32.1 t80 -92.57 115.32 28.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.591 -0.843 . . . . 0.0 112.718 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.86 131.12 53.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.3 tt0 -128.73 148.24 50.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 118.116 0.417 . . . . 0.0 111.977 -171.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.0 m -77.47 106.52 9.29 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.317 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.405 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.43 HE22 ' C ' ' A' ' 7' ' ' GLN . 5.9 tt0 -99.22 157.81 16.12 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.138 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -74.79 165.78 24.68 Favored 'General case' 0 C--O 1.248 1.005 0 C-N-CA 125.192 1.397 . . . . 0.0 113.111 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -64.09 139.74 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.043 1.337 . . . . 0.0 107.61 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 75.61 7.76 3.83 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.295 1.038 . . . . 0.0 113.683 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.32 154.84 21.2 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.815 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 33' ' ' SER . 60.6 tt0 -70.28 107.68 3.85 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.1 p -75.97 -38.03 57.91 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -175.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.01 96.07 0.11 Allowed Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 118.39 -1.862 . . . . 0.0 112.923 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.7 -169.83 19.4 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 62.9 mt -66.22 119.1 10.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.39 -1.82 58.94 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -97.84 130.49 44.75 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 122.006 -0.702 . . . . 0.0 109.114 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -135.7 133.21 37.84 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.23 -141.07 8.17 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.25 98.94 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.392 2.061 . . . . 0.0 111.343 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.5 p -89.42 -11.95 41.66 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.48 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.15 121.79 45.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 37.6 m -86.29 162.68 18.13 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.31 143.92 56.33 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -60.31 128.19 35.49 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.09 -14.07 28.66 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.1 p -123.65 144.17 49.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 p -122.25 138.65 54.42 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.522 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.5 t -70.31 107.96 3.99 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.9 mt-30 -117.96 129.17 55.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.39 119.49 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.704 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.78 -49.99 3.99 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 108.943 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -126.02 166.08 23.55 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.52 -43.0 52.99 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.553 2.169 . . . . 0.0 112.71 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.0 m-85 -101.39 -26.63 13.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.214 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 39.3 t80 -93.58 114.86 27.3 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.259 -0.976 . . . . 0.0 113.128 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.5 138.48 54.34 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.6 tt0 -129.18 143.15 50.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 118.861 0.755 . . . . 0.0 111.813 -172.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 55.6 m -76.08 106.52 7.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 94.7 mt . . . . . 0 C--N 1.289 -2.032 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.87 133.31 34.31 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.367 -172.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -71.33 166.95 20.55 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -66.98 130.04 41.86 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.797 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 75.22 13.87 3.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.549 1.14 . . . . 0.0 113.358 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.44 166.38 20.76 Favored Glycine 0 C--N 1.308 -0.997 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' SER . 63.8 tt0 -76.33 118.98 19.59 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 117.491 0.646 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.0 p -85.16 -37.19 20.46 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.41 68.6 0.04 OUTLIER Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 118.902 -1.618 . . . . 0.0 112.713 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -101.57 176.2 26.17 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.465 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 60.5 mt -60.42 117.85 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 117.372 0.586 . . . . 0.0 110.19 -178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.38 -25.44 13.7 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.532 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.23 134.5 35.29 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 m -135.54 103.11 5.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.76 -156.4 24.87 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.867 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.28 123.18 8.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.271 2.647 . . . . 0.0 111.59 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -92.92 -5.06 51.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.861 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.6 t -74.75 116.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -84.73 165.61 17.7 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.32 162.68 14.39 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.574 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -57.03 119.63 6.64 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.242 1.017 . . . . 0.0 110.712 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.76 65.21 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.855 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -110.23 143.19 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.16 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -116.29 141.0 48.73 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.316 0.246 . . . . 0.0 111.274 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.86 108.24 9.75 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.14 140.62 49.29 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.95 113.6 25.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.74 -30.85 12.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.78 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -148.2 167.75 12.62 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.05 -43.44 48.02 Favored 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.404 2.069 . . . . 0.0 113.391 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 59.0 m-85 -99.68 -25.08 14.51 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -93.64 114.33 26.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.0 m -127.4 129.74 48.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 174.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -131.11 145.4 51.98 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.6 m -78.22 105.52 9.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 20' ' ' ALA . 4.3 m . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.93 140.96 30.72 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 120.916 0.389 . . . . 0.0 111.348 -171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -61.96 153.79 28.31 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.544 1.938 . . . . 0.0 115.489 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.59 132.28 50.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.281 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 72.31 9.05 5.87 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.94 166.87 19.32 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.493 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -79.46 114.45 18.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.6 p -78.56 -52.56 8.3 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.371 -0.832 . . . . 0.0 113.012 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.6 78.15 0.09 OUTLIER Glycine 0 CA--C 1.47 -2.753 0 C-N-CA 119.282 -1.437 . . . . 0.0 111.18 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.41 173.79 16.71 Favored Glycine 0 N--CA 1.412 -2.939 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.86 115.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.28 37.34 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.937 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -97.11 136.58 37.45 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 109.88 11.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.27 -148.59 16.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 119.309 -1.424 . . . . 0.0 112.377 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.93 110.06 2.49 Favored 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.389 2.726 . . . . 0.0 111.643 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.4 p -89.17 -17.81 28.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.91 124.75 41.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -76.22 161.25 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 1' ' ' THR . . . -64.38 172.55 2.49 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.519 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -56.91 112.35 1.3 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.31 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.74 -2.95 67.44 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.525 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.0 p -110.04 146.47 35.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.788 0.794 . . . . 0.0 110.928 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 p -118.35 143.48 46.59 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.37 106.63 11.54 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -113.07 130.05 56.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.135 0.493 . . . . 0.0 110.6 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -77.88 112.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.54 -45.71 6.96 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.523 0.678 . . . . 0.0 110.178 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.1 m-20 -125.85 173.38 5.1 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -53.39 -43.53 56.63 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.377 2.052 . . . . 0.0 113.161 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 60.8 m-85 -105.43 -24.46 12.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 39.2 t80 -92.72 115.58 28.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -119.09 133.72 55.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 36.3 tt0 -126.98 146.68 50.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.784 0.266 . . . . 0.0 111.316 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 67.1 m -82.09 108.81 15.86 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.2 0.524 . . . . 0.0 111.477 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.001 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.38 141.58 43.24 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -76.0 158.19 32.21 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.78 0.8 . . . . 0.0 112.794 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -63.71 134.82 56.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 72.19 18.67 4.69 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.08 169.36 13.07 Favored Glycine 0 C--O 1.249 1.041 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -77.56 122.03 24.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 117.401 0.6 . . . . 0.0 109.901 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.4 p -99.96 7.65 44.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 119.0 91.03 1.35 Allowed Glycine 0 N--CA 1.423 -2.213 0 C-N-CA 118.236 -1.935 . . . . 0.0 113.146 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.9 -170.66 19.37 Favored Glycine 0 N--CA 1.422 -2.266 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 172.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 45.4 mt -62.22 123.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.582 ' O ' ' H2 ' ' A' ' 101' ' ' MAN . . . 100.66 -26.2 25.49 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.466 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 36.3 t80 -79.41 129.7 34.71 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -128.87 98.82 5.08 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.98 -136.78 3.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.468 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -69.57 120.8 7.56 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.859 2.373 . . . . 0.0 112.179 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -110.7 -17.13 13.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.939 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.89 113.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.99 167.32 22.02 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.104 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.52 162.67 7.85 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.066 0.546 . . . . 0.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 m -60.29 121.64 12.5 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.613 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.18 -3.92 57.01 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.939 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -119.12 142.45 47.91 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -118.02 142.77 47.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.9 t -81.63 98.13 8.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -105.89 132.85 51.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.38 115.64 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.56 -56.11 2.62 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.582 0.706 . . . . 0.0 109.75 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -111.18 171.98 3.9 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.88 -40.45 85.29 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 121.998 1.798 . . . . 0.0 112.744 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.601 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 78.9 m-85 -107.11 -23.79 12.17 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -91.49 114.8 27.43 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.095 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.2 m -118.02 138.47 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.419 HE21 HD21 ' A' ' 36' ' ' LEU . 30.4 tt0 -135.53 143.72 45.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 118.922 0.783 . . . . 0.0 112.121 -174.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 56.5 m -75.07 112.41 11.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.85 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 HD21 HE21 ' A' ' 34' ' ' GLN . 95.8 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.582 ' H2 ' ' O ' ' A' ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_